[
  {
    "question_number": "Q221",
    "question_text": "A 2-year-old baby with developmental delay has tonic-clonic seizures and drop seizures. What would you expect to find on the EEG?",
    "options": "{\"A\": \"3 Hz spike-and-wave discharges\", \"B\": \"Spike less than 2 seconds\", \"C\": \"Spike-and-wave complexes at 4-6 Hz\", \"D\": \"Hypsarrhythmia pattern\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Similar to Q145, this question asks about expected EEG findings in a child with developmental delay and multiple seizure types, likely pointing towards an epileptic encephalopathy like Lennox-Gastaut Syndrome.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q268",
    "question_text": "A medical patient with diabetes mellitus, hypertension, hyperlipidemia, osteoporosis, and on warfarin, what antiepileptic medication should be given?",
    "options": "{\"A\": \"Lamictal\", \"B\": \"Phenytoin\", \"C\": \"Carbamazepine\", \"D\": \"Valproic acid\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on selecting an appropriate AED considering patient comorbidities and potential drug interactions (especially warfarin).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q29",
    "question_text": "In a case scenario of a 30-year-old female patient with bizarre nocturnal movements, what is the likely localization of the seizure focus?",
    "options": "{\"A\": \"Frontal operculum\", \"B\": \"Dorsomedial (SMA)\", \"C\": \"Temporal lobe\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Relates seizure semiology (bizarre nocturnal movements) to the likely anatomical origin within the brain, characteristic of frontal lobe epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q72",
    "question_text": "What is the most common cause of sudden unexpected death in epilepsy?",
    "options": "{\"A\": \"Uncontrolled seizures\", \"B\": \"Status epilepticus\", \"C\": \"Drowning\", \"D\": \"Cardiac arrhythmia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly asks about the primary risk factor or cause associated with SUDEP.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q165",
    "question_text": "Patient with typical symptoms of Juvenile Myoclonic Epilepsy (JME), what is a characteristic feature?",
    "options": "{\"A\": \"Seizure induced by photic stimulation\", \"B\": \"Seizures occurring only during sleep\", \"C\": \"Progressive cognitive decline\", \"D\": \"Focal motor seizures without generalization\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the characteristic features and triggers (like photosensitivity) of Juvenile Myoclonic Epilepsy (JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q79",
    "question_text": "A 45-year-old female patient diagnosed with epilepsy is currently on Lacosamide 200 mg BID and Levetiracetam 1500 mg BID. She presented to the epilepsy outpatient clinic for evaluation. She reported a history of generalized seizure preceded by feelings of fear and palpitations. While in the clinic, she had a seizure episode that started with chewing spells and right hand automatism followed by bilateral generalized tonic-clonic seizure. She doesn\u2019t recall the event. Which of the following is the next step in management?",
    "options": "{\"A\": \"Video EEG\", \"B\": \"Routine EEG\", \"C\": \"Interictal SPECT\", \"D\": \"Ictal SPECT\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the diagnostic workup (specifically the type of EEG/monitoring) needed to characterize seizures and guide management in a patient with ongoing events despite medication.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q91",
    "question_text": "A patient has aphasia and multiple seizure types. What is the diagnosis?",
    "options": "{\"A\": \"Landau Kleffner Syndrome\", \"B\": \"Lennox-Gastaut Syndrome\", \"C\": \"West Syndrome\", \"D\": \"Temporal Lobe Epilepsy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis of a specific epilepsy syndrome (Landau-Kleffner) based on the combination of acquired aphasia and seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q252",
    "question_text": "A patient exhibits seizure semiology characterized by flexion in one limb with extension of the other limb and head turning to the extended limb. Where is the likely localization?",
    "options": "{\"A\": \"Orbitofrontal\", \"B\": \"Temporal\", \"C\": \"Dorsolateral frontal\", \"D\": \"SMA\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on specific motor semiology (asymmetric tonic posturing, often called \"fencing posture\"), commonly associated with the Supplementary Motor Area (SMA).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q148",
    "question_text": "In the scenario of an elderly patient with comorbidities including renal stones, heart failure, atrial fibrillation, and post-stroke seizures, what is the best AED to prescribe?",
    "options": "{\"A\": \"Lamictal\", \"B\": \"Phenytoin\", \"C\": \"Topamax\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Involves selecting an appropriate AED for post-stroke seizures, considering multiple comorbidities and potential side effects/interactions in an elderly patient.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q265",
    "question_text": "What is the least medication to interact with oral contraceptive pills (OCP)?",
    "options": "{\"A\": \"Keppra\", \"B\": \"Lamictal\", \"C\": \"Valproate\", \"D\": \"Topiramate\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the clinically important issue of drug interactions between AEDs and OCPs, focusing on identifying AEDs with minimal interaction potential.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q255",
    "question_text": "A scenario about a child who has an attack of stereotypical hyperkinetic behavior occurring during the night (EEG attached showed frontal discharge). What is the diagnosis?",
    "options": "{\"A\": \"Autosomal dominant frontal lobe epilepsy\", \"B\": \"Psychogenic\", \"C\": \"Night terrors\", \"D\": \"Sleepwalking\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Requires diagnosing a specific nocturnal epilepsy syndrome (likely Autosomal Dominant Nocturnal Frontal Lobe Epilepsy - ADNFLE) based on clinical description (stereotypical hyperkinetic nocturnal events) and EEG findings.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q136",
    "question_text": "Multiple seizure types refractory to AEDs",
    "options": "{\"A\": \"Indicates the need for increasing AED doses\", \"B\": \"Suggests drug-resistant epilepsy requiring specialist evaluation\", \"C\": \"Means seizures will resolve spontaneously over time\", \"D\": \"Implies non-epileptic seizures are present\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: This fragment points towards the definition or management implications of drug-resistant or refractory epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q11",
    "question_text": "In a case of catamenial seizures, which statement is true?",
    "options": "{\"A\": \"Estrogen will decrease the seizure threshold\", \"B\": \"Progesterone increases seizure frequency\", \"C\": \"Seizure frequency is unrelated to menstrual cycle\", \"D\": \"Testosterone has no effect on seizure threshold\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests understanding of the hormonal influences (specifically estrogen) on seizure threshold in the context of catamenial epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q70",
    "question_text": "A child who has 2 episodes of seizure, all occurring when he was in the train, associated with nausea and vomiting. EEG showed posterior discharges. What is the diagnosis?",
    "options": "{\"A\": \"Occipital seizure\", \"B\": \"Temporal lobe epilepsy\", \"C\": \"Generalized tonic-clonic seizure\", \"D\": \"Frontal lobe epilepsy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Requires diagnosis of a specific focal epilepsy type (occipital lobe epilepsy) based on clinical features (visual triggers/symptoms like nausea/vomiting) and EEG findings (posterior discharges).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q179",
    "question_text": "A child with recurrent staring episodes, myoclonus, and rare generalized tonic-clonic seizures (GTCs) is being treated. Which of the following anti-seizure medications will worsen his seizures?",
    "options": "{\"A\": \"Lamotrigine\", \"B\": \"Oxcarbazepine\", \"C\": \"Valproate\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of AED selection, specifically identifying medications (like sodium channel blockers, e.g., Oxcarbazepine) that can paradoxically worsen certain seizure types (like myoclonus in JME or similar syndromes).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q199",
    "question_text": "Which EEG finding has the best prognostic value in a 9-year-old boy who has frequent staring spells, especially at school?",
    "options": "{\"A\": \"Seizure onset\", \"B\": \"Absence seizure\", \"C\": \"Normal background activity\", \"D\": \"Generalized delta waves\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on interpreting EEG findings (specifically background activity) for prognostic purposes in a child with suspected absence epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q2",
    "question_text": "An elderly woman with diabetes mellitus, hypertension, and atrial fibrillation had an episode of syncope followed by convulsions. The episode was witnessed by her family, who reported that she was confused for a short period afterward. Upon presentation to the emergency department, her blood pressure was 90/70, and she was fatigued but conscious and oriented. Which of the following will help you with the diagnosis?",
    "options": "{\"A\": \"Rhythmic clonus\", \"B\": \"Multifocal myoclonus\", \"C\": \"Oral automatism\", \"D\": \"Up rolling of eyes\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on differentiating convulsive syncope from an epileptic seizure based on specific clinical signs observed during or after the event (e.g., rhythmic clonus, automatisms suggest seizure; brief confusion can occur in both but may be longer post-seizure). The core is distinguishing seizure phenomena.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q280",
    "question_text": "A pregnant lady post tumor resection on oral contraceptive pills (OCP) and known to have seizures. Which of the following antiepileptic drugs (AED) would be least likely to interact with her oral contraceptive pills?",
    "options": "{\"A\": \"Levetiracetam\", \"B\": \"Carbamazepine\", \"C\": \"Lamotrigine\", \"D\": \"Zonisamide\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Similar to Q265, this question tests knowledge of AED-OCP interactions, asking to identify an AED with low interaction potential (Levetiracetam).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q151",
    "question_text": "In a scenario of uncontrolled epilepsy on 2 AEDs, what is the next step?",
    "options": "{\"A\": \"Refer to surgery\", \"B\": \"Vagal nerve stimulation\", \"C\": \"Add another AED\", \"D\": \"Optimize current AED doses\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses the management pathway for drug-resistant epilepsy, evaluating options like adding more medication versus considering surgical or neuromodulation therapies.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q289",
    "question_text": "What factors favor seizures over syncope?",
    "options": "{\"A\": \"Cyanosis\", \"B\": \"Absence of tonic-clonic seizures\", \"C\": \"Precipitated by intense fear\", \"D\": \"Postictal confusion\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the clinical features used to differentiate epileptic seizures from syncope, focusing on identifying factors more suggestive of seizure (e.g., specific triggers like intense fear can sometimes precipitate psychogenic non-epileptic seizures or rarely true epileptic seizures, while cyanosis can occur in both but might be more prolonged/central in seizure).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q181",
    "question_text": "A lady with diabetes mellitus on multiple anti-diabetic medications, hypertension, and osteoporosis has complex partial epilepsy. What medications will you give?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Valproic acid\", \"C\": \"Lamotrigine\", \"D\": \"Phenytoin\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on AED selection for focal epilepsy (complex partial) in a patient with significant comorbidities, requiring consideration of side effect profiles and drug interactions.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q182",
    "question_text": "Characteristic of temporal lobe epilepsy:",
    "options": "{\"A\": \"Ipsilateral nose rubbing\", \"B\": \"Asymmetric tonic limb posturing\", \"C\": \"Prolonged postictal state\", \"D\": \"Automatisms such as lip-smacking\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of specific seizure semiology associated with temporal lobe epilepsy (e.g., prolonged postictal state, certain automatisms - though nose rubbing is often contralateral).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q46",
    "question_text": "What is the most common type of aura in mesial temporal lobe (MTL) seizures?",
    "options": "{\"A\": \"Visual aura\", \"B\": \"Auditory aura\", \"C\": \"Epigastric rising sensation\", \"D\": \"Olfactory aura\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the characteristic initial symptom (aura) associated with seizures originating in the mesial temporal lobe.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q75",
    "question_text": "In a patient with seizures that include myoclonic jerks, which medication is appropriate to prescribe?",
    "options": "{\"A\": \"Lacosamide\", \"B\": \"Valproic acid (VPA)\", \"C\": \"Levetiracetam (LEV)\", \"D\": \"Topiramate\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on selecting an appropriate broad-spectrum AED (like VPA, LEV, Topiramate) for a patient presenting with myoclonic seizures, avoiding drugs that might worsen them.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q27",
    "question_text": "A young female epileptic patient on Topamax has decreased concentration. What should she be switched to?",
    "options": "{\"A\": \"Lamotrigine\", \"B\": \"Phenytoin\", \"C\": \"Lacosamide\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with managing AED side effects (cognitive issues with topiramate) by switching to an alternative medication with a potentially better cognitive profile.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q150",
    "question_text": "Lennox-Gastaut syndrome is characterized by which of the following triad?",
    "options": "{\"A\": \"Absence seizures, 3 Hz spike-and-wave EEG, normal intelligence\", \"B\": \"Infantile spasms, hypsarrhythmia on EEG, developmental regression\", \"C\": \"Multiple seizure types, slow spike-and-wave EEG pattern, cognitive impairment\", \"D\": \"Focal seizures, temporal lobe EEG abnormalities, normal development\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the defining clinical and/or EEG features (triad) of Lennox-Gastaut syndrome, a specific epilepsy syndrome.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q201",
    "question_text": "A young female with epilepsy on Topamax has worsened difficulty concentrating. Which choice is the best for her?",
    "options": "{\"A\": \"Lamotrigine\", \"B\": \"Zonisamide\", \"C\": \"Valproate\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Similar to Q27, this question addresses the management of cognitive side effects from Topamax by selecting an alternative AED.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q30",
    "question_text": "In a case of Mesial Temporal Lobe Epilepsy (MTLE), a patient is on the maximum dose of Keppra. What is the next recommended medication?",
    "options": "{\"A\": \"Tegretol\", \"B\": \"Phenytoin\", \"C\": \"Lamictal\", \"D\": \"Valproate\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the sequential addition or substitution of AEDs in managing focal epilepsy (MTLE) when the first-line agent (Keppra/Levetiracetam) is insufficient.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q137",
    "question_text": "What\u2019s the EEG finding of Juvenile Myoclonic Epilepsy (JME)?",
    "options": "{\"A\": \"3 Hz spike and wave\", \"B\": \"4-6 Hz poly spike and wave\", \"C\": \"Generalized slow wave\", \"D\": \"Focal temporal spikes\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the characteristic EEG pattern associated with Juvenile Myoclonic Epilepsy (JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q291",
    "question_text": "In a case of laryngeal spasm, what is the localization of the seizure?",
    "options": "{\"A\": \"Insula\", \"B\": \"Temporal lobe\", \"C\": \"Frontal operculum\", \"D\": \"Parietal lobe\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Relates a specific, less common seizure manifestation (laryngeal spasm/ictal cough/vocalization) to its likely brain localization (often insular or peri-opercular cortex).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q56",
    "question_text": "A pregnant lady with epilepsy on valproic acid wants to change her medication. Which of the following is a suitable alternative?",
    "options": "{\"A\": \"Carbamazepine (CBZ)\", \"B\": \"Lamotrigine (LTG)\", \"C\": \"Levetiracetam (LEV)\", \"D\": \"Phenytoin\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on AED management during pregnancy, specifically switching from a high-risk drug (valproic acid) to safer alternatives.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q218",
    "question_text": "In a pregnant patient with seizures, which statement is true?",
    "options": "{\"A\": \"Lamotrigine clearance increases in the 1st and 2nd trimester\", \"B\": \"Levetiracetam is the safest medication during pregnancy\", \"C\": \"Valproate is the first-line treatment\", \"D\": \"All antiepileptic drugs are safe during pregnancy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge about pharmacokinetic changes of AEDs during pregnancy (specifically lamotrigine clearance) and relative safety profiles.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q28",
    "question_text": "The patient, an alcoholic with a known case of epilepsy on antiepileptic medication (ASM), came with an active seizure. After being loaded with IV VPA, he was agitated and then had a decreased level of consciousness. What should be done next?",
    "options": "{\"A\": \"Send for ETOH level\", \"B\": \"Send for ammonia level\", \"C\": \"Administer intravenous glucose\", \"D\": \"Intubate and provide supportive care\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Deals with the acute management of a seizure patient with potential complications related to medication (VPA-induced hyperammonemia) and underlying conditions (alcoholism).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q191",
    "question_text": "A 53-year-old male who presented with a first-time generalized tonic-clonic seizure, normal physical examination, and normal EEG, with no family history of epilepsy, what is his risk of seizure recurrence?",
    "options": "{\"A\": \"10%\", \"B\": \"30%\", \"C\": \"50%\", \"D\": \"70%\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Assesses knowledge of seizure recurrence risk after a first unprovoked seizure in an adult with normal investigations.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q200",
    "question_text": "A young lady diagnosed with mesial temporal lobe epilepsy (MTLE) is on lamotrigine and carbamazepine. Her last generalized tonic-clonic seizure was a couple of months ago, but she presents to the clinic with episodes of partial unaware seizures occurring four times a month. What is the best next step?",
    "options": "{\"A\": \"Adjust lamotrigine dosage\", \"B\": \"Shift to another combination\", \"C\": \"Start epilepsy surgery workup\", \"D\": \"Add clobazam as adjunctive therapy\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the management strategy for medically refractory focal epilepsy (MTLE), specifically deciding when to consider epilepsy surgery evaluation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q16",
    "question_text": "A patient has a history of new onset of generalized tonic-clonic seizures (GTCs) and an EEG picture. What medication will you start?",
    "options": "{\"A\": \"Levetiracetam\", \"B\": \"Valproic acid\", \"C\": \"Carbamazepine\", \"D\": \"Phenytoin\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Concerns the initial choice of AED for generalized tonic-clonic seizures, likely based on interpreting an unseen EEG provided with the original question.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q59",
    "question_text": "Patient with seizure; EEG showed multifocal spikes. What is the surgery for this patient?",
    "options": "{\"A\": \"VNS (Vagus Nerve Stimulation)\", \"B\": \"Temporal lobectomy\", \"C\": \"Corpus callosotomy\", \"D\": \"Responsive neurostimulation (RNS)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses surgical/neuromodulation options (VNS) for patients with epilepsy characterized by multifocal EEG abnormalities, where resective surgery is often not feasible.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q266",
    "question_text": "A young lady who underwent tumor resection presented with a staring spell and loss of awareness. What is the seizure classification?",
    "options": "{\"A\": \"Focal motor onset with impaired awareness\", \"B\": \"Absence seizure\", \"C\": \"Unknown onset\", \"D\": \"Focal non-motor onset with impaired awareness\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to classify a seizure based on its clinical description (staring, loss of awareness) according to the current ILAE classification system, likely indicating a focal non-motor onset seizure with impaired awareness.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q284",
    "question_text": "Patient with MTS seizure; EEG showed left temporal discharges; what symptoms does he have?",
    "options": "{\"A\": \"Left automatism\", \"B\": \"Right hemiparesis\", \"C\": \"Visual field defect\", \"D\": \"Aphasia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: This appears to be a duplicate or very similar question to Q161, focusing on correlating EEG findings in MTS with expected seizure semiology.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q177",
    "question_text": "A child with continuous jerky movement of the right arm for a prolonged time developed mild weakness of the right arm. Brain MRI reported left perisylvian atrophy. What is expected to be found?",
    "options": "{\"A\": \"Focal cortical dysplasia\", \"B\": \"Rasmussen encephalitis\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"Hemimegalencephaly\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes Epilepsia Partialis Continua (EPC) with resulting Todd's paresis and associated structural abnormality (atrophy), focusing on the clinical and imaging features of this specific epilepsy presentation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q222",
    "question_text": "What is the effect of hyperventilation on EEG?",
    "options": "{\"A\": \"Frontal theta/delta slowing\", \"B\": \"Generalized delta slowing\", \"C\": \"Increased alpha rhythm\", \"D\": \"Focal spike activity\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the physiological effects of activation procedures (hyperventilation) used during an EEG recording.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q10",
    "question_text": "A 22-year-old woman with a history of epilepsy on topiramate is now complaining of difficulty in concentration and cognitive functions. What is the best option for her management?",
    "options": "{\"A\": \"Lacosamide\", \"B\": \"Zonisamide\", \"C\": \"Lamotrigine\", \"D\": \"Valproic acid\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Similar to Q27 and Q201, addresses managing cognitive side effects of Topiramate by choosing an alternative AED.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q256",
    "question_text": "A video of a patient with bizarre movements during sleep is presented. What classification does this fall under according to the definition of epilepsy?",
    "options": "{\"A\": \"Bizarre focal\", \"B\": \"Focal motor with impaired awareness\", \"C\": \"Generalized tonic-clonic\", \"D\": \"Absence seizure\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Involves classifying seizures based on observed semiology (bizarre nocturnal movements), likely representing focal motor seizures typical of nocturnal frontal lobe epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q134",
    "question_text": "Regarding mesial temporal sclerosis, which statement is true?",
    "options": "{\"A\": \"History of epilepsy\", \"B\": \"History of febrile seizure\", \"C\": \"Typically presents with sudden onset hemiparesis\", \"D\": \"Commonly associated with multiple sclerosis\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the common historical associations and risk factors for developing mesial temporal sclerosis (MTS), particularly a history of prolonged febrile seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q131",
    "question_text": "In a focal aware seizure, which antiepileptic medication (ASM) is commonly used?",
    "options": "{\"A\": \"LCM (Lacosamide)\", \"B\": \"VPA (Valproic Acid)\", \"C\": \"CBZ (Carbamazepine)\", \"D\": \"LEV (Levetiracetam)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about appropriate AED choices for treating focal onset aware seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q166",
    "question_text": "A child brought to you with a decrease in understanding of language and partial aphasia has recurrent seizures at night. EEG during sleep showed continuous spike and wave discharges. What is the most likely diagnosis?",
    "options": "{\"A\": \"Landau-Kleffner syndrome\", \"B\": \"Benign Rolandic epilepsy\", \"C\": \"Lennox-Gastaut syndrome\", \"D\": \"Childhood absence epilepsy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes classic features of Landau-Kleffner syndrome, an epileptic encephalopathy, focusing on seizure type, EEG findings, and associated cognitive decline.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q196",
    "question_text": "A 23-year-old female is brought to the clinic by her husband, who states she has hyperactive jerky movements, especially during sleep. EEG shows frontal lobe epileptic spikes in waves. What is the best medication for her?",
    "options": "{\"A\": \"Valproate\", \"B\": \"Phenytoin\", \"C\": \"Lacosamide\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "D",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on selecting the appropriate anti-epileptic drug (AED) based on seizure semiology (suggestive of frontal lobe origin) and EEG findings.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q211",
    "question_text": "In a patient with a history of moderate head trauma from a motor vehicle accident, for how long does the risk of seizure persist?",
    "options": "{\"A\": \"2 years\", \"B\": \"5 years\", \"C\": \"10 years\", \"D\": \"15 years\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge about the long-term risk of developing post-traumatic epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q13",
    "question_text": "What is the percentage of juvenile myoclonic epilepsy (JME) patients that will be seizure-free without treatment?",
    "options": "{\"A\": \"15-30%\", \"B\": \"40-50%\", \"C\": \"60-70%\", \"D\": \"80-90%\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the natural history and prognosis of a specific epilepsy syndrome (JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q4",
    "question_text": "A 30-year-old patient with seizures controlled on antiepileptic drugs (AED) developed facial redness and fatigue. What is the likely AED?",
    "options": "{\"A\": \"Vigabatrin\", \"B\": \"Felbamate\", \"C\": \"Phenytoin\", \"D\": \"Valproic acid\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on identifying an AED based on its specific side effect profile.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q349",
    "question_text": "A patient with mesial temporal lobe (MTL) epilepsy on two AEDs came to the clinic. What is the reason for her breakthrough seizure?",
    "options": "{\"A\": \"Non-compliance with medication\", \"B\": \"Subtherapeutic drug levels\", \"C\": \"Progression of MTL epilepsy\", \"D\": \"Intercurrent illness\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses common reasons for treatment failure in epilepsy, specifically differentiating non-compliance from drug-resistant epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q153",
    "question_text": "What is the mean age of onset for Landau-Kleffner syndrome?",
    "options": "{\"A\": \"2 years\", \"B\": \"5.5 years\", \"C\": \"10 years\", \"D\": \"13 years\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests epidemiological knowledge (age of onset) of a specific epileptic encephalopathy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q25",
    "question_text": "A patient came to the emergency room with multiple episodes of decreased level of consciousness. What is the most important indicator that you need to start antiepileptic drugs (AED)?",
    "options": "{\"A\": \"Up rolling of eyes\", \"B\": \"Lack of awareness\", \"C\": \"Postictal confusion\", \"D\": \"Generalized tonic-clonic (GTC) seizure\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on clinical decision-making regarding the initiation of AED therapy based on seizure characteristics distinguishing epileptic seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q26",
    "question_text": "A patient with a seizure scenario is asked about the best EEG predictor for good prognosis. Which of the following is the best predictor?",
    "options": "{\"A\": \"Abrupt seizure activity\", \"B\": \"Slowing\", \"C\": \"Normal background\", \"D\": \"Periodic lateralized epileptiform discharges\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of EEG interpretation and its prognostic value in epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q167",
    "question_text": "A young lady with epilepsy on lamotrigine wants to start oral contraceptive pills (OCP). What should you recommend for her?",
    "options": "{\"A\": \"No effect by OCP, she can start\", \"B\": \"Lamotrigine will decrease efficacy of OCP\", \"C\": \"Increase lamotrigine by 2 folds\", \"D\": \"Increase lamotrigine by 4 folds\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with drug interactions between AEDs (lamotrigine) and OCPs, a common clinical scenario in managing epilepsy in women.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q269",
    "question_text": "Patient with absence seizure; what is the medication that worsens the seizure?",
    "options": "{\"A\": \"Oxycarbazepine\", \"B\": \"Ethosuximide\", \"C\": \"Valproic acid\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of AEDs that can paradoxically worsen specific seizure types (absence seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q294",
    "question_text": "In early myoclonic encephalopathy with migrating myoclonus that then became more generalized, what is the EEG finding?",
    "options": "{\"A\": \"Burst suppression\", \"B\": \"Hypsarrhythmia\", \"C\": \"Generalized spike-and-wave discharges\", \"D\": \"Focal slowing\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses knowledge of characteristic EEG patterns associated with specific severe early-onset epileptic encephalopathies.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q11",
    "question_text": "A young female epileptic patient on Topamax has decreased concentration. What should be switched to?",
    "options": "{\"A\": \"Lamotrigine\", \"B\": \"Phenytoin\", \"C\": \"Lacosamide\", \"D\": \"Zonisamide\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on managing AED side effects (cognitive effects of topiramate) by selecting an alternative AED.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q82",
    "question_text": "In a case involving MRI findings consistent with Mesial Temporal Lobe Epilepsy (MTLE), what type of aura might the patient experience?",
    "options": "{\"A\": \"Cephalic\", \"B\": \"Visual\", \"C\": \"Auditory\", \"D\": \"Olfactory\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links a specific type of epilepsy (MTLE) with characteristic seizure semiology (aura type).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q202",
    "question_text": "A seizure described as early non-focal right head turning with right hand automatism. What is the localization?",
    "options": "{\"A\": \"Right frontal lobe\", \"B\": \"Right temporal lobe\", \"C\": \"Left temporal lobe\", \"D\": \"Left frontal lobe\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on clinical semiology.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q185",
    "question_text": "A female patient known to have complex partial seizures with generalized tonic-clonic (GTC) seizures occurring twice per week. EEG shows temporal spikes and MRI reveals mesial temporal sclerosis. After trying Dilantin (phenytoin) without improvement, she started on carbamazepine and Keppra. After one year of follow-up, she reports improvement in complex partial seizures and no GTC seizures, with attacks occurring once per month. What is the next appropriate management?",
    "options": "{\"A\": \"Follow up after 6 months and adjust the AED\", \"B\": \"Send for pre-surgical evaluation\", \"C\": \"Add a third drug (Depakene)\", \"D\": \"Vagus nerve stimulation\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the management algorithm for drug-resistant epilepsy (specifically MTLE), including consideration for surgical evaluation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q278",
    "question_text": "Which factors favor seizures over syncope?",
    "options": "{\"A\": \"Cyanosis\", \"B\": \"Tongue biting\", \"C\": \"Postictal confusion\", \"D\": \"Incontinence\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of clinical features used to differentiate epileptic seizures from syncope.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q274",
    "question_text": "Patient has focal seizure on treatment and he is well controlled. What is the favorable outcome in this patient?",
    "options": "{\"A\": \"One type seizure\", \"B\": \"Normal neurological examination\", \"C\": \"No seizure recurrence for at least 2 years\", \"D\": \"Good response to first antiepileptic drug\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses understanding of prognostic factors in epilepsy, specifically factors associated with good treatment response.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q271",
    "question_text": "Male patient has migraine and seizure; what medications will you give?",
    "options": "{\"A\": \"Valproic acid\", \"B\": \"Carbamazepine\", \"C\": \"Topiramate\", \"D\": \"Phenytoin\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on selecting an AED (Valproic acid) that can treat co-existing epilepsy and migraine.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q282",
    "question_text": "Patient with MTS seizure on Topamax 200mg BID and Carbamazepine 400mg BID; his seizure is still not controlled; what will you do?",
    "options": "{\"A\": \"Increase Carbamazepine dose\", \"B\": \"Refer to surgery\", \"C\": \"Add a benzodiazepine as adjunct therapy\", \"D\": \"Switch Topamax to Levetiracetam\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the management of drug-resistant Mesial Temporal Sclerosis (MTS) epilepsy, considering dose adjustment versus surgical referral.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q21",
    "question_text": "An 18-year-old girl with MTLE is on lacosamide 200 mg BID, but her seizures remain uncontrolled. What is the best course of action?",
    "options": "{\"A\": \"Increase the lacosamide dose\", \"B\": \"Add carbamazepine\", \"C\": \"Add valproic acid\", \"D\": \"Refer for surgical evaluation\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the management strategy for uncontrolled Mesial Temporal Lobe Epilepsy (MTLE), weighing options like dose increase, adding AEDs, or surgical evaluation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q210",
    "question_text": "A slow EEG is most commonly associated with which condition?",
    "options": "{\"A\": \"Landau-Kleffner syndrome\", \"B\": \"Lennox-Gastaut syndrome (LGS)\", \"C\": \"Ohtahara syndrome\", \"D\": \"West syndrome\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of characteristic EEG findings (slow spike-wave) associated with specific epileptic encephalopathies, particularly LGS.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q240",
    "question_text": "In a case of status epilepticus, when will the compensatory mechanisms fail?",
    "options": "{\"A\": \"5 min\", \"B\": \"10 min\", \"C\": \"30-60 min\", \"D\": \"15 min\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses understanding of the pathophysiology and temporal progression of status epilepticus.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q142",
    "question_text": "A patient with Juvenile Myoclonic Epilepsy (JME) on a single AED has been seizure-free for the last 2 years. They come to the clinic and ask about the possibility of stopping the medication. What would you do?",
    "options": "{\"A\": \"Stop the AED (or start tapering)\", \"B\": \"Order EEG to aid in the management\", \"C\": \"Educate the patient on the need for lifelong medication for JME\", \"D\": \"Refer to a specialist\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on long-term management and counseling regarding AED discontinuation in JME, known for its high relapse rate.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q192",
    "question_text": "Which antiepileptic drugs (AEDs) exacerbate myoclonus?",
    "options": "{\"A\": \"Phenobarbital\", \"B\": \"Carbamazepine\", \"C\": \"Phenytoin\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of AED selection, specifically identifying drugs that can worsen myoclonic seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q251",
    "question_text": "What is the effect of phenytoin when taken with valproic acid?",
    "options": "{\"A\": \"Increase the phenytoin level\", \"B\": \"Decrease the phenytoin level\", \"C\": \"No significant interaction\", \"D\": \"Increase the valproic acid level\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge of pharmacokinetic interactions between commonly used AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q147",
    "question_text": "A patient who has mesial temporal lobe epilepsy (MTLE) and is on 2 antiepileptic drugs (AEDs) presents to the clinic for follow-up. He has around 1-2 attacks every few months. What would you do next?",
    "options": "{\"A\": \"Add a third medication\", \"B\": \"Send the patient for Video EEG\", \"C\": \"Change nothing and give an appointment for follow-up in 6 months\", \"D\": \"Anterior temporal lobectomy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the management of drug-resistant MTLE, considering surgical options when seizures persist despite multiple AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient on three antiepileptic medications is not improving. What is the recommended next step?",
    "options": "{\"A\": \"Refer to surgery\", \"B\": \"Increase medication dosage\", \"C\": \"Change medication\", \"D\": \"Add another antiepileptic\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the definition and management pathway for drug-resistant epilepsy, highlighting surgical evaluation as a key step.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q226",
    "question_text": "A patient presents with epileptic spasms and EEG showing hypsarrhythmia. What is the diagnosis?",
    "options": "{\"A\": \"Hypsarrhythmia\", \"B\": \"Lennox-Gastaut syndrome\", \"C\": \"Infantile spasms\", \"D\": \"Focal seizures\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to diagnose Infantile Spasms (West Syndrome) based on the classic triad of spasms, developmental delay (implied), and hypsarrhythmia on EEG.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q8",
    "question_text": "Which of the following antiepileptic drugs (AEDs) is known to worsen myoclonic seizures?",
    "options": "{\"A\": \"Phenobarbital\", \"B\": \"Carbamazepine\", \"C\": \"Gabapentin\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of AEDs contraindicated or known to exacerbate specific seizure types (myoclonic seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q19",
    "question_text": "What is the risk of recurrence for febrile seizures in the future?",
    "options": "{\"A\": \"Approximately 10%\", \"B\": \"Approximately 30%\", \"C\": \"Approximately 50%\", \"D\": \"Approximately 70%\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses knowledge regarding the prognosis and recurrence risk specifically associated with febrile seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q107",
    "question_text": "Which area, if removed by surgery, will result in seizure freedom?",
    "options": "{\"A\": \"Epileptogenic zone\", \"B\": \"Ictal onset zone\", \"C\": \"Irritative zone\", \"D\": \"Symptomatogenic zone\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests understanding of core concepts and terminology used in epilepsy surgery planning (definition of the epileptogenic zone).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q246",
    "question_text": "In a case scenario of juvenile myoclonic epilepsy (JME), what is a characteristic feature?",
    "options": "{\"A\": \"Photosensitivity\", \"B\": \"Progressive memory loss\", \"C\": \"Unilateral weakness\", \"D\": \"Sensory ataxia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses knowledge of specific clinical features (photosensitivity) characteristic of JME.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q198",
    "question_text": "A young male with nocturnal hyperkinetic movements at night, facial clonic spells, and profuse salivation sometimes evolves to generalized tonic-clonic seizures. A diagnosis of epilepsy was established. Where is the site of seizure focus?",
    "options": "{\"A\": \"Orbitofrontal area\", \"B\": \"Frontal operculum\", \"C\": \"SMA\", \"D\": \"Dorsolateral prefrontal\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on localizing seizure onset based on characteristic nocturnal hypermotor and autonomic semiology (suggestive of frontal operculum).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q184",
    "question_text": "A patient experiences an episode of upraising gastric sensation followed by laryngeal constriction. What is the localization?",
    "options": "{\"A\": \"Insular\", \"B\": \"Temporal lobe\", \"C\": \"Frontal lobe\", \"D\": \"Parietal lobe\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on specific aura semiology (epigastric rising, laryngeal constriction suggesting insular involvement).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q218",
    "question_text": "A known case of epilepsy in a female patient on lamotrigine wants to start on oral contraceptive pills (OCP); what will you tell her?",
    "options": "{\"A\": \"Double the lamotrigine dose\", \"B\": \"Stop lamotrigine before starting OCP\", \"C\": \"No change in lamotrigine dose is needed\", \"D\": \"Switch to a non-hormonal contraceptive method\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with drug interactions between AEDs (lamotrigine) and OCPs, requiring dose adjustment. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q167",
    "question_text": "Which cranial nerve is primarily responsible for the sense of smell?",
    "options": "{\"A\": \"Optic nerve (CN II)\", \"B\": \"Olfactory nerve (CN I)\", \"C\": \"Trigeminal nerve (CN V)\", \"D\": \"Facial nerve (CN VII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q149",
    "question_text": "Landau-Kleffner syndrome (LKS) is also known as:",
    "options": "{\"A\": \"Childhood absence epilepsy\", \"B\": \"Acquired epileptic aphasia\", \"C\": \"Juvenile myoclonic epilepsy\", \"D\": \"Temporal lobe epilepsy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of synonyms or alternative names for specific epilepsy syndromes (LKS = acquired epileptic aphasia).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q100",
    "question_text": "What is the AED that has the highest concentration in breast milk?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Valproate\", \"C\": \"Levetiracetam\", \"D\": \"Phenobarbital\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Assesses knowledge of AED pharmacokinetics related to breastfeeding safety.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q20",
    "question_text": "What is the next step in the management of a patient with refractory epilepsy?",
    "options": "{\"A\": \"Increase current medication dosage\", \"B\": \"Change to a different medication\", \"C\": \"Refer for surgical evaluation\", \"D\": \"Initiate a ketogenic diet\"}",
    "correct_answer": "C",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the definition and management steps for refractory epilepsy, highlighting non-pharmacological options like surgery or diet.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q170",
    "question_text": "A three-month-old baby with early myoclonic encephalopathy had migrating myoclonic seizures that then became more generalized. EEG was done; what is expected to be seen?",
    "options": "{\"A\": \"2 Hz epileptic activity\", \"B\": \"Burst suppression\", \"C\": \"3 second spike and wave\", \"D\": \"Hypsarrhythmia\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of characteristic EEG patterns (burst suppression) in specific severe early-onset epileptic encephalopathies. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q294",
    "question_text": "Which cranial nerve is primarily responsible for the sense of smell?",
    "options": "{\"A\": \"Optic nerve (CN II)\", \"B\": \"Olfactory nerve (CN I)\", \"C\": \"Trigeminal nerve (CN V)\", \"D\": \"Facial nerve (CN VII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q94",
    "question_text": "Patient has focal seizure on treatment and he is well controlled. What is the favorable outcome in this patient?",
    "options": "{\"A\": \"One type seizure\", \"B\": \"Multiple types of seizures\", \"C\": \"Frequent breakthrough seizures\", \"D\": \"Development of status epilepticus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses understanding of prognostic factors in epilepsy. Same question text as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q274",
    "question_text": "Which of the following is the most common cause of ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q36",
    "question_text": "A female patient with epilepsy is on two antiepileptic drugs (AEDs) but is still not controlled. She wants to try a newly released AED. What considerations should be taken into account?",
    "options": "{\"A\": \"Needs Saudi FDA approval\", \"B\": \"Not to interfere with pregnancy\", \"C\": \"Not to have drug-drug interactions\", \"D\": \"Not to elevate her liver enzymes\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on practical considerations when choosing and prescribing AEDs, especially newer agents, including interactions, safety (pregnancy, liver), and regulatory aspects.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q152",
    "question_text": "In the scenario of an elderly patient with comorbidities and polypharmacy who has had frequent seizures in the last 2 years, which drug is the best option considering drug interactions?",
    "options": "{\"A\": \"Lamictal\", \"B\": \"Levetiracetam\", \"C\": \"Phenytoin\", \"D\": \"Topamax\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on AED selection strategy in a specific population (elderly with polypharmacy), emphasizing the importance of minimizing drug-drug interactions (favoring Levetiracetam).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q175",
    "question_text": "A young man with a known case of epilepsy describes his seizure as starting with laryngeal constriction, followed by other symptoms until a generalized tonic-clonic seizure occurs. Where is the likely localization of the seizure focus?",
    "options": "{\"A\": \"Insular\", \"B\": \"Temporal lobe\", \"C\": \"Frontal lobe\", \"D\": \"Parietal lobe\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on specific aura semiology (laryngeal constriction suggesting insular involvement). Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q184",
    "question_text": "Which cranial nerve is primarily responsible for the sense of smell?",
    "options": "{\"A\": \"Optic nerve (CN II)\", \"B\": \"Olfactory nerve (CN I)\", \"C\": \"Trigeminal nerve (CN V)\", \"D\": \"Facial nerve (CN VII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q144",
    "question_text": "A patient in the clinic has continuous facial jerks and hand jerks (partial continua). How should you treat this condition?",
    "options": "{\"A\": \"IV valproic acid\", \"B\": \"IV diazepam\", \"C\": \"IV phenytoin\", \"D\": \"Lamictal\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the management of epilepsia partialis continua (EPC), a form of focal status epilepticus.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q1",
    "question_text": "Which of these is a characteristic of Lennox-Gastaut syndrome (LGS)?",
    "options": "{\"A\": \"Resistant to antiepileptic medications\", \"B\": \"Peak onset 5-10 years\", \"C\": \"Multiple seizure types including tonic and atonic seizures\", \"D\": \"Slow spike-and-wave pattern on EEG\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of key features (drug resistance, age of onset) of a specific epilepsy syndrome (LGS).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q386",
    "question_text": "A long scenario describes a patient with nocturnal epilepsy characterized by brief, abrupt onset seizures lasting less than 1 minute, with hyperkinetic asymmetrical extension of limbs. The patient also experiences morning seizures with an aura. What is the localization of the seizures?",
    "options": "{\"A\": \"Temporal lobe\", \"B\": \"Occipital lobe\", \"C\": \"Frontal lobe\", \"D\": \"Parietal lobe\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on localizing seizure onset based on characteristic nocturnal hypermotor semiology (likely frontal lobe epilepsy).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q264",
    "question_text": "In the same scenario, what should be done next based on the EEG findings indicating nonconvulsive status epilepticus (NCSE)?",
    "options": "{\"A\": \"Give Keppra IV\", \"B\": \"Loading phenytoin\", \"C\": \"Administer lorazepam IV\", \"D\": \"Initiate continuous EEG monitoring\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the acute management of nonconvulsive status epilepticus (NCSE) identified on EEG.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q248",
    "question_text": "A patient experiences seizures with choking. Where is the likely localization of the seizure focus?",
    "options": "{\"A\": \"Mesial temporal sclerosis\", \"B\": \"Insula\", \"C\": \"Frontal lobe\", \"D\": \"Parietal lobe\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on specific semiology (choking sensation, potentially suggesting insular or temporal involvement).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q288",
    "question_text": "In a case scenario typical of childhood absence epilepsy, which antiepileptic medication will worsen his seizures?",
    "options": "{\"A\": \"Trileptal\", \"B\": \"Ethosuximide\", \"C\": \"Valproic acid\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of AEDs (Oxcarbazepine/Trileptal) that can worsen absence seizures. Similar concept to",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q263",
    "question_text": "A child is experiencing repeated staring episodes (absence seizures) at home and school. What is the first-line treatment?",
    "options": "{\"A\": \"Ethosuximide\", \"B\": \"Valproic acid\", \"C\": \"Carbamazepine\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the first-line pharmacological treatment for childhood absence epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q140",
    "question_text": "A pregnant lady on a low dose of levetiracetam is sleeping well and has good compliance, but is still having seizures. What do you want to add?",
    "options": "{\"A\": \"Lamictal\", \"B\": \"Valproic acid\", \"C\": \"Topamax\", \"D\": \"Phenytoin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses the management of epilepsy during pregnancy, specifically choosing an additional AED when the first-line agent is insufficient, considering teratogenic risks.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q74",
    "question_text": "In a similar scenario, the patient experiences loss of awareness and sometimes tonic-clonic seizures (TCS) with a normal interictal EEG and normal MRI. What is the next step?",
    "options": "{\"A\": \"Video EEG\", \"B\": \"Interictal PET\", \"C\": \"Repeat MRI with epilepsy protocol\", \"D\": \"Start empirical antiepileptic treatment\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the diagnostic workup for epilepsy when initial tests (interictal EEG, MRI) are unrevealing, highlighting the utility of video EEG monitoring.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q23",
    "question_text": "A patient with a new onset seizure and a normal neurological examination presents. What will carry the highest risk of recurrence?",
    "options": "{\"A\": \"Family history of epilepsy\", \"B\": \"History of febrile seizures\", \"C\": \"Abnormal EEG findings\", \"D\": \"Presence of a structural brain lesion\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses knowledge of risk factors that predict seizure recurrence after a first unprovoked seizure.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q155",
    "question_text": "A young patient with a 10-year history of focal seizures on treatment has been seizure-free for 2 years. What is the best predictor of seizure remission?",
    "options": "{\"A\": \"Long duration of active disease\", \"B\": \"Short duration of seizure remission\", \"C\": \"Having one type of seizure\", \"D\": \"Early response to antiepileptic drugs\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of factors predicting successful AED withdrawal and long-term seizure remission.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q49",
    "question_text": "Patient came with absence seizure with rare GTC; EEG showed 3Hz. What are the other associated symptoms this patient can have?",
    "options": "{\"A\": \"Eyelid myotonia\", \"B\": \"Ataxia\", \"C\": \"Visual aura\", \"D\": \"Muscle weakness\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on recognizing associated features (eyelid myoclonia/myotonia) within specific epilepsy syndromes (like Juvenile Absence Epilepsy or Jeavons syndrome) characterized by absence and GTC seizures with 3Hz EEG.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q154",
    "question_text": "After moderate traumatic brain injury and an episode of transient global amnesia, for how long does the risk of seizure persist?",
    "options": "{\"A\": \"Up to 5 years\", \"B\": \"Up to 10 years\", \"C\": \"Up to 15 years\", \"D\": \"Up to 20 years\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses knowledge about the duration of increased risk for post-traumatic epilepsy following moderate TBI. Similar to Q211 &",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q6",
    "question_text": "Which of the following is the most common cause of acute ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q285",
    "question_text": "A 26-year-old female, who is known to have epilepsy, has increased seizure frequency and is pregnant. She was on Keppra 500 mg BID. What medication should be added?",
    "options": "{\"A\": \"Lamotrigine\", \"B\": \"Valproic acid\", \"C\": \"Topiramate\", \"D\": \"Carbamazepine\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with managing worsening seizures during pregnancy in a patient already on an AED, involving choosing an appropriate add-on therapy. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q140",
    "question_text": "Which of the following is the most common cause of ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q293",
    "question_text": "What is the most significant predictor of seizure recurrence in a patient known to have epilepsy who has stopped his medications?",
    "options": "{\"A\": \"Medication compliance\", \"B\": \"Generalized type of epilepsy\", \"C\": \"Duration of seizure freedom before withdrawal\", \"D\": \"Presence of abnormal EEG findings\"}",
    "correct_answer": "B",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of factors predicting seizure recurrence after AED withdrawal, highlighting underlying epilepsy type as a key factor.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q219",
    "question_text": "A 20-year-old male with generalized tonic-clonic seizures on lamotrigine 200 mg bid has had a breakthrough seizure. What is the next appropriate medication?",
    "options": "{\"A\": \"Valproate\", \"B\": \"Levetiracetam\", \"C\": \"Topiramate\", \"D\": \"Clonazepam\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on selecting an appropriate second-line AED for generalized tonic-clonic seizures when the first agent (lamotrigine) is insufficient.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q224",
    "question_text": "A patient had recurrent nocturnal seizures with hypermotor features, a history of asymmetric posturing, strange feelings, and brief loss of awareness. Where is the likely seizure focus?",
    "options": "{\"A\": \"Orbitofrontal\", \"B\": \"Supplementary motor area (SMA)\", \"C\": \"Temporal lobe\", \"D\": \"Insular cortex\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on complex nocturnal semiology including hypermotor features and posturing (suggestive of frontal lobe, potentially SMA).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q174",
    "question_text": "A patient was brought in from a dental clinic unconscious. In the emergency department, the patient woke up. What finding would support the diagnosis of seizure rather than syncope?",
    "options": "{\"A\": \"Cyanosis\", \"B\": \"Multifocal myoclonus\", \"C\": \"No postictal confusion\", \"D\": \"Intense pain before the event\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of clinical features (like cyanosis, postictal confusion) used to differentiate epileptic seizures from syncope. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q278",
    "question_text": "Which of the following is the most common cause of subarachnoid hemorrhage?",
    "options": "{\"A\": \"Arteriovenous malformation\", \"B\": \"Trauma\", \"C\": \"Ruptured berry aneurysm\", \"D\": \"Hypertensive intracerebral hemorrhage\"}",
    "correct_answer": "C",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Ruptured berry (saccular) aneurysm is the most common cause of spontaneous subarachnoid hemorrhage.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q267",
    "question_text": "A young lady who underwent tumor resection presented with a staring spell and loss of awareness. What is your treatment?",
    "options": "{\"A\": \"Levetiracetam\", \"B\": \"Valproic Acid\", \"C\": \"Gabapentin\", \"D\": \"Carbamazepine\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Although occurring post-tumor resection (Neuro-oncology context), the core question is the choice of AED (Levetiracetam often preferred post-operatively) for treating a likely symptomatic focal seizure.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q243",
    "question_text": "MTS seizure with normal MRI; EEG showed right frontotemporal discharge; what is the next step?",
    "options": "{\"A\": \"Scalp EEG\", \"B\": \"Interictal PET\", \"C\": \"Interictal SPECT\", \"D\": \"Video EEG monitoring\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the pre-surgical evaluation pathway for suspected Mesial Temporal Sclerosis (MTS) epilepsy when MRI is normal but EEG is focal, considering functional imaging (PET/SPECT).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q64",
    "question_text": "What is the most common cause of sudden unexpected death in epilepsy (SUDEP)?",
    "options": "{\"A\": \"Uncontrolled seizure\", \"B\": \"Cardiac arrhythmia\", \"C\": \"Respiratory depression\", \"D\": \"Status epilepticus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge about SUDEP, a major complication of epilepsy, and its primary risk factor (uncontrolled seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q207",
    "question_text": "A 45-year-old female patient diagnosed with epilepsy is currently on Lacosamide 200 mg BID and Levetiracetam 1500 mg BID. She presented to the epilepsy outpatient clinic for evaluation. She reported a history of generalized seizure preceded by feelings of fear and palpitation. While in the clinic, she had a seizure episode that started with chewing spells and right hand automatism followed by bilateral generalized tonic-clonic seizure. She doesn\u2019t recall the event. What is the pathophysiology responsible for this case?",
    "options": "{\"A\": \"Trisynaptic glutamergic neuron inhibition\", \"B\": \"Trisynaptic glutamergic neuron excitation\", \"C\": \"Dentate granular cell inhibition\", \"D\": \"Dentate granular cell excitation\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Links complex partial seizure semiology suggestive of temporal lobe origin (fear, automatisms) to the underlying cellular pathophysiology within the hippocampal circuit.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q33",
    "question_text": "A patient with MTLE is on two anti-seizure medications but still experiences monthly seizures. What is the next step?",
    "options": "{\"A\": \"Start workup for epilepsy surgery\", \"B\": \"Add a third AED\", \"C\": \"Increase the dose of current medications\", \"D\": \"Refer for vagus nerve stimulation evaluation\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the management algorithm for drug-resistant Mesial Temporal Lobe Epilepsy (MTLE), highlighting the indication for surgical evaluation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q272",
    "question_text": "Patient came with absence seizure with rare GTC; EEG showed 3Hz; what are the other associated symptoms this patient can have?",
    "options": "{\"A\": \"Eyelid myotonia\", \"B\": \"Myoclonic jerks\", \"C\": \"Ataxia\", \"D\": \"Sensory loss\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on recognizing associated features within specific epilepsy syndromes characterized by absence and GTC seizures. Same question as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q49",
    "question_text": "Which of the following cranial nerves is primarily responsible for controlling the muscles of facial expression?",
    "options": "{\"A\": \"Trigeminal nerve (CN V)\", \"B\": \"Facial nerve (CN VII)\", \"C\": \"Glossopharyngeal nerve (CN IX)\", \"D\": \"Vagus nerve (CN X)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q290",
    "question_text": "A patient known to have epilepsy for more than 10 years, who reports no aura, arrives at the emergency department unwitnessed with tonic-clonic seizures. What is the classification of his seizures?",
    "options": "{\"A\": \"Unknown onset, tonic-clonic\", \"B\": \"Generalized onset tonic-clonic\", \"C\": \"Focal to bilateral tonic-clonic\", \"D\": \"Psychogenic non-epileptic seizures\"}",
    "correct_answer": "C",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the application of current seizure classification guidelines (ILAE 2017), particularly regarding \"unknown onset\" when the beginning is unwitnessed.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q292",
    "question_text": "In a case of palpitation and sweating, what is the localization of the seizure?",
    "options": "{\"A\": \"Insula\", \"B\": \"Amygdala\", \"C\": \"Temporal lobe\", \"D\": \"Hypothalamus\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on autonomic semiology (palpitations, sweating suggesting amygdala or insular involvement).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q213",
    "question_text": "A 25-year-old pregnant lady with epilepsy is currently on Valproic acid 500 mg daily. She has had no seizures in the last 3 years, and her last EEG and brain MRI were normal. Which of the following is the appropriate management?",
    "options": "{\"A\": \"Stop Valproic acid\", \"B\": \"Switch to Lamotrigine\", \"C\": \"Quality of life counseling\", \"D\": \"Counsel her about breastfeeding\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on pre-conception/pregnancy management in epilepsy, specifically addressing the high teratogenic risk of Valproic acid and the need for medication adjustment or counseling.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q178",
    "question_text": "A patient diagnosed with epilepsy started on antiepileptic medication and was later found to have aplastic anemia. What is the likely cause of the aplastic anemia?",
    "options": "{\"A\": \"Felbamate\", \"B\": \"Phenytoin\", \"C\": \"Carbamazepine\", \"D\": \"Valproate\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of serious, potentially fatal side effects (aplastic anemia) associated with specific AEDs (Felbamate).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q5",
    "question_text": "In a case of generalized tonic-clonic (GTC) seizures, what is the percentage of recurrence within 2 years?",
    "options": "{\"A\": \"10%\", \"B\": \"25%\", \"C\": \"50%\", \"D\": \"75%\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses knowledge of the prognosis and risk of recurrence after a first generalized tonic-clonic seizure.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q190",
    "question_text": "A child with developmental delay has an EEG that shows hypsarrhythmia. What is the diagnosis?",
    "options": "{\"A\": \"West syndrome\", \"B\": \"Lennox-Gastaut syndrome\", \"C\": \"Juvenile Myoclonic Epilepsy\", \"D\": \"Aicardi syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the ability to diagnose West Syndrome (Infantile Spasms) based on the combination of developmental delay and the characteristic EEG pattern (hypsarrhythmia). Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q197",
    "question_text": "A 61-year-old male with diabetes, hypertension, dyslipidemia, osteoporosis, and epilepsy is being evaluated. Which medication is suitable for him?",
    "options": "{\"A\": \"Phenytoin\", \"B\": \"Valproate\", \"C\": \"Carbamazepine\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "D",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on AED selection strategy considering patient age, comorbidities (osteoporosis risk with enzyme inducers like Phenytoin/Carbamazepine), and potential drug interactions.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q14",
    "question_text": "A young female presents with a right arm focal clonic seizure lasting for 1 hour, triggered by stress, and has been on 4 antiepileptic drugs (AEDs) with normal prolonged video EEG results. What finding supports the diagnosis of psychogenic non-epileptic seizures?",
    "options": "{\"A\": \"Persistent eye opening\", \"B\": \"Tongue biting\", \"C\": \"Absence of aura\", \"D\": \"Postictal confusion\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses knowledge of clinical features observed during video EEG that help differentiate psychogenic non-epileptic seizures (PNES) from epileptic seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q92",
    "question_text": "A patient has been on levetiracetam (LEV) for a long time. What is a possible side effect?",
    "options": "{\"A\": \"Suicidal thoughts\", \"B\": \"Liver toxicity\", \"C\": \"Dizziness\", \"D\": \"Fatigue\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of specific long-term or neuropsychiatric side effects associated with a common AED (Levetiracetam).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q104",
    "question_text": "A young patient with developmental delay and multiple seizure types is on Clobazam 10 mg BID, Levetiracetam 1500 mg BID, and Valproic acid. The EEG report shows slow spikes and waves at 1-1.5 Hz. Which of the following is the best management for this patient?",
    "options": "{\"A\": \"Hemispherectomy\", \"B\": \"Vagal nerve stimulation\", \"C\": \"Corpus callosotomy\", \"D\": \"Add fourth antiepileptic medication\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses management options for severe, drug-resistant pediatric epilepsy (likely LGS based on features), including palliative surgical procedures (VNS, callosotomy) versus adding more medication.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q205",
    "question_text": "A 35-year-old male presented to the emergency room with a cluster of seizures a few hours ago. He is on Lacosamide 100 mg BID and reported good compliance with the medication. He has a history of congenital heart disease. Which of the following is the next step in the management?",
    "options": "{\"A\": \"Add Topiramate\", \"B\": \"IV Phenytoin\", \"C\": \"IV Levetiracetam\", \"D\": \"Increase Lacosamide dose\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the acute management of cluster seizures or impending status epilepticus, involving choices between IV rescue medications or adjusting baseline AEDs, considering comorbidities (heart disease potentially influencing choices).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q206",
    "question_text": "A young patient presented to the neurology outpatient clinic for epilepsy evaluation. He has seizure semiology in the form of right upper limb tonic posturing followed by limb jerking with lack of awareness, then bilateral tonic-clonic seizure. He doesn\u2019t recall the episode. He has a history of 4 car accidents, one of which required ICU admission for 3 days. What is the likely localization for his seizure semiology?",
    "options": "{\"A\": \"Premotor\", \"B\": \"Primary motor\", \"C\": \"Supplementary motor area\", \"D\": \"Temporal lobe\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset (likely SMA given tonic posturing) based on motor semiology, within the context of potential post-traumatic epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q172",
    "question_text": "A patient presented to the emergency department with a first onset seizure. The examination was normal, and brain MRI and EEG were normal. What is the risk of recurrence of seizure in 3 years?",
    "options": "{\"A\": \"10%\", \"B\": \"30%\", \"C\": \"50%\", \"D\": \"80%\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses knowledge of the prognosis and risk of recurrence after a first unprovoked seizure with a normal diagnostic workup.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q287",
    "question_text": "A young female with epilepsy wants to start oral contraceptive pills (OCP). What is the correct response?",
    "options": "{\"A\": \"Increase lamotrigine to 2 folds\", \"B\": \"Decrease lamotrigine dose\", \"C\": \"No change in lamotrigine dose is needed\", \"D\": \"Switch to non-enzyme inducing antiepileptic drug\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with the specific quantitative dose adjustment needed for lamotrigine when co-administered with estrogen-containing OCPs. Same concept as Q167.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q218",
    "question_text": "Which of the following cranial nerves is primarily responsible for controlling the muscles of facial expression?",
    "options": "{\"A\": \"Trigeminal nerve (CN V)\", \"B\": \"Facial nerve (CN VII)\", \"C\": \"Glossopharyngeal nerve (CN IX)\", \"D\": \"Vagus nerve (CN X)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q220",
    "question_text": "A patient with seizures who is on antiepileptic drugs (AEDs) develops aplastic anemia. What is the medication associated with this condition?",
    "options": "{\"A\": \"Phenytoin\", \"B\": \"Valproate\", \"C\": \"Felbamate\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of serious AED side effects (aplastic anemia), likely pointing towards Felbamate or Carbamazepine. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q178",
    "question_text": "Which of the following cranial nerves is primarily responsible for the sense of smell?",
    "options": "{\"A\": \"Optic nerve (CN II)\", \"B\": \"Olfactory nerve (CN I)\", \"C\": \"Trigeminal nerve (CN V)\", \"D\": \"Facial nerve (CN VII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q132",
    "question_text": "A patient presents with no aura but has focal aware seizure presentations and is uncontrolled on two ASM. What is the next step?",
    "options": "{\"A\": \"FDG-PET\", \"B\": \"Video EEG\", \"C\": \"SPECT\", \"D\": \"Repeat MRI with high resolution\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the diagnostic strategy (pre-surgical evaluation) for drug-resistant focal epilepsy, weighing the utility of different investigations like Video EEG, PET, SPECT, or high-resolution MRI.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q120",
    "question_text": "What is the risk of having a second seizure within 2 years after the first seizure?",
    "options": "{\"A\": \"5%\", \"B\": \"30%\", \"C\": \"50%\", \"D\": \"70%\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Assesses knowledge of the general risk of recurrence after a single unprovoked seizure.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q262",
    "question_text": "A 9-month-old child with a history of developmental delay and atonic spasms for seconds has an attached ECG showing hypsarrhythmia. What is the diagnosis?",
    "options": "{\"A\": \"Infantile spasm\", \"B\": \"Severe myoclonus of infancy\", \"C\": \"Lennox-Gastaut syndrome\", \"D\": \"Benign myoclonic epilepsy of infancy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to diagnose Infantile Spasms (West Syndrome) based on age, seizure type (spasms, although described as 'atonic' here, context implies epileptic spasms), developmental delay, and EEG (hypsarrhythmia). Also considers Pediatric Neurology.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q6",
    "question_text": "A patient had moderate head trauma in a motor vehicle accident (MVA). For how long does the risk of seizure persist?",
    "options": "{\"A\": \"5 years\", \"B\": \"10 years\", \"C\": \"15 years\", \"D\": \"20 years\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses knowledge about the duration of increased risk for post-traumatic epilepsy following moderate TBI. Same concept as Q211,",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q154",
    "question_text": "A 65-year-old man presents with sudden onset of right-sided weakness and aphasia. Imaging reveals an infarct in the left middle cerebral artery territory. Which of the following is the most likely cause of his stroke?",
    "options": "{\"A\": \"Embolism from atrial fibrillation\", \"B\": \"Lacunar infarct due to hypertension\", \"C\": \"Subarachnoid hemorrhage from ruptured aneurysm\", \"D\": \"Carotid artery dissection\"}",
    "correct_answer": "A",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q211",
    "question_text": "A child who has had 2 episodes of seizure, both occurring while he was on a train, associated with nausea and vomiting. EEG showed posterior discharges. What is the diagnosis?",
    "options": "{\"A\": \"Occipital seizure\", \"B\": \"Temporal lobe epilepsy\", \"C\": \"Frontal lobe epilepsy\", \"D\": \"Generalized tonic-clonic seizure\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links seizure semiology (nausea/vomiting suggest autonomic features, visual triggers possible) and posterior EEG findings to diagnose occipital lobe epilepsy (possibly Panayiotopoulos syndrome given age/autonomics).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q168",
    "question_text": "A 35-year-old patient with epilepsy on anti-seizure medication (ASM) has been controlled for the last year. What carries the risk of seizure recurrence in case of medication discontinuation?",
    "options": "{\"A\": \"Generalized seizure\", \"B\": \"Young age of onset\", \"C\": \"Medication compliance\", \"D\": \"Structural brain abnormality\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of factors predicting seizure relapse after successful AED withdrawal, such as underlying epilepsy type (generalized vs focal).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q163",
    "question_text": "A young patient presented with seizure, denies any aura, and has a normal brain MRI. He was witnessed to have recurrent generalized tonic-clonic seizures. What is the classification for his seizure?",
    "options": "{\"A\": \"Generalized onset, motor\", \"B\": \"Unknown onset, motor\", \"C\": \"Focal with secondary generalization\", \"D\": \"Focal unaware seizure\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the application of seizure classification principles based on the available clinical information (witnessed GTC without aura, suggesting generalized onset).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q7",
    "question_text": "What is the localization of juvenile myoclonic epilepsy (JME) based on the semiology of seizures with a figure of 4?",
    "options": "{\"A\": \"Fronto-polar\", \"B\": \"Mesial-frontal\", \"C\": \"Dorsolateral\", \"D\": \"Medial prefrontal cortex\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Although JME is a generalized epilepsy, this question attempts to link specific motor semiology sometimes seen ('figure of 4' usually implies contralateral SMA) to a specific localization concept, testing understanding of motor seizure semiology.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q93",
    "question_text": "A patient with epilepsy wants to get pregnant. Which of the following statements is correct?",
    "options": "{\"A\": \"Lamotrigine clearance will increase in the first and second trimester\", \"B\": \"Levetiracetam is the safest AED\", \"C\": \"Valproate is the first-line treatment\", \"D\": \"All AEDs are equally safe during pregnancy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on key aspects of managing epilepsy during pregnancy, including pharmacokinetic changes (lamotrigine clearance) and relative safety profiles of AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q187",
    "question_text": "EEG changes associated with hyperventilation?",
    "options": "{\"A\": \"Generalized delta/theta\", \"B\": \"Prominent anterior slowing\", \"C\": \"No changes\", \"D\": \"Focal epileptiform discharges\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of normal physiological responses (generalized slowing) seen on EEG during activation procedures like hyperventilation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q275",
    "question_text": "A patient with generalized tonic-clonic seizures and interictal myoclonus (typical scenario for juvenile myoclonic epilepsy). What is the mechanism?",
    "options": "{\"A\": \"GABA A mutation\", \"B\": \"Ion Channel\", \"C\": \"Autoimmune encephalitis\", \"D\": \"Structural brain lesion\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Probes the underlying pathophysiology or genetic basis (channelopathy, GABAergic dysfunction) of common generalized epilepsy syndromes like JME.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q94",
    "question_text": "A 26-year-old woman presents to the emergency room with 4 tonic-clonic seizures. Lorazepam and a loading dose of phenytoin have been given, and the seizures have aborted. Neurology is consulted because the patient remains unresponsive for 5 hours. What is the most appropriate next step?",
    "options": "{\"A\": \"Give an additional 50 mg/kg IV phenytoin\", \"B\": \"Order continuous EEG\", \"C\": \"Leave the patient until she wakes up\", \"D\": \"Perform a lumbar puncture (LP)\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the management of prolonged postictal state after status epilepticus, emphasizing the need to rule out ongoing nonconvulsive status epilepticus (NCSE) with continuous EEG.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q286",
    "question_text": "In a child with a typical scenario of benign rolandic epilepsy, what is the finding on EEG?",
    "options": "{\"A\": \"Centrotemporal spikes\", \"B\": \"Generalized spike-and-wave discharges\", \"C\": \"Occipital spikes\", \"D\": \"Diffuse slowing\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the characteristic EEG finding (centrotemporal spikes) associated with benign rolandic epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q203",
    "question_text": "What is the direction of gaze deviation in a patient experiencing a seizure?",
    "options": "{\"A\": \"Toward the lesion\", \"B\": \"Away from the lesion\", \"C\": \"Toward hemiparesis\", \"D\": \"Away from hemiparesis\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of seizure semiology, specifically the localizing value of ictal head/eye deviation (typically away from the seizure focus in frontal/temporal seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q169",
    "question_text": "A 26-year-old female, who is known to have epilepsy and had increased seizure frequency. She is pregnant and on Levetiracetam 1500 mg BID, what should you add?",
    "options": "{\"A\": \"Lamotrigine\", \"B\": \"Valproic acid\", \"C\": \"Topiramate\", \"D\": \"Carbamazepine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with managing worsening seizures during pregnancy in a patient already on an AED, involving choosing an appropriate add-on therapy, considering risks/benefits. Same concept as Q140,",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q285",
    "question_text": "Which of the following is the most common cause of acute ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion (lacunar infarct)\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q12",
    "question_text": "A patient with features of Rolandic epilepsy presents for an EEG. What is the expected finding?",
    "options": "{\"A\": \"Continuous spike and wave during sleep\", \"B\": \"Central sharp wave in the mid-temporal area\", \"C\": \"Generalized 3 Hz spike-and-wave discharges\", \"D\": \"Occipital intermittent rhythmic delta activity\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the characteristic EEG finding (centrotemporal spikes/sharp waves) in benign rolandic epilepsy. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q286",
    "question_text": "Which of the following cranial nerves is primarily responsible for controlling the muscles of facial expression?",
    "options": "{\"A\": \"Trigeminal nerve (Cranial Nerve V)\", \"B\": \"Facial nerve (Cranial Nerve VII)\", \"C\": \"Glossopharyngeal nerve (Cranial Nerve IX)\", \"D\": \"Vagus nerve (Cranial Nerve X)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q278",
    "question_text": "What is the most common type of aura in mesial temporal lobe (MTL) seizures?",
    "options": "{\"A\": \"Epigastric rising sensation\", \"B\": \"Visual hallucinations\", \"C\": \"Auditory hallucinations\", \"D\": \"Olfactory hallucinations\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of common seizure semiology (aura types, e.g., epigastric rising, fear) associated with MTLE.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q273",
    "question_text": "A patient presented with hallucinations followed by a headache. What is the likely diagnosis?",
    "options": "{\"A\": \"Occipital seizure\", \"B\": \"Migraine with aura\", \"C\": \"Temporal lobe epilepsy\", \"D\": \"Cluster headache\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on interpreting symptoms (visual hallucinations) as potential seizure semiology localizing to the occipital lobe, differentiating from migraine aura.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q178",
    "question_text": "A young male with a first-time generalized tonic-clonic seizure during the daytime has no previous seizures or risk factors. After examination, MRI, and EEG are normal. What is the 2-year recurrence risk?",
    "options": "{\"A\": \"10%\", \"B\": \"30%\", \"C\": \"50%\", \"D\": \"70%\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Assesses knowledge of the prognosis and risk of recurrence after a first unprovoked seizure with a normal diagnostic workup. Similar to Q172,",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q208",
    "question_text": "Which of the following is the most common cause of acute ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q29",
    "question_text": "What is the pathology responsible for MTL (medial temporal lobe) epilepsy?",
    "options": "{\"A\": \"Increased dentate gating\", \"B\": \"Mossy fibers sprouting\", \"C\": \"Neuronal loss\", \"D\": \"All of the above\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests understanding of the underlying neuropathological and pathophysiological mechanisms (neuronal loss, synaptic reorganization like mossy fiber sprouting) in MTLE.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q388",
    "question_text": "An 18-month-old baby had one febrile seizure. What is the chance of developing epilepsy in the future?",
    "options": "{\"A\": \"3%\", \"B\": \"10%\", \"C\": \"30%\", \"D\": \"60%\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Assesses knowledge of the long-term risk of developing epilepsy following a simple febrile seizure.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q212",
    "question_text": "A child with a history of absence seizures and auditory agnosia is most likely diagnosed with which condition?",
    "options": "{\"A\": \"Landau-Kleffner syndrome\", \"B\": \"Lennox-Gastaut syndrome (LGS)\", \"C\": \"Ohtahara syndrome\", \"D\": \"West syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the ability to diagnose Landau-Kleffner syndrome based on its core features of seizures and acquired auditory agnosia/aphasia. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q166",
    "question_text": "Which of the following is the most common cause of acute ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion (lacunar infarct)\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Large artery atherosclerosis is the most common cause of acute ischemic stroke, followed by cardioembolism and small vessel occlusion.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q178",
    "question_text": "Which cranial nerve is primarily responsible for the sense of smell?",
    "options": "{\"A\": \"Optic nerve (CN II)\", \"B\": \"Olfactory nerve (CN I)\", \"C\": \"Trigeminal nerve (CN V)\", \"D\": \"Facial nerve (CN VII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q283",
    "question_text": "What is the most common cause of sudden unexpected death in epilepsy (SUDEP)?",
    "options": "{\"A\": \"Uncontrolled seizure\", \"B\": \"Cardiac arrhythmia\", \"C\": \"Respiratory depression\", \"D\": \"Medication overdose\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge about the primary risk factor for SUDEP. Same question as Q64 (Part 2 2021).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q60",
    "question_text": "What is the treatment for focal seizures?",
    "options": "{\"A\": \"IV diazepam\", \"B\": \"IV Keppra\", \"C\": \"IV phenytoin\", \"D\": \"IV Depakine\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the acute treatment options (likely referring to focal status epilepticus or cluster seizures given IV options) for focal seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q63",
    "question_text": "A 6-year-old with a staring episode has an EEG showing 3 Hz, consistent with absence epilepsy. The mother is concerned about slight developmental delay, and her skin is normal. There is a history of one of the parents having absence seizures in adulthood. Which comorbidities can be associated with this condition in the future?",
    "options": "{\"A\": \"ADHD\", \"B\": \"Cardiac rhabdomyoma\", \"C\": \"Renal angiomyolipoma\", \"D\": \"Learning disabilities\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on common comorbidities (like ADHD) associated with childhood absence epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q171",
    "question_text": "A patient experiences an aura of palpitations and sweating. Where is the likely localization of the seizure focus?",
    "options": "{\"A\": \"Amygdala\", \"B\": \"Insular\", \"C\": \"Temporal lobe\", \"D\": \"Hypothalamus\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the ability to localize seizure onset based on autonomic semiology. Same concept as",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q292",
    "question_text": "Which of the following is the most common cause of acute ischemic stroke?",
    "options": "{\"A\": \"Cardioembolism\", \"B\": \"Large artery atherosclerosis\", \"C\": \"Small vessel occlusion\", \"D\": \"Cerebral venous thrombosis\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q214",
    "question_text": "A 53-year-old male presents with his first generalized tonic-clonic seizure and a normal EEG. He has no family history of epilepsy. What is his risk of seizure recurrence?",
    "options": "{\"A\": \"10%\", \"B\": \"30%\", \"C\": \"50%\", \"D\": \"70%\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the prognosis and risk stratification after a first unprovoked seizure.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q99",
    "question_text": "Multiple seizure types with intellectual impairment, what will you see in the EEG?",
    "options": "{\"A\": \"Slow spike/wave less than 2Hz\", \"B\": \"Normal EEG\", \"C\": \"Fast spike/wave greater than 2Hz\", \"D\": \"Focal discharges\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of characteristic EEG patterns (slow spike-wave) associated with specific epileptic encephalopathies like Lennox-Gastaut Syndrome (LGS).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q34",
    "question_text": "A patient with frontal lobe epilepsy has been on antiepileptic drugs (AED) since the age of 15 and has been seizure-free for three years. Now at 18, she wants to stop her medication. What is the risk of seizure recurrence?",
    "options": "{\"A\": \"Low risk\", \"B\": \"Moderate risk\", \"C\": \"High risk\", \"D\": \"Risk increases with abrupt withdrawal of carbamazepine\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the risk of seizure recurrence upon AED withdrawal in a patient with established focal epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q25",
    "question_text": "An old lady with diabetes mellitus, hypertension, and atrial fibrillation had an episode of syncope followed by convulsions. The episode was witnessed by the family, who reported that the patient was confused for a short period afterward. Upon presentation to the emergency department, her blood pressure was 90/70, and she was fatigued but conscious and oriented. Which of the following findings would help you with the diagnosis?",
    "options": "{\"A\": \"Rhythmic clonus\", \"B\": \"Multifocal myoclonus\", \"C\": \"Oral automatism\", \"D\": \"Up rolling of eyes\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on differentiating convulsive syncope from an epileptic seizure based on specific clinical features observed during or after the event.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q260",
    "question_text": "A patient with MRI showing mesial temporal sclerosis (MTS) has a fear aura. What is the best approach to achieve long-term seizure control?",
    "options": "{\"A\": \"Surgery\", \"B\": \"Vagus nerve stimulation (VNS)\", \"C\": \"Antiepileptic drug therapy\", \"D\": \"Ketogenic diet\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Discusses treatment options (surgery vs. VNS) for drug-resistant mesial temporal lobe epilepsy (MTLE) associated with a specific structural lesion (MTS).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q157",
    "question_text": "In a scenario involving a child with nocturnal seizures and ictal speech, which EEG finding is most likely?",
    "options": "{\"A\": \"Frontal spikes\", \"B\": \"Centrotemporal spikes\", \"C\": \"Occipital spikes\", \"D\": \"Generalized slowing\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Relates pediatric seizure semiology (nocturnal seizures, ictal speech) to expected EEG findings, typical for Benign Rolandic Epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q164",
    "question_text": "An 18-year-old male with epilepsy on Valproic acid and Topiramate remains uncontrolled. He was found in bed in a prone position and was announced dead upon arrival to the emergency department. What increases the risk of death in epilepsy?",
    "options": "{\"A\": \"Generalized seizure\", \"B\": \"Sleep deprivation\", \"C\": \"MRI lesion\", \"D\": \"Focal changes on EEG\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses risk factors for Sudden Unexpected Death in Epilepsy (SUDEP), a critical topic in epilepsy management.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q373",
    "question_text": "Which antiepileptic drug (AED) is known to worsen myoclonus?",
    "options": "{\"A\": \"Phenobarbital\", \"B\": \"Topiramate\", \"C\": \"Carbamazepine\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of specific adverse effects of antiepileptic drugs, particularly the potential worsening of certain seizure types (myoclonus).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q32",
    "question_text": "For a patient experiencing a first-time seizure with normal imaging and EEG, what is the risk of seizure recurrence at 20 months?",
    "options": "{\"A\": \"17%\", \"B\": \"26%\", \"C\": \"30%\", \"D\": \"40%\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the prognosis and quantitative risk of seizure recurrence after a first unprovoked seizure with normal initial investigations.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q131",
    "question_text": "In a scenario about Rolandic epilepsy, what are the expected EEG findings?",
    "options": "{\"A\": \"Generalized spike-and-wave\", \"B\": \"Focal spikes in the centrotemporal region\", \"C\": \"Slow waves in the frontal lobe\", \"D\": \"No abnormalities\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the characteristic EEG finding specifically associated with Benign Rolandic Epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q217",
    "question_text": "A patient presents to the ER with a history of 3 unprovoked seizures, and all labs are normal. She has now returned to baseline. What should you do?",
    "options": "{\"A\": \"Give AED\", \"B\": \"Don't give AED, outpatient with MRI and EEG\", \"C\": \"Give AED and discharge with outpatient EEG and MRI\", \"D\": \"Admit for continuous EEG monitoring\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the initial management decision (starting AEDs) after a diagnosis of epilepsy is established (>=2 unprovoked seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q259",
    "question_text": "A patient with an arched back and repeated similar attacks has tried several medications with no improvement. What is the likely diagnosis?",
    "options": "{\"A\": \"Psychogenic\", \"B\": \"Epileptic seizures\", \"C\": \"Tension-type headache\", \"D\": \"Cluster headache\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of seizure-like events, particularly recognizing features suggestive of psychogenic non-epileptic seizures (PNES) based on semiology and treatment resistance.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q216",
    "question_text": "What are the features of right temporal epilepsy?",
    "options": "{\"A\": \"Olfactory hallucinations, d\\u00e9j\\u00e0 vu, and automatisms\", \"B\": \"Aphasia and right-sided weakness\", \"C\": \"Left-sided sensory loss and visual field defects\", \"D\": \"Auditory hallucinations, emotional disturbances, and memory impairment\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the characteristic clinical features (semiology) of seizures originating from a specific brain region (right temporal lobe). (Note: Question is incomplete).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q121",
    "question_text": "In a scenario with EEG showing interictal discharges, which term describes the source zone?",
    "options": "{\"A\": \"Irritative Zone\", \"B\": \"Epileptogenic zone\", \"C\": \"Symptomatic zone\", \"D\": \"Seizure onset zone\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of specific terminology used in presurgical epilepsy evaluation to define brain regions based on EEG findings (irritative zone).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q180",
    "question_text": "Which condition shows slow spike and wave?",
    "options": "{\"A\": \"Absence seizure\", \"B\": \"LGS\", \"C\": \"Generalized epilepsy\", \"D\": \"Juvenile myoclonic epilepsy\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks to identify the epilepsy syndrome (Lennox-Gastaut Syndrome - LGS) associated with a characteristic EEG pattern (slow spike-and-wave).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q64",
    "question_text": "Male patient has migraine and seizure; what medications will you give?",
    "options": "{\"A\": \"Valproic acid\", \"B\": \"Carbamazepine\", \"C\": \"Topiramate\", \"D\": \"Phenytoin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the choice of medication (AED) suitable for treating comorbid epilepsy and migraine.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q234",
    "question_text": "A patient with epilepsy is taking carbamazepine and valproic acid. What are the effects of these two medications?",
    "options": "{\"A\": \"Increase the epoxide\", \"B\": \"Increase the risk of hyponatremia\", \"C\": \"Increase the valproic acid level\", \"D\": \"Decrease carbamazepine clearance\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of pharmacokinetic interactions between commonly used antiepileptic drugs (carbamazepine and valproic acid).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q173",
    "question_text": "A child was seen during an interview and had continuous jerks of the right arm with few interruptions. What is the management?",
    "options": "{\"A\": \"IV Diazepam\", \"B\": \"IV Levetiracetam\", \"C\": \"IV Valproic acid\", \"D\": \"IV Phenytoin\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a scenario suggestive of focal status epilepticus (Epilepsia Partialis Continua) and asks for appropriate acute management with IV AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q261",
    "question_text": "A female patient had a seizure at the mall, described as a temporal lobe seizure. What is the recommended next step?",
    "options": "{\"A\": \"Refer to surgery\", \"B\": \"Start antiepileptic medication\", \"C\": \"Perform an EEG\", \"D\": \"Conduct a CT scan\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the appropriate next step in the diagnostic workup after a suspected first focal seizure (likely temporal lobe).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q85",
    "question_text": "A patient presented with hallucinations followed by a headache. What is the likely diagnosis?",
    "options": "{\"A\": \"Occipital seizure\", \"B\": \"Migraine with aura\", \"C\": \"Temporal lobe epilepsy\", \"D\": \"Visual migraine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes symptoms (visual hallucinations followed by headache) suggestive of a seizure originating from the occipital lobe.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q18",
    "question_text": "A male patient with a known history of epilepsy has been on carbamazepine and is free of seizures for a long time. Which of the following will carry the highest risk of recurrence?",
    "options": "{\"A\": \"Abruptly stopping carbamazepine\", \"B\": \"Gradually tapering carbamazepine over several weeks\", \"C\": \"Switching carbamazepine to another antiepileptic drug without tapering\", \"D\": \"Continuing carbamazepine at the same dose\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses the significant risk associated with the abrupt withdrawal of antiepileptic medication in a patient with previously controlled epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q253",
    "question_text": "What is the definition of ictal speech?",
    "options": "{\"A\": \"Intelligible talking localizing to the dominant hemisphere\", \"B\": \"Unintelligible talking localizing to the dominant hemisphere\", \"C\": \"Intelligible talking localizing to the non-dominant hemisphere\", \"D\": \"Unintelligible talking localizing to the non-dominant hemisphere\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the definition and localizing significance of a specific seizure semiology feature (ictal speech).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q242",
    "question_text": "A 7-year-old boy playing PlayStation all night has facial twitching and right arm movements. The patient cannot speak during the seizure, and postictally he complains of right upper limb numbness. What is the most likely diagnosis?",
    "options": "{\"A\": \"Landau-Kleffner syndrome\", \"B\": \"Centrotemporal epilepsy\", \"C\": \"Juvenile myoclonic epilepsy\", \"D\": \"Absence seizure\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes a classic clinical presentation (semiology, triggers, age) of Benign Rolandic Epilepsy (Centrotemporal epilepsy) and asks for the diagnosis.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q130",
    "question_text": "In a case where the seizure was idiopathic and the patient has a sibling with seizures, what is the risk of seizure recurrence at 4 months?",
    "options": "{\"A\": \"17%\", \"B\": \"29%\", \"C\": \"30%\", \"D\": \"40%\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses seizure recurrence risk after a first seizure, specifically considering the impact of a positive family history of seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q22",
    "question_text": "A case of hypsarrhythmia, mental regression, and infantile spasms is presented. What is the diagnosis?",
    "options": "{\"A\": \"West syndrome\", \"B\": \"Lennox-Gastaut syndrome\", \"C\": \"Dravet syndrome\", \"D\": \"Landau-Kleffner syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the diagnosis based on the classic triad of infantile spasms, developmental regression, and hypsarrhythmia, which defines West Syndrome.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q223",
    "question_text": "A patient with Landau-Kleffner syndrome presents with auditory agnosia and aphasia. During slow-wave sleep, the patient has electrical status epilepticus during sleep (ESES). What is the diagnosis?",
    "options": "{\"A\": \"Landau-Kleffner syndrome\", \"B\": \"Lennox-Gastaut syndrome\", \"C\": \"Childhood absence epilepsy\", \"D\": \"West syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the diagnosis (Landau-Kleffner syndrome) based on its characteristic features, including acquired auditory agnosia/aphasia and ESES.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q35",
    "question_text": "A female patient on four AEDs still has abnormal movements for more than one hour, with a normal prolonged EEG and MRI brain. What is the next step?",
    "options": "{\"A\": \"Stop all AEDs (consider PNES)\", \"B\": \"Repeat prolonged EEG\", \"C\": \"Start intravenous benzodiazepines\", \"D\": \"Perform video EEG monitoring\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a scenario highly suggestive of psychogenic non-epileptic seizures (PNES) due to refractoriness, prolonged duration, and normal investigations, asking for the next management step.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q162",
    "question_text": "MTS seizure with normal MRI; EEG showed right frontotemporal discharge. What is the next step?",
    "options": "{\"A\": \"Scalp EEG\", \"B\": \"Interictal PET\", \"C\": \"Interictal SPECT\", \"D\": \"Invasive EEG monitoring\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the next step in the presurgical evaluation for suspected mesial temporal lobe epilepsy (based on semiology/EEG) when the structural MRI is non-lesional, considering functional imaging.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q23",
    "question_text": "An EEG shows slow spikes characteristic of which condition?",
    "options": "{\"A\": \"Lennox-Gastaut syndrome\", \"B\": \"West syndrome\", \"C\": \"Juvenile myoclonic epilepsy (JME)\", \"D\": \"Temporal lobe epilepsy\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks to identify the epilepsy syndrome (Lennox-Gastaut Syndrome) characterized by slow spike-and-wave EEG patterns.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q281",
    "question_text": "What is the treatment for focal seizures?",
    "options": "{\"A\": \"IV diazepam\", \"B\": \"IV Keppra\", \"C\": \"IV phenytoin\", \"D\": \"IV Depakin\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the acute pharmacological treatment options (IV AEDs) for focal seizures, likely implying management of status epilepticus or seizure clusters.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q17",
    "question_text": "Young female with right arm focal clonic seizure lasting for 1 hour and triggered by stress on 4 AEDs, prolonged video EEG was repeated multiple times and was always normal. What supports the diagnosis?",
    "options": "{\"A\": \"Persistent eye opening\", \"B\": \"Tongue biting\", \"C\": \"Absence of aura\", \"D\": \"Ictal incontinence\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes features suggestive of psychogenic non-epileptic seizures (PNES) and asks which clinical sign observed during an event would further support this diagnosis.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q55",
    "question_text": "A patient has a history of no aura with a seizure while on two ASM. An EEG showed left temporal frontal spikes. What is the next step?",
    "options": "{\"A\": \"Video EEG\", \"B\": \"Intracranial EEG monitoring\", \"C\": \"Increase the dose of current ASM\", \"D\": \"Brain MRI\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the next diagnostic step (prolonged Video EEG) in evaluating drug-resistant focal epilepsy with identified interictal discharges.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q509",
    "question_text": "A male patient with early morning seizures and an EEG showing juvenile myoclonic epilepsy (JME) is being treated. Which of the following medications is appropriate?",
    "options": "{\"A\": \"Keppra\", \"B\": \"Depakin\", \"C\": \"Carbamazepine\", \"D\": \"Ethosuximide\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for appropriate first-line or commonly used antiepileptic drug choices for a classic presentation of Juvenile Myoclonic Epilepsy (JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q78",
    "question_text": "A patient presented with a history of stroke followed by one episode of seizure in the form of generalized tonic-clonic seizure. He is a known case of well-controlled bipolar disorder. Which of the following is the appropriate antiepileptic medication for this patient?",
    "options": "{\"A\": \"Valproic acid\", \"B\": \"Topiramate\", \"C\": \"Levetiracetam\", \"D\": \"Lacosamide\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the selection of an appropriate antiepileptic drug (AED) for post-stroke seizures, considering the patient's comorbidity (bipolar disorder) and the mood-stabilizing properties of some AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q227",
    "question_text": "A patient presents with laryngeal discomfort and tonic posturing. What type of seizure is likely occurring?",
    "options": "{\"A\": \"Insular seizure\", \"B\": \"Temporal lobe seizure\", \"C\": \"Frontal lobe seizure\", \"D\": \"Parietal lobe seizure\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the likely seizure localization (Insula) based on specific ictal semiology including autonomic/sensory symptoms (laryngeal discomfort) and motor features (tonic posturing).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q138",
    "question_text": "A patient with seizure semiology that suggests Mesial Temporal Lobe Epilepsy (MTLE) with epigastric sensation and auditory hallucinations is being evaluated. What is the responsible gene?",
    "options": "{\"A\": \"LGI1 gene\", \"B\": \"SCN1A gene\", \"C\": \"CACNA1A gene\", \"D\": \"GABRG2 gene\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific genetic associations (LGI1 gene) linked to familial focal epilepsy syndromes with particular semiology (auditory features).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q183",
    "question_text": "Which of these is a characteristic of LGS?",
    "options": "{\"A\": \"Resistant to antiepileptic medications\", \"B\": \"Peak onset 5-10 years\", \"C\": \"Multiple seizure types including tonic and atonic seizures\", \"D\": \"Associated with slow spike-and-wave pattern on EEG\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about key clinical characteristics of Lennox-Gastaut Syndrome (LGS), such as typical age of onset and resistance to treatment.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q15",
    "question_text": "In a patient with features of Rolandic epilepsy, what is the treatment?",
    "options": "{\"A\": \"Not necessary, but carbamazepine (CBZ) can be used in prolonged high-frequency cases\", \"B\": \"Immediate initiation of valproate therapy\", \"C\": \"Surgical resection of the epileptogenic focus\", \"D\": \"Phenobarbital as first-line treatment\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses the typical management approach for Benign Rolandic Epilepsy, including the general indication for treatment.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q92",
    "question_text": "In patients with head trauma, what is the risk of seizure recurrence at 12 months?",
    "options": "{\"A\": \"30%\", \"B\": \"40%\", \"C\": \"46%\", \"D\": \"50%\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the risk of developing seizures (post-traumatic epilepsy) following significant head trauma.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q7",
    "question_text": "A 3-Hz spike EEG is characteristic of which condition?",
    "options": "{\"A\": \"Absence seizure\", \"B\": \"West syndrome\", \"C\": \"Juvenile myoclonic epilepsy\", \"D\": \"Temporal lobe epilepsy\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks to identify the epilepsy syndrome (Childhood Absence Epilepsy) characterized by the classic 3-Hz generalized spike-and-wave EEG pattern.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q99",
    "question_text": "A patient with generalized tonic-clonic seizures and interictal myoclonus (typical scenario for juvenile myoclonic epilepsy). What is the mechanism?",
    "options": "{\"A\": \"GABA A mutation\", \"B\": \"Ion Channel\", \"C\": \"Autoimmune antibody-mediated\", \"D\": \"Mitochondrial dysfunction\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Inquires about the suspected underlying pathophysiology (e.g., ion channel dysfunction, neurotransmitter system defects) in Juvenile Myoclonic Epilepsy (JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q135",
    "question_text": "A patient with epilepsy denies any aura, and the MRI shows heterotopia. What is the classification of the epilepsy?",
    "options": "{\"A\": \"Unknown\", \"B\": \"Genetic\", \"C\": \"Structural\", \"D\": \"Symptomatic\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the classification of epilepsy based on its underlying etiology, specifically identifying a structural cause (heterotopia) found on MRI.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q139",
    "question_text": "Which of the following is a characteristic feature of Benign Rolandic Epilepsy of Childhood?",
    "options": "{\"A\": \"Onset usually between 2-13 years\", \"B\": \"Seizures primarily occur during the day\", \"C\": \"EEG shows generalized spike-and-wave discharges\", \"D\": \"Seizures are always tonic-clonic\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the key clinical characteristics (e.g., typical age of onset) of Benign Rolandic Epilepsy of Childhood.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q176",
    "question_text": "A child with a typical scenario of benign rolandic epilepsy is being evaluated. What is the finding on EEG?",
    "options": "{\"A\": \"Centrotemporal spikes\", \"B\": \"Generalized spike-and-wave discharges\", \"C\": \"Occipital spikes\", \"D\": \"Temporal lobe slowing\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the specific, characteristic EEG finding associated with Benign Rolandic Epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q277",
    "question_text": "Typical JME on topiramate and well controlled; he wants to stop the medication. What is the recommendation?",
    "options": "{\"A\": \"Lifelong treatment\", \"B\": \"Gradual withdrawal after 2 years seizure-free\", \"C\": \"Immediate cessation of medication\", \"D\": \"Switch to another antiepileptic drug before stopping\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the long-term management strategy and prognosis for Juvenile Myoclonic Epilepsy (JME), specifically regarding the high relapse risk upon medication cessation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q159",
    "question_text": "Which of the following is NOT a common behavioral problem associated with Landau-Kleffner syndrome?",
    "options": "{\"A\": \"Irritability\", \"B\": \"Poor attention span\", \"C\": \"Hyperactivity\", \"D\": \"Auditory agnosia\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the associated features of Landau-Kleffner syndrome, requiring differentiation between core neurological deficits (like auditory agnosia) and common comorbid behavioral issues.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q31",
    "question_text": "In a scenario of infantile spasms, if an EEG is provided, what is the EEG description?",
    "options": "{\"A\": \"Hypsarrhythmia\", \"B\": \"Normal EEG\", \"C\": \"Focal spikes\", \"D\": \"Generalized slowing\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the characteristic EEG pattern (Hypsarrhythmia) associated with infantile spasms (West Syndrome).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q228",
    "question_text": "In the context of focal seizures, which factors favor a good prognosis?",
    "options": "{\"A\": \"One seizure type\", \"B\": \"Long duration of disease activity\", \"C\": \"MRI lesion of nonspecific white matter changes\", \"D\": \"Short duration of remission\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of factors that influence the prognosis and likelihood of achieving seizure freedom in patients with focal epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q33",
    "question_text": "Localization of palpitation in seizure attacks is more commonly associated with which structure?",
    "options": "{\"A\": \"Amygdala\", \"B\": \"Insula\", \"C\": \"Hippocampus\", \"D\": \"Thalamus\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the likely cerebral localization (Insula, Amygdala) associated with specific autonomic ictal semiology (palpitations).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q270",
    "question_text": "Patient with seizure and mental retardation, EEG showed 2Hz; what is the treatment?",
    "options": "{\"A\": \"Valproic acid\", \"B\": \"Carbamazepine\", \"C\": \"Phenytoin\", \"D\": \"Ethosuximide\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a likely Lennox-Gastaut Syndrome scenario (seizures, intellectual disability, slow spike-wave EEG) and asks for an appropriate broad-spectrum AED treatment (Valproic acid).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q31",
    "question_text": "In a case scenario of a patient with seizure associated hypersalivation, which area of the brain is likely involved?",
    "options": "{\"A\": \"Temporal lobe\", \"B\": \"Insula\", \"C\": \"Frontal lobe\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the likely cerebral localization (e.g., Insula, temporal operculum) associated with specific autonomic ictal semiology (hypersalivation).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q209",
    "question_text": "What is the risk of developing epilepsy following a febrile seizure?",
    "options": "{\"A\": \"2%\", \"B\": \"6%\", \"C\": \"10%\", \"D\": \"15%\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the long-term risk (prognosis) of developing epilepsy after experiencing febrile seizures in childhood.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q32",
    "question_text": "A young female was brought by her family due to bizarre nocturnal hyperactive abnormal movements, with a similar history in her family. What is the appropriate antiepileptic drug (AED) to start for suspected autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Zonisamide\", \"C\": \"Valproate\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a likely scenario of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) based on semiology and family history, and asks for the appropriate first-line treatment (Carbamazepine).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q389",
    "question_text": "In a scenario of Lennox-Gastaut syndrome, what is the first-line treatment for drop attacks?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Clobazam\", \"C\": \"Depakine\", \"D\": \"Rufinamide\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks specifically about first-line treatment options (e.g., Valproate, Clobazam, Rufinamide, Topiramate, Cannabidiol) for a particular seizure type (drop attacks) within Lennox-Gastaut Syndrome (LGS).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q372",
    "question_text": "A patient has seizure recurrence while on topiramate 200 mg and carbamazepine 400 mg bid. An EEG shows spikes in the temporal lobe, and an MRI shows mesial temporal sclerosis (MTS). What is the likely cause of the breakthrough seizures?",
    "options": "{\"A\": \"Drug interactions\", \"B\": \"MTS\", \"C\": \"Interictal spikes\", \"D\": \"Poor compliance\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks to identify the most likely underlying reason (the structural lesion - MTS) for medically refractory seizures in a patient with known temporal lobe epilepsy, despite being on AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q143",
    "question_text": "What is the typical EEG finding in a patient with Benign Rolandic Epilepsy of Childhood?",
    "options": "{\"A\": \"Bilateral independent centrotemporal spikes\", \"B\": \"Generalized spike-and-wave activity\", \"C\": \"Focal slowing in the frontal lobe\", \"D\": \"Normal background activity\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the specific, typical EEG finding associated with Benign Rolandic Epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q146",
    "question_text": "Slow spike-and-wave activity on EEG (1.5 \u2013 2.5 Hz)",
    "options": "{\"A\": \"Childhood absence epilepsy\", \"B\": \"Juvenile myoclonic epilepsy\", \"C\": \"Lennox-Gastaut syndrome\", \"D\": \"Benign epilepsy with centrotemporal spikes\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes the characteristic slow spike-and-wave EEG pattern typically seen in Lennox-Gastaut Syndrome (LGS). (Note: Question is incomplete but the EEG description itself points to epilepsy).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q141",
    "question_text": "A patient who is epileptic and on Topamax and Carbamazepine (CBZ CR) presents with breakthrough seizures. The EEG shows epileptiform discharges and the MRI shows mesial temporal sclerosis. What is the likely cause of seizures for this patient?",
    "options": "{\"A\": \"Missed dose of carbamazepine\", \"B\": \"Missed dose of Topamax\", \"C\": \"Mesial temporal sclerosis\", \"D\": \"Bilateral interictal discharges\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks to identify the most likely underlying reason (the structural lesion - MTS) for medically refractory seizures in a patient with known temporal lobe epilepsy, despite being on AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q280",
    "question_text": "Patient with seizure; EEG showed multifocal spikes; what is the surgery for this patient?",
    "options": "{\"A\": \"VNS\", \"B\": \"Temporal lobectomy\", \"C\": \"Corpus callosotomy\", \"D\": \"Hemispherectomy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about appropriate surgical treatment options (palliative neuromodulation like VNS) for medically refractory epilepsy characterized by multifocal onset on EEG.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q24",
    "question_text": "A patient came with a history of right early non-forced head turning and right-side automatism. What is the localization of the seizure focus?",
    "options": "{\"A\": \"Right frontal\", \"B\": \"Forced contralateral frontal\", \"C\": \"Right temporal\", \"D\": \"Left temporal\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of seizure semiology and its lateralizing/localizing value, correlating specific ictal signs (head turn, automatisms) to the likely hemisphere and lobe of seizure onset.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q276",
    "question_text": "Patient with GTC seizure; what increases the recurrence of seizure?",
    "options": "{\"A\": \"Long duration\", \"B\": \"Early treatment initiation\", \"C\": \"Normal EEG findings\", \"D\": \"Single seizure episode\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about factors known to increase the risk of seizure recurrence after a first seizure or in established epilepsy. (Note: Question/options are incomplete).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q188",
    "question_text": "In focal seizures, where is the localization of the seizure in the semiology of absence?",
    "options": "{\"A\": \"Mesial temporal lobe\", \"B\": \"Occipital lobe\", \"C\": \"Frontal lobe\", \"D\": \"Parietal lobe\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the common localization (e.g., mesial temporal, frontal lobe) of focal seizures that manifest with impaired awareness, sometimes mimicking absence seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q49",
    "question_text": "A patient with hyperkinetic nocturnal seizures and a positive family history. How would you treat him?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Phenytoin\", \"C\": \"Valproate\", \"D\": \"Levetiracetam\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes a specific epilepsy syndrome (likely Autosomal Dominant Sleep-related Hypermotor Epilepsy/ADNFLE) and asks for the appropriate treatment (Carbamazepine).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q264",
    "question_text": "A 3-year-old boy presents with auditory agnosia and delay in language development. EEG shows ESES. What is the syndrome?",
    "options": "{\"A\": \"Landau-Kleffner syndrome\", \"B\": \"Rolandic epilepsy\", \"C\": \"West syndrome\", \"D\": \"Lennox-Gastaut syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the diagnosis of a specific pediatric epilepsy syndrome (Landau-Kleffner) based on characteristic clinical (acquired auditory agnosia) and EEG (ESES) features.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q216",
    "question_text": "In a scenario of mesiotemporal epilepsy, what is the typical semiology used to ask about the diagnosis?",
    "options": "{\"A\": \"Seizure duration\", \"B\": \"Aura characteristics\", \"C\": \"Postictal state\", \"D\": \"EEG findings\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the clinical features (seizure semiology, particularly the aura) characteristic of mesiotemporal lobe epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q263",
    "question_text": "A 23-year-old male patient on lamotrigine 200 mg BID had a tonic-clonic seizure that was not fully controlled and came to the clinic. What medication would you add for him? All other neurological examinations are intact.",
    "options": "{\"A\": \"Keppra\", \"B\": \"Depakine\", \"C\": \"Topamax\", \"D\": \"Carbamazepine\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Deals with the pharmacological management of epilepsy, specifically selecting an appropriate add-on antiepileptic drug for refractory seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q290",
    "question_text": "A patient came to the clinic with facial and arm twitches, and pronator drift, occasionally stopping without mention of loss of consciousness. What is the likely diagnosis?",
    "options": "{\"A\": \"Subtle status epilepticus\", \"B\": \"Status epilepticus\", \"C\": \"Epileptic partial complex (EPC)\", \"D\": \"Seizure cluster\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the diagnosis of Epilepsia Partialis Continua (EPC), a type of focal motor status epilepticus, based on the description of continuous focal seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q410",
    "question_text": "A patient with features suggestive of absence seizures and EEG showing 3Hz spike-wave discharges. Which of the following medications might worsen the seizure?",
    "options": "{\"A\": \"Oxcarbazepine\", \"B\": \"Ethosuximide\", \"C\": \"Valproic acid\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on seizure type (absence), characteristic EEG, and contraindications/worsening effects of specific AEDs (carbamazepine/oxcarbazepine can worsen absence seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q308",
    "question_text": "A 6-month-old infant presents with typical infantile spasms and developmental delay. EEG shows hypsarrhythmia. What is the diagnosis?",
    "options": "{\"A\": \"West syndrome\", \"B\": \"Dravet syndrome\", \"C\": \"Lennox-Gastaut syndrome\", \"D\": \"Ohtahara syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes the classic triad (infantile spasms, developmental delay, hypsarrhythmia) of West syndrome.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q447",
    "question_text": "What EEG finding suggests a poor prognosis?",
    "options": "{\"A\": \"Prolonged suppression\", \"B\": \"Prolonged burst\", \"C\": \"High amplitude burst\", \"D\": \"Variation of burst suppression\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests interpretation of EEG patterns (specifically burst-suppression characteristics) in the context of prognostication, often in critically ill or encephalopathic patients.* (Could also fit Critical Care).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q307",
    "question_text": "A 25-year-old pregnant lady came to the clinic and needs counseling regarding antiepileptic drugs (AEDs) during pregnancy. Which of the following statements is true?",
    "options": "{\"A\": \"Increase the dose of lamotrigine in the 1st and 2nd trimester\", \"B\": \"Keppra is the safest drug during pregnancy\", \"C\": \"Carbamazepine is the most teratogenic during pregnancy\", \"D\": \"Phenytoin and Depakine increase metabolism during pregnancy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Deals with the management of epilepsy during pregnancy, including pharmacokinetic changes (Lamotrigine clearance increases) and relative teratogenicity of AEDs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q215",
    "question_text": "If the seizures were deemed idiopathic with spike-wave discharges on EEG, what is the risk of seizure recurrence at 18 months?",
    "options": "{\"A\": \"17%\", \"B\": \"26%\", \"C\": \"30%\", \"D\": \"50%\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about the prognosis and risk of recurrence specifically related to idiopathic epilepsy characterized by generalized spike-wave discharges on EEG.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q333",
    "question_text": "In the same scenario, if the patient came to the emergency room, what is the treatment?",
    "options": "{\"A\": \"IV diazepam\", \"B\": \"IV phenytoin\", \"C\": \"IV valproate\", \"D\": \"IV levetiracetam\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about acute seizure management in the emergency setting. The specific scenario is missing, but the options relate to status epilepticus treatment.* (Vague context).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q332",
    "question_text": "A patient underwent a dental procedure and experienced brief loss of consciousness. What favors a diagnosis of seizure rather than syncope?",
    "options": "{\"A\": \"Cyanosis\", \"B\": \"Dizziness\", \"C\": \"Nausea\", \"D\": \"Confusion\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of clinical features that help differentiate seizure from syncope (post-event confusion is characteristic of seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q108",
    "question_text": "Patient with GTC seizure; what increases the recurrence of seizures?",
    "options": "{\"A\": \"Long duration\", \"B\": \"Presence of focal neurological signs\", \"C\": \"Abnormal EEG findings\", \"D\": \"History of status epilepticus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about factors predicting seizure recurrence after a first generalized tonic-clonic (GTC) seizure.* (Vague, assumes context about first seizure).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q350",
    "question_text": "What is the normal response to hyperventilation on EEG?",
    "options": "{\"A\": \"Generalized delta wave\", \"B\": \"Anterior theta/delta wave\", \"C\": \"Generalized theta wave\", \"D\": \"Diffuse slowing of background rhythm\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of normal EEG findings, specifically the characteristic generalized slowing (delta/theta activity) induced by hyperventilation, a standard activation procedure during EEG recording used often in epilepsy evaluation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q102",
    "question_text": "In the scenario of Panayiotopoulos Syndrome, which of the following is a characteristic feature of the syndrome?",
    "options": "{\"A\": \"Electrographic occipital spikes\", \"B\": \"Autonomic seizures\", \"C\": \"Early onset benign childhood seizures\", \"D\": \"Prolonged seizures with vomiting\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific clinical and electrographic features of a defined epilepsy syndrome (Panayiotopoulos Syndrome).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q101",
    "question_text": "A patient on lamotrigine wants to start oral contraceptive pills (OCP). What should you tell the patient?",
    "options": "{\"A\": \"The effect of OCP might be affected.\", \"B\": \"She needs to increase the dose of lamotrigine by 2 folds.\", \"C\": \"She needs to increase the dose of lamotrigine by 4 folds.\", \"D\": \"She should avoid OCP due to risk of seizures.\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns a common and clinically important drug interaction between an antiepileptic drug (lamotrigine) and oral contraceptives, directly relevant to epilepsy management.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q27",
    "question_text": "A 20-year-old female known to have seizures presented to the outpatient clinic. She is on Lacosamide 100 mg BID and has been compliant with her medication, with her last seizure occurring 18 months ago. Examination was unremarkable. EEG showed electrical discharges, and Brain MRI is normal. What is the next step?",
    "options": "{\"A\": \"Increase Lacosamide dose\", \"B\": \"Add Carbamazepine\", \"C\": \"Consider surgery\", \"D\": \"Add Topiramate\"}",
    "correct_answer": "D",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the clinical management strategy for a patient with epilepsy, involving decisions about antiepileptic drug therapy based on seizure control, medication compliance, and EEG findings.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q83",
    "question_text": "A 70-year-old man with a history of obesity, hypertension, hypercholesterolemia, nephrolithiasis, and atrial fibrillation is evaluated for recent onset seizures. An MRI of the head shows an old right frontal ischemic stroke. Which of the following is the most appropriate drug for seizure treatment in this patient?",
    "options": "{\"A\": \"Gabapentin\", \"B\": \"Lamotrigine\", \"C\": \"Phenytoin\", \"D\": \"Topiramate\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the selection of an appropriate anti-epileptic drug (AED) considering patient age, comorbidities, and etiology (post-stroke epilepsy).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q25",
    "question_text": "A 25-year-old pregnant lady came to the outpatient neurology clinic for follow-up. She is a known case of epilepsy and currently on Valproic acid 500 mg daily. The last time she had a breakthrough seizure was at least 3 years ago. Her last EEG and brain MRI were normal. Which of the following is the appropriate management?",
    "options": "{\"A\": \"Stop Valproic acid\", \"B\": \"Switch to Lamotrigine\", \"C\": \"Quality of life counseling\", \"D\": \"Counsel her about breastfeeding\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the management of epilepsy during pregnancy, specifically regarding the teratogenicity of AEDs like Valproic acid and safer alternatives.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q26",
    "question_text": "A young patient presented to the neurology outpatient clinic for epilepsy evaluation. He has seizure semiology in the form of right upper limb tonic posturing followed by limb jerking with lack of awareness, then bilateral tonic-clonic seizure. He doesn\u2019t recall the episode. He has a history of 4 car accidents, one of which required ICU admission for 3 days. What is the best description for his seizure semiology?",
    "options": "{\"A\": \"Jacksonian March\", \"B\": \"Impaired awareness to bilateral tonic-clonic seizure\", \"C\": \"Focal aware seizure\", \"D\": \"Absence seizure\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests the ability to classify seizure semiology based on a clinical description.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q212",
    "question_text": "What is the electrodecremental response in EEG associated with hypsarrhythmia?",
    "options": "{\"A\": \"2/sec\", \"B\": \"4/sec\", \"C\": \"6/sec\", \"D\": \"8/sec\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of specific EEG patterns (electrodecremental events) associated with epileptic syndromes like West Syndrome (hypsarrhythmia).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q214",
    "question_text": "Which of the following is associated with seizures and asymmetrical atrophy?",
    "options": "{\"A\": \"Glut1\", \"B\": \"GAD\", \"C\": \"GLUR3\", \"D\": \"NMDA receptor\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links clinical features (seizures, asymmetrical atrophy) to a potential underlying cause involving specific receptors/antibodies (GLUR3 implicated in Rasmussen's encephalitis, an epileptic encephalopathy).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q277",
    "question_text": "A child with perisylvian atrophy and unilateral weakness had initially focal seizures and then focal status epilepticus. What is the likely abnormality?",
    "options": "{\"A\": \"GluR3\", \"B\": \"KCNQ2\", \"C\": \"SCN1A\", \"D\": \"CDKL5\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes Rasmussen's encephalitis presentation (progressive atrophy, focal seizures/status epilepticus) and asks about an associated antibody (Anti-GluR3), placing the focus on this specific epilepsy syndrome.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q300",
    "question_text": "A 28-year-old man with a one-year history of episodes of posturing of both arms, described by his wife as flexion of one arm and extension of the other arm, head turn, and facial grimacing, with no loss of consciousness, occurring once a week and lasting less than 1 minute. What is the most likely localization of these symptoms?",
    "options": "{\"A\": \"Cingulate\", \"B\": \"Supplementary motor area\", \"C\": \"Orbitofrontal\", \"D\": \"Temporal lobe\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks to localize seizure semiology (asymmetric tonic posturing) to a specific brain region (Supplementary Motor Area).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q347",
    "question_text": "Valproic acid",
    "options": "{\"A\": \"Used primarily in Parkinson\\u2019s disease\", \"B\": \"An antibiotic agent\", \"C\": \"A common anti-epileptic drug\", \"D\": \"A medication for migraine prophylaxis only\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Names a common anti-epileptic drug. Too incomplete for specific classification, but best fit is Epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q45",
    "question_text": "A female patient with a history of epilepsy experiences seizures more frequently during menstruation. What is the underlying pathophysiology?",
    "options": "{\"A\": \"Estradiol lowers seizure threshold\", \"B\": \"Progesterone lowers seizure threshold\", \"C\": \"Seizure clusters around ovulation\", \"D\": \"Increased cortisol during menstruation\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the specific pathophysiology (hormonal influence - estradiol) of catamenial epilepsy, a sub-topic within epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q13",
    "question_text": "A patient with progressive myoclonus and dementia is being evaluated. How can the diagnosis be confirmed?",
    "options": "{\"A\": \"MRI\", \"B\": \"NCL skin biopsy\", \"C\": \"MERRF muscle biopsy\", \"D\": \"Muscle biopsy\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a phenotype suggestive of Progressive Myoclonus Epilepsy (PME), specifically asking about diagnostic tests relevant to subtypes like MERRF (muscle biopsy) or NCL (skin biopsy).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q58",
    "question_text": "A patient with recurrent episodes of staring followed by a ringing tone and rare generalized tonic-clonic seizures (GTCs) has a brother with a similar condition. What is the gene associated with this condition?",
    "options": "{\"A\": \"GABRA1\", \"B\": \"LGI1\", \"C\": \"KCNQ1\", \"D\": \"SCN1A\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a specific familial epilepsy syndrome (likely Autosomal Dominant Lateral Temporal Lobe Epilepsy with auditory features) and asks for the associated gene (LGI1).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q135",
    "question_text": "A mother brought her 2-month-old baby with seizures and a history of the same seizures in his older brother. The seizures resolved at 8 months of age. What is the likely gene involved?",
    "options": "{\"A\": \"SCN1A\", \"B\": \"SCN4A\", \"C\": \"KCNQ2\", \"D\": \"GABRA1\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes Benign Familial Neonatal Seizures (BFNS), characterized by onset and resolution age, familial pattern, and asks for the most common associated gene (KCNQ2).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q142",
    "question_text": "A 3-month-old infant has a history of clonic and possible tonic or myoclonic seizures. The sibling had a similar history that resolved. What is the likely gene affected?",
    "options": "{\"A\": \"KCNQ2 on chromosome 20\", \"B\": \"KCNQ3\", \"C\": \"SCN1A\", \"D\": \"CDKL5\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Scenario points towards Benign Familial Neonatal/Infantile Seizures, asking for the key gene (KCNQ2).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q149",
    "question_text": "A patient with seizures who sometimes had febrile seizures is diagnosed with Dravet syndrome. What is the correct statement regarding this condition?",
    "options": "{\"A\": \"Carbamazepine worsens the seizures.\", \"B\": \"It is associated with SCN1A mutations.\", \"C\": \"It leads to cognitive decline and motor deficits.\", \"D\": \"It typically responds well to sodium channel blockers.\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the clinical features, genetic association (SCN1A), and treatment considerations (Carbamazepine worsening) specific to Dravet syndrome, a severe epileptic encephalopathy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q150",
    "question_text": "What is the channel involved in juvenile myoclonic epilepsy (JME)?",
    "options": "{\"A\": \"Sodium (Na)\", \"B\": \"Calcium (Ca)\", \"C\": \"Chloride (Cl)\", \"D\": \"Potassium (K)\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the underlying channelopathy (specifically GABA-A receptor related, involving Chloride channels, though other channels are implicated) associated with a common genetic epilepsy syndrome (JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q191",
    "question_text": "In a case of temporal lobe epilepsy (TLE) with auditory features, which genetic mutation is typically asked about?",
    "options": "{\"A\": \"LGI-1\", \"B\": \"SCN1A\", \"C\": \"CACNA1A\", \"D\": \"KCNQ2\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Connects a specific epilepsy phenotype (TLE with auditory features) to its known genetic cause (LGI1).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q80",
    "question_text": "A 12-year-old patient presented with a history of seizures that started 3 years ago. The parents describe seizure semiology in the form of frequent staring episodes that cause poor school performance. Which of the following is the most likely gene mutation responsible for the patient's seizure type?",
    "options": "{\"A\": \"KNCT-1\", \"B\": \"KNCN-1\", \"C\": \"GABRA-1\", \"D\": \"SCN1A\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Links a specific epilepsy phenotype (childhood absence epilepsy) to potential underlying genetic causes (channelopathies/receptor mutations), placing it within the Epilepsy domain focused on etiology.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q53",
    "question_text": "A patient presents with short stature, a long history of seizures, and multiple skin macular and cutaneous tumors. Which of the following findings is most likely associated with this condition?",
    "options": "{\"A\": \"Tram track calcification\", \"B\": \"Multiple enhanced cortical tubers\", \"C\": \"Bilateral Optic Glioma\", \"D\": \"Subependymal giant cell astrocytoma\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes clinical features highly suggestive of Tuberous Sclerosis Complex (TSC), a genetic disorder, but focuses on seizures and asks about cortical tubers, which are key epileptogenic lesions, placing the emphasis on the epilepsy manifestation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q211",
    "question_text": "A history of seizures in a few months old baby, with a similar history in the older brother, is most likely associated with which genetic mutation?",
    "options": "{\"A\": \"KCNQ2/chr 12 [Typo, should be chr 20]\", \"B\": \"NCNQ1/chr 20 [Typo, likely KCNQ1]\", \"C\": \"SCN4A/chr 20 [Typo, SCN4A is chr 17]\", \"D\": \"KCNQ2/chr 20\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on identifying the specific genetic mutation (KCNQ2) responsible for an inherited epilepsy syndrome (benign familial neonatal seizures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q20",
    "question_text": "In a case involving Landau-Kleffner syndrome (verbal auditory agnosia and progressive aphasia) who was found to have electrographic seizures during sleep on EEG, what is the diagnosis?",
    "options": "{\"A\": \"Landau-Kleffner syndrome (LKS)\", \"B\": \"Childhood absence epilepsy\", \"C\": \"Benign Rolandic epilepsy\", \"D\": \"Lennox-Gastaut syndrome\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on recognizing Landau-Kleffner syndrome, a specific pediatric epilepsy syndrome characterized by language regression and EEG abnormalities.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q21",
    "question_text": "In a patient with developmental delay and multiple seizure types (tonic spasms, drop attacks), what is the finding on EEG?",
    "options": "{\"A\": \"Spike and slow waves slower than 2 Hz\", \"B\": \"Generalized 3 Hz spike-and-wave discharges\", \"C\": \"Focal temporal sharp waves\", \"D\": \"Hypsarrhythmia pattern\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a clinical scenario suggestive of Lennox-Gastaut Syndrome (LGS) and asks for the characteristic EEG finding (slow spike-and-wave), making it primarily an epilepsy question.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q409",
    "question_text": "In a normal child with a simple febrile seizure, what is the risk of developing epilepsy?",
    "options": "{\"A\": \"3%\", \"B\": \"7%\", \"C\": \"10%\", \"D\": \"15%\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the specific risk of developing epilepsy following febrile seizures, a core concept in epileptology and seizure prognosis.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q436",
    "question_text": "In a scenario where an infant with myoclonus started focally and became progressive, what would you expect to see on EEG?",
    "options": "{\"A\": \"Burst suppression\", \"B\": \"Focal spikes\", \"C\": \"Generalized slowing\", \"D\": \"Normal findings\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on interpreting the EEG pattern (burst suppression) associated with a specific infantile seizure presentation (progressive myoclonus), characteristic of early infantile epileptic encephalopathies (e.g., Ohtahara syndrome).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q61",
    "question_text": "In the same scenario of the young lady post-aneurysm clipping, what is the recommended antiepileptic drug (AED) to use?  [Implicit scenario involves post-SAH/clipping seizure]",
    "options": "{\"A\": \"Keppra\", \"B\": \"Gabapentin\", \"C\": \"Depakine\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the choice of antiepileptic drug (AED) for seizure prophylaxis or treatment in a specific clinical context (post-neurosurgery/SAH).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q30",
    "question_text": "A patient experiences a visual aura lasting for 10 seconds followed by a headache. What is the most likely explanation for this phenomenon?",
    "options": "{\"A\": \"Occipital seizures\", \"B\": \"Migraine aura\", \"C\": \"Tension-type headache\", \"D\": \"Cluster headache\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Presents a brief neurological event (visual aura) where occipital seizures are a key differential diagnosis, testing the ability to distinguish seizure from other paroxysmal events like migraine aura based on duration.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q65",
    "question_text": "A young lady who underwent tumor resection presents with a staring spell and loss of awareness. EEG shows frontal discharges. What is the classification of her seizure?",
    "options": "{\"A\": \"Focal motor onset with impaired awareness\", \"B\": \"Absence seizure\", \"C\": \"Unknown onset\", \"D\": \"Focal non-motor onset with impaired awareness\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the specific electro-clinical classification of a seizure based on semiology (staring, loss of awareness) and EEG findings (frontal discharges) following brain surgery.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q36",
    "question_text": "Patient with absence seizure; what is the medication that worsens the seizure?",
    "options": "{\"A\": \"Oxycarbazepine\", \"B\": \"Ethosuximide\", \"C\": \"Valproic acid\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The question directly addresses the management of absence seizures and the potential for certain anti-epileptic drugs (like Oxcarbazepine) to worsen this specific seizure type.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q10",
    "question_text": "A patient presents with a figure of 4, fencing posture, and right side nose rubbing. Which localization is most likely?",
    "options": "{\"A\": \"Left temporal\", \"B\": \"Right temporal\", \"C\": \"Left frontal\", \"D\": \"Right parietal\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on localizing seizure onset based on specific ictal semiology (automatisms and postures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q28",
    "question_text": "In a case scenario of a patient with Mesial Temporal Lobe Epilepsy (MTLE) on two sufficient anti-seizure medications, but still experiencing monthly seizures, what is the next step?",
    "options": "{\"A\": \"Start workup for epilepsy surgery\", \"B\": \"Add a third anti-seizure medication\", \"C\": \"Increase the dose of current anti-seizure medications\", \"D\": \"Recommend lifestyle modifications and stress reduction\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Concerns the management pathway for medically refractory focal epilepsy (MTLE), specifically considering epilepsy surgery evaluation.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q2",
    "question_text": "An elderly patient with a history of diabetes mellitus, hypertension, hyperlipidemia, and osteoporosis presents with seizures. Which medication is commonly used for seizure management in this patient?",
    "options": "{\"A\": \"Valproate\", \"B\": \"Phenytoin\", \"C\": \"Lamotrigine\", \"D\": \"Lacosamide\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on selecting an appropriate anti-seizure medication considering the patient's age and comorbidities.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q42",
    "question_text": "A patient with partial seizures has a PET scan showing hypometabolism in the perisylvian region. Which receptor is most likely involved?",
    "options": "{\"A\": \"GluR3\", \"B\": \"GLUT-1\", \"C\": \"NMDA\", \"D\": \"AMPA\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Links neuroimaging findings (PET hypometabolism) in epilepsy to underlying receptor pathophysiology.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q25",
    "question_text": "A patient has an abdominal rising sensation and d\u00e9j\u00e0 vu. Which of the following is involved in the pathophysiology?",
    "options": "{\"A\": \"Activation of dentate nucleus\", \"B\": \"Schaffer collateral from C3 to C1\", \"C\": \"Mossy fiber\", \"D\": \"Hippocampal pyramidal neurons\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes classic temporal lobe seizure semiology (aura) and asks about the underlying neuroanatomical/physiological substrate related to seizure propagation in the hippocampus.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q2",
    "question_text": "A boy with uncontrolled seizures is known to have bipolar disorder. What is the most appropriate management option for his seizures?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Levetiracetam\", \"C\": \"Valproate\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on selecting an appropriate anti-epileptic drug (AED) while considering a significant psychiatric comorbidity (bipolar disorder) that influences AED choice (Valproate often used for both).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q200",
    "question_text": "Which of the following statements is true regarding absence seizures?",
    "options": "{\"A\": \"Carbamazepine is effective\", \"B\": \"Ethosuximide can cause status in absence seizures\", \"C\": \"The pathophysiology is related to T calcium channels\", \"D\": \"Absence seizures typically originate in the frontal lobe\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the pathophysiology and treatment specifics (T-type calcium channels, ethosuximide use) of absence seizures.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q11",
    "question_text": "What is true about Juvenile Myoclonic Epilepsy (JME)?",
    "options": "{\"A\": \"Can be provoked by photic stimulation\", \"B\": \"Most patients will be seizure-free\", \"C\": \"Typically presents with myoclonic jerks on awakening\", \"D\": \"Usually begins in early childhood\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the clinical characteristics (photic sensitivity) of a specific epilepsy syndrome (JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q145",
    "question_text": "An elderly male with a history of diabetes mellitus, hypertension, dyslipidemia, and ischemic heart disease presented with an episode of loss of consciousness preceded by sweating and palpitations. The episode lasted a few seconds, and he immediately regained full baseline. His heart rate was borderline low at 50 beats per minute. What is the most likely diagnosis?",
    "options": "{\"A\": \"Typical syncope\", \"B\": \"Rhythmic jerking\", \"C\": \"Epileptic seizure\", \"D\": \"Oral automatism\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to differentiate syncope (likely cardiogenic/vasovagal given prodrome and bradycardia) from epileptic seizure based on clinical description.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q201",
    "question_text": "A 33-year-old with a history of generalized tonic-clonic seizure with an aura of a rising abdominal sensation. What is the most likely localization of the seizure focus?",
    "options": "{\"A\": \"Temporal lobe epilepsy\", \"B\": \"Frontal lobe\", \"C\": \"Parietal lobe\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of seizure semiology (epigastric rising aura) and its correlation with seizure localization (temporal lobe).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q8",
    "question_text": "A patient experiences an abdominal rising sensation and d\u00e9j\u00e0 vu. Which localization is most likely associated with this pathophysiology?",
    "options": "{\"A\": \"Frontal\", \"B\": \"Frontotemporal\", \"C\": \"Mesial Temporal\", \"D\": \"Occipital\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of specific seizure auras (epigastric rising, d\u00e9j\u00e0 vu) and their typical localization (mesial temporal structures).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q112",
    "question_text": "A 45-year-old patient with a known case of diabetes mellitus (DM) and hypertension (HTN) presents with new onset seizure. A brain MRI shows a left temporal lesion (cavernoma). What is the most appropriate next step?",
    "options": "{\"A\": \"Start lamotrigine\", \"B\": \"Refer to neurosurgery\", \"C\": \"EEG\", \"D\": \"Start phenytoin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the management of a new-onset seizure secondary to a structural lesion (cavernoma), involving antiepileptic drug choice, EEG, and potential surgical referral.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q262",
    "question_text": "A 28-year-old female with a hemorrhagic lesion in the brain had a staring episode followed by post-event confusion. Which of the following is a suitable antiepileptic medication?",
    "options": "{\"A\": \"Phenytoin\", \"B\": \"Ethosuximide\", \"C\": \"Carbamazepine\", \"D\": \"Valproic acid\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the selection of an appropriate antiepileptic drug for managing seizures secondary to a structural brain lesion (hemorrhage).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q73",
    "question_text": "An elderly patient with a history of diabetes mellitus (DM), hypertension (HTN), and end-stage renal disease (ESRD) came with decreased level of consciousness (LOC). His wife mentioned that he told her he was seeing animals before deteriorating. A CT scan showed left occipital hypodensity. What will you do?",
    "options": "{\"A\": \"CTA\", \"B\": \"EEG\", \"C\": \"MRI brain\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: While a stroke is present (occipital hypodensity), the preceding visual hallucinations and decreased LOC raise suspicion for non-convulsive status epilepticus originating from the stroke area, making EEG a crucial next step.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q263",
    "question_text": "Keppra",
    "options": "{\"A\": \"Used primarily for Parkinson\\u2019s disease\", \"B\": \"An anti-epileptic drug used in seizure management\", \"C\": \"A medication for migraine prophylaxis\", \"D\": \"A treatment for multiple sclerosis\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: This MCQ only provides the name of an anti-epileptic drug (Levetiracetam/Keppra). While used in various settings, its primary association is with epilepsy management. (Note: Insufficient information for definitive classification without a question).* **Reclassified to Other_Unclassified due to lack of a question.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q62",
    "question_text": "A 5-year-old child presents with cognitive decline since 7 months of age and has frequent spasms with hypsarrhythmia. After receiving ACTH, there was some improvement. What is the likely diagnosis?",
    "options": "{\"A\": \"West Syndrome\", \"B\": \"Lennox-Gastaut Syndrome (LGS)\", \"C\": \"Infantile Spasms\", \"D\": \"Dravet Syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Classic presentation of West Syndrome, an epilepsy syndrome.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q34",
    "question_text": "A 30-year-old patient with seizures controlled on antiepileptic drugs (AED) developed facial redness and fatigue. What is the most likely AED causing these side effects?",
    "options": "{\"A\": \"Vigabatrin\", \"B\": \"Felbamate\", \"C\": \"Phenytoin\", \"D\": \"Valproic acid\"}",
    "correct_answer": "C",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on side effects of anti-epileptic drugs.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q35",
    "question_text": "A patient with features of Rolandic epilepsy presents with what EEG finding?",
    "options": "{\"A\": \"Continuous spike and wave during sleep\", \"B\": \"Central sharp wave in the mid-temporal area\", \"C\": \"Generalized 3 Hz spike-and-wave discharges\", \"D\": \"Occipital intermittent rhythmic delta activity\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Question about the EEG findings in Rolandic epilepsy",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q67",
    "question_text": "In a patient with occipital seizure and migraine with aura, which of the following is in favor of visual aura?",
    "options": "{\"A\": \"Circular coloring\", \"B\": \"Typical migraine headache\", \"C\": \"Scintillating\", \"D\": \"30 seconds to 1 minute in duration\"}",
    "correct_answer": "C",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Differentiates between seizure and migraine aura characteristics.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q18",
    "question_text": "Patients presented with symptoms suggestive of mitochondrial disorder. What investigation will be most helpful?",
    "options": "{\"A\": \"Acylcarnitine profile\", \"B\": \"Lactate/pyruvate profile\", \"C\": \"Thymidine level\", \"D\": \"Muscle biopsy for mitochondrial DNA analysis\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the specific biochemical investigation profile (lactate/pyruvate) characteristic for suspected broad category of inherited mitochondrial disorders.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q33",
    "question_text": "Which of the following brain MRI findings is characteristic of Kearns-Sayre Syndrome?",
    "options": "{\"A\": \"Increased T2W signal in the periventricular region\", \"B\": \"Increased T2W signal in the thalamus and globus pallidus\", \"C\": \"Decreased T2W signal in the subcortical white matter\", \"D\": \"No significant findings\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about specific neuroimaging findings characteristic of a primary mitochondrial genetic syndrome (Kearns-Sayre).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q43",
    "question_text": "A young patient presents with neuropathy, headache, and visual symptoms. An MRI shows anterior temporal and occipital changes versus atrophy. What is the most appropriate next step?",
    "options": "{\"A\": \"Skin biopsy\", \"B\": \"Muscle biopsy\", \"C\": \"Mitochondrial testing for MELAS\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: The clinical picture and MRI findings raise suspicion for MELAS, and the question asks for the specific diagnostic approach (mitochondrial testing).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q53",
    "question_text": "A young patient has tics and seizures, and MRI shows diffuse high signal intensity. How can the diagnosis be made?",
    "options": "{\"A\": \"Skin biopsy\", \"B\": \"Muscle biopsy\", \"C\": \"Genetic testing\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Presents a complex neurological picture (tics, seizures, MRI changes) where the diagnostic approach points towards potentially underlying genetic causes requiring specific tissue biopsy or genetic testing, without fitting clearly into another subspecialty based on the limited info.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q54",
    "question_text": "In a typical scenario of MELAS, how can the diagnosis be made?",
    "options": "{\"A\": \"Lactate-pyruvate profile\", \"B\": \"MRI of the brain\", \"C\": \"Muscle biopsy\", \"D\": \"Genetic testing\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the diagnostic methods (biopsy, genetics, biochemical profile) for a specific mitochondrial genetic syndrome (MELAS).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q62",
    "question_text": "A 16-year-old female presented with oculomotor apraxia and ataxia; she had normal immunoglobulin levels and high AFP. What is the diagnosis?",
    "options": "{\"A\": \"Ataxia telangiectasia\", \"B\": \"Oculomotor apraxia type 1\", \"C\": \"Oculomotor apraxia type 2\", \"D\": \"Friedreich ataxia\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on differentiating genetic syndromes (Ataxia Telangiectasia vs Oculomotor Apraxia types) based on clinical features (ataxia, OMA) and specific lab findings (AFP).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q82",
    "question_text": "A patient presents with ataxia and has a family history of X-linked recessive disorders. What is the most likely diagnosis?",
    "options": "{\"A\": \"Adrenoleukodystrophy\", \"B\": \"Friedreich's ataxia\", \"C\": \"Ataxia-telangiectasia\", \"D\": \"Spinocerebellar ataxia\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: The question asks for the differential diagnosis of ataxia based primarily on the inheritance pattern (X-linked) and clinical presentation.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q137",
    "question_text": "A 20-year-old patient presents with ataxia, spasticity, sensorimotor neuropathy, hypometric saccades, and brain MRI shows mild cerebellar atrophy. What is the most likely diagnosis?",
    "options": "{\"A\": \"Friedreich's ataxia\", \"B\": \"Ataxic telangiectasia\", \"C\": \"OPA1\", \"D\": \"OPA2\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the ability to diagnose a specific hereditary ataxia syndrome (likely Friedreich's Ataxia given the constellation of symptoms) based on clinical features.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q170",
    "question_text": "A child with insomnia and low gonadotropin levels underwent an MRI that showed agenesis of the olfactory bulb. What is the most likely diagnosis?",
    "options": "{\"A\": \"Hypogonadotropic Hypogonadism (HNPH)\", \"B\": \"Kal-1\", \"C\": \"MEPRC2\", \"D\": \"TSC1\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes the features of Kallmann syndrome (hypogonadism, anosmia due to olfactory bulb agenesis) and asks for the diagnosis or associated gene (Kal-1).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q179",
    "question_text": "A patient came with ataxia, optic atrophy, hearing loss, and slow saccades; what is the diagnosis?",
    "options": "{\"A\": \"Machado-Joseph disease\", \"B\": \"SCA 6\", \"C\": \"SCA 7\", \"D\": \"NARP\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Requires differentiating between different spinocerebellar ataxias (SCAs) and mitochondrial disorders (NARP) based on a specific constellation of neurological deficits (ataxia, optic atrophy, hearing loss, saccades).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q69",
    "question_text": "A 20-year-old patient presents with a 10-year history of lower limb proximal weakness and difficulty standing from a sitting position. He has siblings with the same problem, and his parents are related. EMG findings are not available, and CK levels are 2800. What is the chance that the patient will pass the disease to his offspring?",
    "options": "{\"A\": \"50% normal\", \"B\": \"25% normal\", \"C\": \"25% carrier\", \"D\": \"50% affected\"}",
    "correct_answer": "D",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests understanding of autosomal recessive inheritance probability calculation in the context of a likely genetic neuromuscular disorder (LGMD), focusing on the genetic risk transmission.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q17",
    "question_text": "A case of spastic paraplegia with a family history of multiple sclerosis in the brother shows periventricular white matter lesions on MRI. What is the gene associated with this condition?",
    "options": "{\"A\": \"SPAST\", \"B\": \"SPG4\", \"C\": \"SPG3A\", \"D\": \"ATL1\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying a gene associated with Hereditary Spastic Paraplegia, despite potentially confounding information.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q10",
    "question_text": "A case of ataxia with one sister and brother affected but none of the parents involved (autosomal recessive) presents with ataxia and decreased reflexes. The patient closes his eyes and shakes his head to change his gaze, with a normal musculoskeletal exam. What is the likely diagnosis?",
    "options": "{\"A\": \"Friedreich's ataxia\", \"B\": \"Ataxia oculomotor apraxia (if no systemic manifestations, this is the answer)\", \"C\": \"Spinocerebellar ataxia III\", \"D\": \"Ataxia telangiectasia (if there are systemic manifestations, this is the answer)\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Involves the differential diagnosis of inherited ataxias based on clinical features (oculomotor apraxia) and inheritance pattern.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q83",
    "question_text": "A 14-year-old boy presents with lancinating pain in his feet. His sister has similar symptoms. There is a significant family history of strokes in his maternal grandfather before age 50. On examination, he has pain sensation scaling. His lower extremities show normal skin lesions. What is the best test to diagnose?",
    "options": "{\"A\": \"Galactosidase activity\", \"B\": \"Transferrin\", \"C\": \"VLCFA\", \"D\": \"PMP 22 gene\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the specific diagnostic enzymatic test for Fabry disease, a genetic metabolic disorder, based on clinical features (neuropathic pain, family history of stroke).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q75",
    "question_text": "A young male with diabetes mellitus presents with gait and limb ataxia, lower limb weakness, and hearing loss. Examination shows lower limb weakness and areflexia. What is the most appropriate next step in management?",
    "options": "{\"A\": \"Send him to cardiology to rule out cardiomyopathy\", \"B\": \"Most of them are autosomal dominant\", \"C\": \"Related to CAG\", \"D\": \"Related to CTG\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on managing a key systemic complication (cardiomyopathy) associated with a specific hereditary ataxia (likely Friedreich's Ataxia based on the clinical picture).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q131",
    "question_text": "A patient presents with hypomelanotic lesions. Which condition is most likely?",
    "options": "{\"A\": \"Neurofibromatosis Type 1 (NF1)\", \"B\": \"Neurofibromatosis Type 2 (NF2)\", \"C\": \"Tuberous Sclerosis (TS)\", \"D\": \"Sturge-Weber Syndrome\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links a specific cutaneous finding (hypomelanotic macules) to its associated phakomatosis (Tuberous Sclerosis).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q130",
    "question_text": "A case of ADHD is presented alongside a hyperpigmented brownish skin lesion with axillary freckling. Which condition is most likely?",
    "options": "{\"A\": \"Neurofibromatosis Type 1 (NF1)\", \"B\": \"Neurofibromatosis Type 2 (NF2)\", \"C\": \"Tuberous Sclerosis (TS)\", \"D\": \"Sturge-Weber Syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links characteristic cutaneous findings (cafe-au-lait, freckling) and associated neurodevelopmental features (ADHD) to Neurofibromatosis Type 1.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q168",
    "question_text": "Case of X-linked inheritance (all the men in the family have similar symptoms); what is the answer?",
    "options": "{\"A\": \"Adrenoleukodystrophy\", \"B\": \"Duchenne Muscular Dystrophy\", \"C\": \"Hemophilia A\", \"D\": \"Fragile X Syndrome\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Uses the inheritance pattern (X-linked) to identify a likely diagnosis (Adrenoleukodystrophy), focusing on the genetic transmission.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q192",
    "question_text": "In a case of Refsum's disease, a patient had trouble with vision during the night and has polyneuropathy. What is the diagnosis?",
    "options": "{\"A\": \"Refsum's disease\", \"B\": \"Retinitis pigmentosa\", \"C\": \"Charcot-Marie-Tooth disease\", \"D\": \"Vitamin A deficiency\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests recognition of a specific inherited metabolic disorder (Refsum's disease) based on key clinical features (retinitis pigmentosa, polyneuropathy). While it has neuromuscular and neuro-ophthalmological aspects, the core is recognizing the genetic syndrome itself.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q50",
    "question_text": "What is the mode of inheritance for Fahr disease?",
    "options": "{\"A\": \"Autosomal Recessive\", \"B\": \"Autosomal Dominant\", \"C\": \"X-linked\", \"D\": \"There are 2 modes of transmission\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Directly asks about the mode of inheritance for a specific neurogenetic condition (Fahr disease/Idiopathic Basal Ganglia Calcification) which doesn't fit neatly into another clinical subspecialty.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q41",
    "question_text": "In the scenario of Wilson's disease, what is the recommended treatment?",
    "options": "{\"A\": \"D-penicillamine\", \"B\": \"Zinc\", \"C\": \"Tetrathiomolybdate\", \"D\": \"Liver transplant\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the primary treatment targeting the underlying metabolic defect (copper accumulation) in Wilson's disease, an inherited metabolic disorder. While it has movement disorder manifestations, the question focuses on treating the core genetic/metabolic issue.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q183",
    "question_text": "In a case of Fabry disease, what is the recommended treatment?",
    "options": "{\"A\": \"Alpha galactosidase, enzyme replacement\", \"B\": \"Bone marrow transplantation\", \"C\": \"Corticosteroid therapy\", \"D\": \"Plasma exchange\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the specific enzyme replacement therapy for Fabry disease, an inherited lysosomal storage disorder. The focus is on the treatment targeting the underlying genetic defect.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q30",
    "question_text": "A patient with Marfanoid habitus and lens dislocation is being evaluated. What treatment will you give to him?",
    "options": "{\"A\": \"Vitamin B6\", \"B\": \"Vitamin B12\", \"C\": \"Folic acid\", \"D\": \"Beta-blockers\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes features suggestive of Homocystinuria (an inherited metabolic disorder) and asks for its specific treatment (Vitamin B6 cofactor therapy), focusing on the management of the core genetic/metabolic defect.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q24",
    "question_text": "Which of the following cardiac abnormalities is commonly associated with Kearns-Sayre Syndrome?",
    "options": "{\"A\": \"Atrial fibrillation\", \"B\": \"Ventricular septal defect\", \"C\": \"Cardiac conduction defects\", \"D\": \"Myocardial infarction\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about a specific systemic complication (cardiac conduction defects) intrinsically linked to Kearns-Sayre Syndrome, a primary mitochondrial genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q31",
    "question_text": "What is the common genetic mutation found in most patients with Kearns-Sayre Syndrome?",
    "options": "{\"A\": \"Point mutation in nuclear DNA\", \"B\": \"Large deletion of mitochondrial DNA\", \"C\": \"Duplication of mitochondrial DNA\", \"D\": \"Translocation of mitochondrial DNA\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Directly asks specifically for the common type of genetic mutation (mitochondrial DNA deletion) underlying Kearns-Sayre Syndrome.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q3",
    "question_text": "A patient has had two strokes, sensory peripheral neuropathy, and a skin rash. What enzyme is involved in this disease?",
    "options": "{\"A\": \"Alpha-Galactosidase\", \"B\": \"Hexosaminidase A\", \"C\": \"Glucocerebrosidase\", \"D\": \"Arylsulfatase A\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes the classic triad for Fabry disease and asks for the underlying deficient enzyme. Although stroke is mentioned, the core of the question is the biochemical basis of this inherited disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q100",
    "question_text": "A young male patient presented for evaluation of limb numbness. He is complaining of paresthesia and burning sensation over the hands. He is also following with cardiology regarding coronary artery disease. On physical examination, there are lymphadenopathy, enlarged tonsils, and hepatomegaly. Which of the following is a common finding during laboratory evaluation for this disorder (Tangier disease)?",
    "options": "{\"A\": \"Low HDL\", \"B\": \"High HDL\", \"C\": \"High Cholesterol\", \"D\": \"Low triglyceride\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes the clinical features of a specific genetic lipid metabolism disorder (Tangier disease) and asks for its characteristic laboratory finding (low HDL), focusing on the diagnosis of this inherited condition.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q84",
    "question_text": "How should a young patient with Wilson disease be treated?",
    "options": "{\"A\": \"Chelation therapy\", \"B\": \"Liver transplant\", \"C\": \"Zinc supplementation\", \"D\": \"Dietary copper restriction\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Although Wilson disease has neurological manifestations (often movement disorders), the question asks about the primary treatment (chelation, zinc) targeting the underlying genetic metabolic disorder (copper accumulation).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q41",
    "question_text": "A patient exhibits startle reflex with sudden closure of his eyelids, worsening with cold. What is the gene or channel involved?",
    "options": "{\"A\": \"Chloride channel\", \"B\": \"Potassium channel\", \"C\": \"Sodium channel\", \"D\": \"Calcium channel\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes symptoms suggestive of hyperekplexia (startle disease), a condition often caused by genetic mutations (e.g., in GLRA1 affecting glycine receptors, linked functionally to chloride channels), and asks about the underlying molecular basis (channel/gene). It doesn't fit neatly into other clinical categories.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q93",
    "question_text": "What is the case for the diagnosis of Fabry Disease?",
    "options": "{\"A\": \"Alpha galactosidase\", \"B\": \"Beta glucocerebrosidase\", \"C\": \"Hexosaminidase A\", \"D\": \"Arylsulfatase A\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the key diagnostic marker (deficient enzyme activity - alpha galactosidase) for Fabry Disease, an inherited metabolic disorder. The focus is on diagnosing the underlying genetic condition.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q93",
    "question_text": "What is the case for the diagnosis of Fabry Disease?",
    "options": "{\"A\": \"Alpha galactosidase\", \"B\": \"Beta glucocerebrosidase\", \"C\": \"Hexosaminidase A\", \"D\": \"Arylsulfatase A\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the key diagnostic marker (enzyme deficiency - alpha galactosidase) for Fabry Disease, a core aspect of this inherited metabolic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q44",
    "question_text": "In a case scenario of spinal muscular atrophy (SMA) suggestive of autosomal recessive inheritance, what is the likelihood of being affected in the offspring?",
    "options": "{\"A\": \"25% affected\", \"B\": \"25% carriers\", \"C\": \"50% carriers\", \"D\": \"50% normal\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses purely on calculating Mendelian inheritance risk (autosomal recessive), using SMA as the example disease context, testing fundamental genetic principles.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q437",
    "question_text": "What would be the response to a dopamine agonist in a patient who does not respond to L-dopa?",
    "options": "{\"A\": \"Aromatic decarboxylase deficiency\", \"B\": \"Parkinson\\u2019s disease\", \"C\": \"Multiple system atrophy\", \"D\": \"Dopamine transporter deficiency syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on diagnosing a specific genetic metabolic disorder affecting neurotransmitter synthesis (Aromatic L-amino acid decarboxylase deficiency) based on differential therapeutic response, relating to the underlying biochemical genetics.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q439",
    "question_text": "A patient presents with recurrent falls and an abnormal brain MRI, with a family history of similar symptoms. What is the likely diagnosis?",
    "options": "{\"A\": \"Adrenomyeloneuropathy\", \"B\": \"Multiple sclerosis\", \"C\": \"Parkinson\\u2019s disease\", \"D\": \"Spinocerebellar ataxia\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Points towards the diagnosis of Adrenomyeloneuropathy (AMN), a genetic leukodystrophy, based on clinical features, MRI findings, and family history suggesting an inherited disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q104",
    "question_text": "A patient with ADHD has a mother with brown pigmentations in her neck. What is the diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis type 1 (NF1).\", \"B\": \"Tuberous sclerosis complex\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"McCune-Albright syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Connects neurological/behavioral features (ADHD) with characteristic physical signs (cafe-au-lait spots implied) in a family member to diagnose an inherited neurocutaneous disorder (NF1).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q139",
    "question_text": "A patient presents with clinical features of night blindness, disequilibrium, hearing loss, itchy dry skin, symmetrical polyneuropathy, distal muscle weakness, pes cavus, and hammer toe. His total serum protein was increased, and nerve conduction velocities were slow. What is the diagnosis?",
    "options": "{\"A\": \"Refsum disease\", \"B\": \"Friedrich ataxia\", \"C\": \"NARP\", \"D\": \"Charcot-Marie-Tooth disease\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a constellation of symptoms characteristic of Refsum disease, an inherited disorder of phytanic acid metabolism, testing recognition of this specific genetic syndrome.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q145",
    "question_text": "In a scenario of symptoms suggestive of Fabry disease, what is the treatment?",
    "options": "{\"A\": \"Agalsidase (Enzyme replacement therapy)\", \"B\": \"L-arginine\", \"C\": \"Chaperone therapy (e.g., Migalastat)\", \"D\": \"Supportive care including pain management\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the specific disease-modifying treatment (enzyme replacement therapy) targeting the underlying defect in Fabry disease, a genetic lysosomal storage disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q97",
    "question_text": "A child with insomnia and low gonadotropin levels underwent an MRI that showed agenesis of the olfactory bulb. What is the likely diagnosis?",
    "options": "{\"A\": \"Hypogonadotropic Hypogonadism (HNPH)\", \"B\": \"Kallmann Syndrome (Kal-1)\", \"C\": \"MEPRC2\", \"D\": \"TSC1\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes key features (hypogonadotropic hypogonadism and anosmia/olfactory bulb agenesis) defining Kallmann Syndrome, a specific genetic developmental disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q450",
    "question_text": "A scenario presents with oculomotor apraxia, spasticity, myoclonic seizures, and hepatosplenomegaly. Which of the following is the most likely associated enzyme deficiency?",
    "options": "{\"A\": \"Progranulin\", \"B\": \"Glucocerebrosidase\", \"C\": \"Hexosaminidase A\", \"D\": \"Arylsulfatase A\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes features suggestive of Neuronopathic Gaucher disease (a lysosomal storage disorder) and asks for the associated enzyme deficiency (Glucocerebrosidase), focusing on the biochemical basis of this genetic condition.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q341",
    "question_text": "A scenario is typical for Guillain-Barr\u00e9 Syndrome (GBS) except that the patient had intermittent epigastric pain with recent vaccination and facial sweating. What is the likely diagnosis?",
    "options": "{\"A\": \"Acute Intermittent Porphyria (AIP)\", \"B\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\", \"C\": \"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\", \"D\": \"Autonomic Neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires differentiating an acquired neuropathy (GBS/AIDP) from an inherited metabolic disorder (AIP) presenting with similar neurological but distinct systemic symptoms (abdominal pain, autonomic features).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q76",
    "question_text": "What are potential endocrine abnormalities associated with Kearns-Sayre Syndrome?",
    "options": "{\"A\": \"Hyperthyroidism and hyperaldosteronism\", \"B\": \"Hypothyroidism and diabetes mellitus\", \"C\": \"Hypoparathyroidism and adrenal insufficiency\", \"D\": \"Growth hormone deficiency\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about systemic (endocrine) manifestations of Kearns-Sayre Syndrome, a primary mitochondrial genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q86",
    "question_text": "Case of X-linked inheritance (all the men in the family have similar symptoms); what is the answer?",
    "options": "{\"A\": \"Adrenoleukodystrophy\", \"B\": \"Duchenne muscular dystrophy\", \"C\": \"Hemophilia A\", \"D\": \"Fragile X syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of X-linked inheritance patterns and association with specific neurological disorders like Adrenoleukodystrophy (ALD), focusing on the genetic transmission and diagnosis.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q294",
    "question_text": "What is the likely diagnosis for a patient presenting with hyperammonemia and low L-citrulline levels?",
    "options": "{\"A\": \"Urea cycle disorder\", \"B\": \"Maple syrup urine disease\", \"C\": \"Mitochondrial encephalopathy\", \"D\": \"Ornithine transcarbamylase deficiency\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests interpretation of characteristic metabolic lab abnormalities (hyperammonemia, amino acid levels) to diagnose an inherited metabolic condition (Urea Cycle Disorder).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q26",
    "question_text": "Which disease is characterized by the presence of globoid cells?",
    "options": "{\"A\": \"Krabbe Disease\", \"B\": \"Tay-Sachs Disease\", \"C\": \"Metachromatic Leukodystrophy\", \"D\": \"Niemann-Pick Disease\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of a specific pathognomonic pathological hallmark (globoid cells) directly linked to a specific inherited metabolic neurological disorder (Krabbe disease).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q37",
    "question_text": "Pediatric patient had a bullous rash that worsens with sun exposure, and he has conjunctivitis; what is the diagnosis?",
    "options": "{\"A\": \"Xeroderma pigmentosum\", \"B\": \"Epidermolysis bullosa\", \"C\": \"Porphyria cutanea tarda\", \"D\": \"Systemic lupus erythematosus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the diagnosis of a specific genetic syndrome (Xeroderma Pigmentosum) based on characteristic non-neurological clinical features (dermatological, ophthalmological) linked to a DNA repair defect.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q51",
    "question_text": "Pediatric patient had mental retardation, tremor, and ataxia; his sister had ovarian insufficiency; what is the typical imaging finding?",
    "options": "{\"A\": \"Bilateral cerebellar hyperintensity\", \"B\": \"Cerebral cortical atrophy\", \"C\": \"Basal ganglia calcifications\", \"D\": \"White matter demyelination\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The combination of pediatric neurological symptoms, family history (premature ovarian insufficiency suggests FMR1 premutation), and potential imaging findings points towards diagnosing an underlying genetic disorder (like Fragile X premutation/FXTAS spectrum).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q175",
    "question_text": "A 60-year-old male presented at age 40 with ophthalmoplegia and visual symptoms but no visual loss. Later, at age 50, he developed parkinsonism and gait issues along with cardiac symptoms. What is the likely diagnosis?",
    "options": "{\"A\": \"Kearns-Sayre syndrome\", \"B\": \"Leber's Hereditary Optic Neuropathy (LHON)\", \"C\": \"Chronic Progressive External Ophthalmoplegia (CPEO)\", \"D\": \"Myasthenia Gravis\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: The constellation of progressive external ophthalmoplegia, parkinsonism, and cardiac symptoms over time strongly suggests a mitochondrial disorder (KSS/CPEO), classifying it based on the underlying genetic pathophysiology.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q235",
    "question_text": "A patient with ADHD presents with light brown lesions. What is the most likely diagnosis?",
    "options": "{\"A\": \"Tuberous sclerosis complex (TSC)\", \"B\": \"Neurofibromatosis (NF)\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"Von Hippel-Lindau disease\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on diagnosing a neurocutaneous syndrome (Neurofibromatosis Type 1) based on the association of neurological/behavioral features (ADHD) and characteristic skin findings (cafe-au-lait spots), recognizing a specific genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q40",
    "question_text": "In a scenario of Fabry disease, what is the enzyme that is defective?",
    "options": "{\"A\": \"Alpha-galactosidase A\", \"B\": \"Beta-glucocerebrosidase\", \"C\": \"Sphingomyelinase\", \"D\": \"Hexosaminidase A\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks specifically about the underlying biochemical defect (deficient alpha-galactosidase enzyme leading to Gb3 accumulation) in Fabry disease, a genetic lysosomal storage disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q55",
    "question_text": "Same scenario asking about diagnosis:",
    "options": "{\"A\": \"Fragile X syndrome\", \"B\": \"Down syndrome\", \"C\": \"Rett syndrome\", \"D\": \"Angelman syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Points towards Fragile X syndrome, a primary genetic disorder causing intellectual disability and other features, assuming the (missing) prior scenario described relevant clinical characteristics.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q22",
    "question_text": "A patient presents with blurry vision, ataxia, and ophthalmoplegia. Which condition is most likely?",
    "options": "{\"A\": \"SCA3\", \"B\": \"Ataxia with ocular apraxia\", \"C\": \"Leber Hereditary Optic Neuropathy\", \"D\": \"Wernicke Encephalopathy\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Involves the differential diagnosis of hereditary ataxias and optic neuropathies based on clinical features, focusing on distinguishing between different potential genetic causes (e.g., SCAs, LHON).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q15",
    "question_text": "A 7-year-old boy presents with myoclonic epilepsy, cognitive decline, and hypotonia. Pathology shows lysosome accumulation. Which of the following conditions is most likely?",
    "options": "{\"A\": \"Gaucher disease\", \"B\": \"Tay-Sachs disease\", \"C\": \"Neuronal ceroid lipofuscinosis\", \"D\": \"Krabbe disease\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the diagnosis of a specific category of inherited metabolic/storage disorders (Neuronal Ceroid Lipofuscinosis) based on clinical features (progressive myoclonic epilepsy, decline) and pathology (lysosomal storage).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q59",
    "question_text": "A child presents with encephalopathy and hyperammonemia. What is the diagnosis?",
    "options": "{\"A\": \"Urea cycle disorder.\", \"B\": \"Maple syrup urine disease\", \"C\": \"Mitochondrial encephalopathy\", \"D\": \"Organic acidemia\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on diagnosing an inborn error of metabolism (urea cycle disorder) based on a classic acute presentation (encephalopathy, hyperammonemia).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q235",
    "question_text": "In a case of Neurofibromatosis type 1 (NF1) with light brown macules, what is the name of the skin lesion?",
    "options": "{\"A\": \"Caf\\u00e9 au lait spot\", \"B\": \"Lisch nodules\", \"C\": \"Ash leaf spot\", \"D\": \"Port-wine stain\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of specific clinical terminology (Caf\u00e9 au lait spot) for a characteristic sign of a neurogenetic disorder (Neurofibromatosis type 1).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q296",
    "question_text": "An infant presents with a head circumference at the 100th percentile, height at the 10th percentile, and weight at the 20th percentile. The infant also has multiple caf\u00e9 au lait spots and axillary flickering [freckling]. What is the most likely diagnosis?",
    "options": "{\"A\": \"Neurofibromatosis Type 1 (NF1)\", \"B\": \"Neurofibromatosis Type 2 (NF2)\", \"C\": \"Tuberous Sclerosis Complex (TSC)\", \"D\": \"Fetal Alcohol Spectrum Disorder\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests recognition of Neurofibromatosis Type 1 (NF1) based on a constellation of characteristic clinical features present in infancy, diagnosing a specific genetic syndrome.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q297",
    "question_text": "A child with a facial port wine stain and a CT brain showing tram-track calcification is diagnosed with:",
    "options": "{\"A\": \"Sturge-Weber syndrome\", \"B\": \"Neurofibromatosis\", \"C\": \"Tuberous sclerosis\", \"D\": \"Meningioma\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests recognition of Sturge-Weber syndrome based on classic clinical (port-wine stain) and imaging (tram-track calcification) findings associated with this neurocutaneous disorder (caused by a somatic GNAQ mutation).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q2",
    "question_text": "A child presents with areas of sun-exposed pigmentation, eye problems, and seizures. What is the most likely diagnosis?",
    "options": "{\"A\": \"Hypomelanosis\", \"B\": \"Neurocutaneous melanosis\", \"C\": \"Tuberous sclerosis\", \"D\": \"Sturge-Weber syndrome\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes features (photosensitivity, neurological symptoms) suggestive of a genetic disorder like Xeroderma Pigmentosum, focusing on syndrome recognition based on clinical features associated with an underlying genetic defect.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q6",
    "question_text": "A 2-week-old infant developed progressive hypotonia and feeding difficulties. He was found to have increased branched amino acids in urine. What is the diagnosis?",
    "options": "{\"A\": \"Urea cycle defect\", \"B\": \"Maple syrup urine disease\", \"C\": \"Methylmalonic acidemias\", \"D\": \"Organic acidemia\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on diagnosing Maple Syrup Urine Disease (MSUD), an inborn error of metabolism, based on the clinical presentation and key biochemical marker (branched-chain amino acids).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q9",
    "question_text": "A 4-year-old male patient presents with microcephaly, seizures, and has a musty odor to his urine. Which of the following conditions is most likely?",
    "options": "{\"A\": \"Biotinidase deficiency\", \"B\": \"Phenylketonuria\", \"C\": \"Maple syrup urine disease\", \"D\": \"Galactosemia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the recognition of Phenylketonuria (PKU), an inborn error of metabolism, based on its classic clinical features (microcephaly, seizures, musty odor).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q10",
    "question_text": "Phenylketonuria (PKU) is caused by a defect in the hydroxylation of which amino acid?",
    "options": "{\"A\": \"Tyrosine\", \"B\": \"Tryptophan\", \"C\": \"Phenylalanine\", \"D\": \"Leucine\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the specific biochemical defect underlying Phenylketonuria (PKU), focusing on the genetic/metabolic basis of the disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q11",
    "question_text": "Which of the following is a symptom of untreated Phenylketonuria (PKU)?",
    "options": "{\"A\": \"Normal development at birth\", \"B\": \"Severe mental retardation\", \"C\": \"Eczema\", \"D\": \"Seizures\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the clinical consequences of untreated Phenylketonuria (PKU), an inherited metabolic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q22",
    "question_text": "Pediatric patients with presentations suggestive of Menkes disease (friable hair) will typically show which of the following findings?",
    "options": "{\"A\": \"Low copper level\", \"B\": \"Elevated serum ceruloplasmin\", \"C\": \"Increased urinary copper excretion\", \"D\": \"Normal serum copper level\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying the key biochemical abnormality (low copper) associated with Menkes disease, a specific X-linked genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q34",
    "question_text": "A hypotonic baby with colorless hair and seizures has a CT brain showing subdural collection. What lab findings are expected in Glutaric aciduria type 1 (GA1)?",
    "options": "{\"A\": \"High cholesterol\", \"B\": \"High pyruvate\", \"C\": \"Elevated glutaric acid and 3-hydroxyglutaric acid in urine\", \"D\": \"Low serum copper\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Although the initial description might suggest Menkes disease, the question explicitly asks about lab findings in Glutaric Aciduria type 1 (GA1), focusing on the biochemical aspects of this specific inherited metabolic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q45",
    "question_text": "A child is diagnosed with ataxia-telangiectasia. Which of the following is a common non-neurologic sign associated with this condition?",
    "options": "{\"A\": \"Oculomotor apraxia\", \"B\": \"High incidence of malignancies\", \"C\": \"Dysarthria\", \"D\": \"Myoclonus\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on recognizing associated systemic features (malignancy risk) of Ataxia-Telangiectasia, a specific autosomal recessive neurodegenerative genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q92",
    "question_text": "A patient with developmental delay and bilateral basal ganglia high signal intensity. What is the diagnosis?",
    "options": "{\"A\": \"Leigh syndrome\", \"B\": \"Wilson disease\", \"C\": \"Pantothenate kinase-associated neurodegeneration\", \"D\": \"Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to correlate clinical presentation (developmental delay) and specific neuroimaging findings (bilateral basal ganglia signal changes) to diagnose Leigh syndrome, a mitochondrial genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q100",
    "question_text": "Pediatric patient had hepatosplenomegaly, hypotonia, flaccid paralysis, MRI showed white matter changes; what is the diagnosis?",
    "options": "{\"A\": \"Hexosaminidase A\", \"B\": \"Glucocerebrosidase\", \"C\": \"Arylsulfatase\", \"D\": \"Galactocerebrosidase\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Presents a constellation of symptoms (neurological regression, systemic signs, white matter changes) suggesting an inherited metabolic disorder, likely a lysosomal storage disease or leukodystrophy, diagnosed by identifying the deficient enzyme.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q123",
    "question_text": "A child presents with short stature, microcephaly, sensorineural hearing loss (SNHL), developmental delay, and optic atrophy. Which of the following is the most likely associated finding?",
    "options": "{\"A\": \"Occipital gyral malformation\", \"B\": \"Midbrain abnormalities\", \"C\": \"Cerebellar abnormalities\", \"D\": \"High signal in the basal ganglia\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes a complex phenotype suggestive of a specific genetic syndrome and asks about associated features, falling under the scope of recognizing neurogenetic syndromes.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q147",
    "question_text": "A young boy presents with cognitive decline and behavioral changes, and has very long-chain fatty acids (VLCFA) in his blood. What is the most likely diagnosis?",
    "options": "{\"A\": \"X-linked adrenoleukodystrophy\", \"B\": \"Adrenomyeloneuropathy\", \"C\": \"Refsum disease\", \"D\": \"Krabbe disease\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on diagnosing X-linked adrenoleukodystrophy (X-ALD) based on the clinical presentation and the specific biochemical marker (elevated VLCFA).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q154",
    "question_text": "Which of the following metabolic diseases is associated with bilateral subdural hematoma?",
    "options": "{\"A\": \"Niemann-Pick disease\", \"B\": \"Glutaric Aciduria Type 1 (GA1)\", \"C\": \"Maple syrup urine disease\", \"D\": \"Phenylketonuria\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks to identify the inherited metabolic disorder (Glutaric Aciduria Type 1 - GA1, often mistakenly written as GLUT1 def in MCQs) associated with a specific complication (subdural hematomas).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q169",
    "question_text": "A patient with developmental delay and bilateral basal ganglia high signal intensity on imaging. What is the diagnosis?",
    "options": "{\"A\": \"Leigh syndrome\", \"B\": \"Wilson disease\", \"C\": \"Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)\", \"D\": \"Huntington disease\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Similar to Q92, connects developmental delay and characteristic imaging to diagnose Leigh syndrome, a specific mitochondrial genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q173",
    "question_text": "A pediatric patient had bullous lesions that worsen with sun exposure, and he has conjunctivitis. What is the diagnosis?",
    "options": "{\"A\": \"Xeroderma pigmentosa\", \"B\": \"Epidermolysis bullosa\", \"C\": \"Porphyria cutanea tarda\", \"D\": \"Lupus erythematosus\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the recognition of Xeroderma Pigmentosum (XP), a genetic disorder of DNA repair, based on its characteristic dermatological and ophthalmological features.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q178",
    "question_text": "A child presents with encephalopathy and hyperammonemia. What is the diagnosis?",
    "options": "{\"A\": \"Urea cycle disorder.\", \"B\": \"Mitochondrial disorder\", \"C\": \"Organic acidemia\", \"D\": \"Maple syrup urine disease\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying a Urea Cycle Disorder based on the classic presentation of encephalopathy with hyperammonemia, a specific category of inherited metabolic diseases.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q185",
    "question_text": "In a case of Gaucher disease, which visual manifestation is commonly observed?",
    "options": "{\"A\": \"Ocular apraxia (Saccadic initiation failure)\", \"B\": \"Vertical gaze palsy\", \"C\": \"Blindness\", \"D\": \"Nystagmus\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about specific neurological signs (oculomotor abnormalities) associated with Gaucher disease, an inherited lysosomal storage disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q242",
    "question_text": "A young patient has tics and seizures. An MRI showed diffuse high signal intensity. How can the diagnosis be made?",
    "options": "{\"A\": \"Skin biopsy\", \"B\": \"Muscle biopsy\", \"C\": \"Genetic testing\", \"D\": \"Electroencephalogram (EEG)\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Presents a scenario where the differential diagnosis likely includes pediatric-onset neurogenetic or metabolic disorders (given tics, seizures, diffuse MRI changes), and asks about diagnostic approaches often used for these conditions (e.g., biopsy for mitochondrial or storage diseases).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q375",
    "question_text": "A 5-year-old male with developmental delay shows bilateral symmetrical putamen and globus pallidus signal changes. What is the most likely diagnosis?",
    "options": "{\"A\": \"Leigh disease\", \"B\": \"MELAS syndrome\", \"C\": \"MNGIE\", \"D\": \"Wilson disease\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the diagnosis of Leigh syndrome based on the combination of developmental delay and characteristic bilateral basal ganglia imaging findings in a child, pointing to this specific mitochondrial genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q17",
    "question_text": "In a typical scenario of CADASIL, which gene is associated with the condition?",
    "options": "{\"A\": \"NOTCH1 gene\", \"B\": \"NOTCH2 gene\", \"C\": \"NOTCH3 gene\", \"D\": \"NOTCH4 gene\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly tests knowledge of the specific gene (NOTCH3) responsible for a hereditary neurological disorder (CADASIL).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q181",
    "question_text": "In a typical scenario of MELAS, how can the diagnosis be made?",
    "options": "{\"A\": \"Lactate-pyruvate profile\", \"B\": \"Brain biopsy\", \"C\": \"Electroencephalogram (EEG)\", \"D\": \"Cerebrospinal fluid (CSF) analysis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the diagnostic workup (metabolic testing like lactate/pyruvate) for MELAS, a mitochondrial genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q178",
    "question_text": "A patient presents with seven flat brown lesions. What is the most likely diagnosis?",
    "options": "{\"A\": \"Caf\\u00e9 au lait spots\", \"B\": \"Nevus simplex\", \"C\": \"Melanocytic nevi\", \"D\": \"Seborrheic keratosis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks to identify caf\u00e9 au lait spots, a key diagnostic feature of Neurofibromatosis type 1 (NF1), a genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q47",
    "question_text": "You inherited a 14-year-old boy who was diagnosed with Duchenne muscular dystrophy (DMD) at age 4. You found that maternal relatives are affected by DMD. What will you request for his mother?",
    "options": "{\"A\": \"CK level\", \"B\": \"Refer to cardiology\", \"C\": \"Genetic counseling\", \"D\": \"Echocardiogram\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Deals with the implications for carrier status and associated health risks (cardiomyopathy) in the mother of a patient with DMD, an X-linked genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q22",
    "question_text": "An elderly 50-year-old patient presents with seizures and has a history of recurrent emergency room visits due to vague abdominal pain. What laboratory test should be requested?",
    "options": "{\"A\": \"Porphyria\", \"B\": \"Paraproteinemia\", \"C\": \"Electrolyte panel\", \"D\": \"Liver function tests\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: The combination of seizures and recurrent, unexplained abdominal pain is highly suggestive of an acute intermittent porphyria attack, an inherited metabolic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q103",
    "question_text": "A patient with stroke and marfanoid features is being treated. What is the recommended treatment? [Scenario suggests Homocystinuria]",
    "options": "{\"A\": \"Vitamin B6\", \"B\": \"Aspirin\", \"C\": \"Warfarin\", \"D\": \"Clopidogrel\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Although presenting with stroke, the core concept tested is the recognition and specific treatment (Vitamin B6) of a genetic/metabolic disorder (likely Homocystinuria) causing the stroke.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q287",
    "question_text": "A patient with stroke and marfanoid features. What is the treatment?",
    "options": "{\"A\": \"Vitamin B6\", \"B\": \"Anticoagulants\", \"C\": \"Thrombolytic therapy\", \"D\": \"Beta-blockers\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The combination of stroke and marfanoid features strongly suggests Homocystinuria, a genetic metabolic disorder. The treatment mentioned (Vitamin B6) targets the underlying metabolic defect, making Neurogenetics the primary classification.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q4",
    "question_text": "A patient with a family history of speech and motor issues is brought in for evaluation. The family is concerned about the child's IQ and potential genetic conditions. Which test would be appropriate to confirm or rule out fragile X syndrome?",
    "options": "{\"A\": \"Inherited anti-psychiatric test\", \"B\": \"Metabolic test\", \"C\": \"Chromosomal analysis\", \"D\": \"DNA methylation analysis\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Directly asks about the specific diagnostic test (chromosomal/genetic analysis) required to confirm Fragile X syndrome, an inherited neurodevelopmental disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q181",
    "question_text": "Patient came with Leber optic neuropathy; what is your next step?",
    "options": "{\"A\": \"ECG\", \"B\": \"Visual field testing\", \"C\": \"Genetic counseling\", \"D\": \"MRI brain\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about systemic workup (ECG for cardiac conduction defects) specifically related to Leber Hereditary Optic Neuropathy (LHON), a mitochondrial genetic disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q449",
    "question_text": "In a scenario suggestive of oculomotor apraxia, what is the gene associated with this condition?",
    "options": "{\"A\": \"ROBO1\", \"B\": \"TUBB3\", \"C\": \"KIF21A\", \"D\": \"APTX\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Directly asks for the genetic basis (specific genes) associated with a specific eye movement disorder (oculomotor apraxia).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q5",
    "question_text": "A patient with MELAS presents with tic manifestations. What is the most appropriate diagnostic procedure?",
    "options": "{\"A\": \"Skin biopsy\", \"B\": \"Muscle biopsy\", \"C\": \"Electroencephalogram (EEG)\", \"D\": \"Brain MRI\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the diagnostic approach (muscle biopsy for mitochondrial evaluation) for MELAS, a specific neurogenetic (mitochondrial) disorder, even though the presenting symptom mentioned is tics.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q10",
    "question_text": "In a child with dopa-responsive dystonia, what is the gene responsible?",
    "options": "{\"A\": \"GCH1\", \"B\": \"TOR1A\", \"C\": \"TH (Tyrosine Hydroxylase)\", \"D\": \"SPR (Sepiapterin Reductase)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Directly asks for the gene (GCH1 is typical, though TOR1A causes other dystonias - question might be flawed/simplified) associated with dopa-responsive dystonia (Segawa syndrome), a specific neurogenetic movement disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q10",
    "question_text": "In a child with dopa-responsive dystonia, what is the gene responsible?",
    "options": "{\"A\": \"GCH1\", \"B\": \"TOR1A\", \"C\": \"TH\", \"D\": \"SPR\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Directly asks for the gene (GCH1 is typical, though TOR1A causes other dystonias - question might be flawed/simplified) associated with dopa-responsive dystonia (Segawa syndrome), a specific neurogenetic movement disorder.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q2",
    "question_text": "Which of the following is associated with Congenital Myasthenia Gravis?",
    "options": "{\"A\": \"Slow channel\", \"B\": \"Fast channel\", \"C\": \"Dok7\", \"D\": \"Rapson [Rapsyn]\"}",
    "correct_answer": "C",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the specific genetic/molecular subtypes (e.g., slow-channel, fast-channel, DOK7, RAPSN mutations) underlying Congenital Myasthenic Syndromes, which are neurogenetic disorders of the neuromuscular junction.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q17",
    "question_text": "A 30-year-old female presents with progressive gait and limb ataxia. Genetic testing reveals a mutation in the ataxin-3 gene. What is the most likely diagnosis?",
    "options": "{\"A\": \"Ataxia-telangiectasia\", \"B\": \"Spinocerebellar ataxia type 3 (SCA3)\", \"C\": \"Friedreich's ataxia\", \"D\": \"Ataxia with oculomotor apraxia\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Directly tests knowledge of a specific genetic mutation (ataxin-3) causing a specific hereditary ataxia syndrome (SCA3/Machado-Joseph disease).",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q247",
    "question_text": "A 40-year-old male patient presented with a history of left-sided weakness, numbness, and dysarthria. He was found to have a stroke and reported a history of migraine headaches and cognitive decline. His father died at a young age. What will you order in this case?",
    "options": "{\"A\": \"NOTCH 3\", \"B\": \"Echo\", \"C\": \"Antiphospholipid antibodies (APLs)\", \"D\": \"MRI brain\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Similar to Q16, the constellation of early-onset stroke, migraine, cognitive decline, and positive family history is highly suggestive of CADASIL. The question asks directly for the specific *genetic* test (NOTCH3) required for diagnosis. Therefore, the classification is Neurogenetics.",
    "subspecialty": "Neurogenetics"
  },
  {
    "question_number": "Q7",
    "question_text": "In neonatal mild hypoxic ischemic encephalopathy, what is the most common presentation?",
    "options": "{\"A\": \"Seizures\", \"B\": \"Apnea\", \"C\": \"Hypotonia\", \"D\": \"Irritability\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the clinical presentation of Hypoxic Ischemic Encephalopathy (HIE), a condition specific to the neonatal period and managed within pediatric neurology.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q16",
    "question_text": "A case of a child with a rash on the face, contralateral hemiparesis, and radiographic findings of gyral calcifications giving a tram-track appearance is most likely:",
    "options": "{\"A\": \"Neurofibromatosis type 1 (NF1)\", \"B\": \"Neurofibromatosis type 2 (NF2)\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"Tuberous sclerosis\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the recognition of the classic clinical and radiological features of Sturge-Weber syndrome, a neurocutaneous disorder typically diagnosed and managed in childhood.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q17",
    "question_text": "A case of a child with caf\u00e9 au lait spots, axillary freckling, and Lisch nodules is indicative of:",
    "options": "{\"A\": \"Neurofibromatosis type 1 (NF1)\", \"B\": \"Tuberous sclerosis complex\", \"C\": \"Sturge-Weber syndrome\", \"D\": \"Von Hippel-Lindau disease\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the recognition of diagnostic criteria for Neurofibromatosis type 1 (NF1), a common neurocutaneous disorder presenting in childhood.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q19",
    "question_text": "In a patient with tic disorder and ADHD, which medication is commonly used?",
    "options": "{\"A\": \"Atomoxetine\", \"B\": \"Methylphenidate\", \"C\": \"Clonidine\", \"D\": \"Guanfacine\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the pharmacological management of co-morbid tic disorder and ADHD, a common scenario encountered in pediatric neurology and developmental pediatrics.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q21",
    "question_text": "In a case of Sturge-Weber syndrome (hint: port wine stain on the face), what associated condition is commonly asked about?",
    "options": "{\"A\": \"Renal Angiofibroma\", \"B\": \"Cardiac Rhabdomyosarcoma\", \"C\": \"Glaucoma\", \"D\": \"Seizures\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on recognizing a common association (glaucoma) of Sturge-Weber syndrome, a condition primarily managed within pediatric neurology.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q62",
    "question_text": "An infant presented with choreoathetosis and hearing loss. Brain MRI reported globus pallidus hyperintensity. What is the most likely diagnosis?",
    "options": "{\"A\": \"Kernicterus\", \"B\": \"Leigh syndrome\", \"C\": \"Wilson disease\", \"D\": \"Mitochondrial encephalopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes the classic clinical and imaging findings of Kernicterus, a neurological condition resulting from severe neonatal hyperbilirubinemia, falling under the scope of pediatric/neonatal neurology.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q79",
    "question_text": "A patient with facial weakness and seizures presents with what other condition?",
    "options": "{\"A\": \"Sturge-Weber disease\", \"B\": \"Mitochondrial myopathy\", \"C\": \"Arnold-Chiari malformation\", \"D\": \"Neurofibromatosis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links clinical features (facial weakness, seizures) often associated with the neurological consequences of the facial port-wine stain in Sturge-Weber syndrome, a condition typically managed within pediatric neurology.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q6",
    "question_text": "A neonate developed seizures within 24 hours of birth and has high bilirubin. What would be the most affected area on MRI?",
    "options": "{\"A\": \"Thalamus\", \"B\": \"Caudate\", \"C\": \"Globus Pallidus\", \"D\": \"Subthalamic nucleus\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a neonatal neurological complication (seizures) related to hyperbilirubinemia (kernicterus) and asks about the typical location of brain injury (Globus Pallidus), a topic central to pediatric neurology.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q52",
    "question_text": "A pregnant woman at 10 weeks is concerned about the side effects of steroids. Which of the following is a potential risk?",
    "options": "{\"A\": \"Spina bifida\", \"B\": \"Premature labor\", \"C\": \"Cleft palate\", \"D\": \"Cardiac defect\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the teratogenic potential (risk of birth defects like cleft palate) of medication (steroids) taken during pregnancy, relevant to fetal neurological and structural development.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q206",
    "question_text": "When should brain imaging be performed in pediatric patients with headaches?",
    "options": "{\"A\": \"Unilateral symptoms\", \"B\": \"Occipital headache\", \"C\": \"Photophobia\", \"D\": \"Aura\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses specifically on indications (red flags like occipital location) for neuroimaging in the pediatric population presenting with headache, addressing pediatric-specific guidelines.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q119",
    "question_text": "What is the first-line treatment for migraine in children?",
    "options": "{\"A\": \"Acetaminophen\", \"B\": \"Triptans\", \"C\": \"Aspirin\", \"D\": \"Ibuprofen\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Specifically addresses the first-line acute treatment for migraine within the pediatric population.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q47",
    "question_text": "What is the indication for brain imaging in a pediatric patient with migraine?",
    "options": "{\"A\": \"Occipital headache\", \"B\": \"Bilateral headache\", \"C\": \"New onset neurological deficit\", \"D\": \"Headache worsening with Valsalva maneuver\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on identifying \"red flags\" (like occipital location) that warrant neuroimaging specifically in children presenting with headache/migraine.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q118",
    "question_text": "A 10-year-old boy has a headache that is preceded by red circular colors for a few seconds. What is the most likely diagnosis?",
    "options": "{\"A\": \"Occipital seizures\", \"B\": \"Migraine\", \"C\": \"Visual aura without headache\", \"D\": \"Transient ischemic attack\"}",
    "correct_answer": "B",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the differential diagnosis between migraine visual aura and occipital lobe seizures, a common diagnostic challenge in pediatric neurology.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q213",
    "question_text": "A baby presents with diplopia, dysarthria, ataxia followed by headache. What is the most likely diagnosis?",
    "options": "{\"A\": \"Migraine with brainstem aura\", \"B\": \"Familial hemiplegic migraine (FHM)\", \"C\": \"Cyclic vomiting syndrome\", \"D\": \"Brainstem encephalitis\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on recognizing specific neurological syndromes (likely complex migraine variants like migraine with brainstem aura) presenting in infancy/early childhood.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q1",
    "question_text": "A 7-year-old boy presents with visual hallucinations in the form of colorful and circular objects moving from right to left, lasting for seconds to minutes, sometimes followed by a headache. An EEG shows occipital lobe spikes. What is the management?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Amitriptyline\", \"C\": \"Valproic acid\", \"D\": \"Phenytoin\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a classic presentation of a childhood epilepsy syndrome (likely Panayiotopoulos or Gastaut type of benign occipital epilepsy) and asks for appropriate management.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q197",
    "question_text": "In a scenario of a young child with seizures, hypotonia, and a cherry red spot, which enzyme is affected?",
    "options": "{\"A\": \"Hexosaminidase A\", \"B\": \"Glucocerebrosidase\", \"C\": \"Arylsulfatase A\", \"D\": \"Galactocerebrosidase\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of a specific metabolic/genetic disorder (Tay-Sachs disease) presenting in childhood with characteristic neurological and ophthalmological findings, linking it to the deficient enzyme.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q7",
    "question_text": "In a case of Sturge-Weber syndrome (hint: port wine stain on the face), what associated condition is commonly asked about?",
    "options": "{\"A\": \"Renal Angiofibroma\", \"B\": \"Cardiac Rhabdomyosarcoma\", \"C\": \"Glaucoma\", \"D\": \"Seizures\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a common association (glaucoma) with Sturge-Weber syndrome, a congenital neurocutaneous disorder typically presenting in childhood.",
    "subspecialty": "Pediatric Neurology"
  },
  {
    "question_number": "Q236",
    "question_text": "A patient presented with a history of tingling sensation, numbness, and paresthesia, indicating small fiber neuropathy. He has pale bands over his nails. What is the likely diagnosis?",
    "options": "{\"A\": \"Gold\", \"B\": \"Lead\", \"C\": \"Arsenic\", \"D\": \"Mercury\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Directly asks to identify a specific toxin (arsenic) based on characteristic neurological (neuropathy) and physical (Mees' lines) signs of poisoning.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q457",
    "question_text": "An HIV patient presents with a seizure. What is the likely culprit medication?",
    "options": "{\"A\": \"Efavirenz\", \"B\": \"Zidovudine\", \"C\": \"Lamivudine\", \"D\": \"Tenofovir\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on identifying a medication (Efavirenz) known for its neurotoxic potential (lowering seizure threshold) as the cause of a seizure.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q476",
    "question_text": "A patient with resected breast cancer who received radiotherapy developed Horner's syndrome and plexopathy. What is the underlying mechanism?",
    "options": "{\"A\": \"Compressive\", \"B\": \"Neoplastic\", \"C\": \"Radiation-induced syndrome\", \"D\": \"Inflammatory\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on neurological damage (plexopathy, Horner's) caused by an external agent (radiation), a form of localized toxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q453",
    "question_text": "A lady with a history of lung cancer, treated with radiation therapy 6 months ago, presents with 2 months of shoulder discomfort, weak shoulder abduction, and elbow flexion. NCS/EMG showed fibrillations in her hands and forearm muscles. What should be done next?",
    "options": "{\"A\": \"Order MRI of the brachial plexus to assess for tumor recurrence or radiation fibrosis\", \"B\": \"Start high-dose corticosteroids immediately\", \"C\": \"Perform surgical decompression of the brachial plexus\", \"D\": \"Reassure the patient and observe for spontaneous recovery\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The scenario describes likely radiation-induced brachial plexopathy (a toxic effect of radiation given history, timing, EMG findings), and the question revolves around diagnosing/managing this specific complication.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q226",
    "question_text": "What is the recommended treatment for severe arsenic poisoning?",
    "options": "{\"A\": \"Supportive care\", \"B\": \"Chelating agents\", \"C\": \"Anticonvulsants\", \"D\": \"Corticosteroids\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses specifically on the treatment (chelation) for poisoning caused by a neurotoxin (arsenic).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q102",
    "question_text": "A tuberculosis (TB) patient started on treatment and then had a seizure. What medication is causing the seizure?",
    "options": "{\"A\": \"Isoniazid\", \"B\": \"Ethambutol\", \"C\": \"Rifampicin\", \"D\": \"Pyrazinamide\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Identifies a specific neurological side effect (seizure) caused by a medication (Isoniazid), representing drug-induced neurotoxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q529",
    "question_text": "A 52-year-old female with dyslipidemia on statin had pneumonia and was admitted to the hospital. After starting on erythromycin, she developed weakness. What increases the risk of suspected toxic myopathy?",
    "options": "{\"A\": \"Old age\", \"B\": \"Female\", \"C\": \"Recent infection\", \"D\": \"Concomitant use of erythromycin\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The question centers on a drug interaction (statin + erythromycin) causing muscle toxicity (myopathy), a form of drug-induced neuromuscular toxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q192",
    "question_text": "What is the most common side effect of lithium?",
    "options": "{\"A\": \"Seizures\", \"B\": \"Tremors\", \"C\": \"Weight gain\", \"D\": \"Renal impairment\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about a common neurological side effect (tremor) of a specific medication (lithium), falling under drug-induced neurotoxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q540",
    "question_text": "What medication causes sensory ataxia?",
    "options": "{\"A\": \"Pyridoxine\", \"B\": \"Phenytoin\", \"C\": \"Metronidazole\", \"D\": \"Isoniazid\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a specific drug toxicity (pyridoxine excess) causing a distinct neurological syndrome (sensory neuronopathy/ataxia).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q241",
    "question_text": "What is the medication that causes neuropathy and myopathy?",
    "options": "{\"A\": \"Dapsone\", \"B\": \"Chloroquine\", \"C\": \"Hydralazine\", \"D\": \"Statins\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a medication (Chloroquine) known for its combined neurotoxic and myotoxic effects.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q172",
    "question_text": "A patient receiving intrathecal methotrexate presents with clinical and biological findings typical for subacute combined degeneration of the spinal cord. What else would you give the patient besides stopping methotrexate?",
    "options": "{\"A\": \"Vitamin E\", \"B\": \"Zinc\", \"C\": \"Folinic acid (leucovorin)\", \"D\": \"Thiamine\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes a specific neurotoxic effect (myelopathy mimicking SCD) caused by intrathecal methotrexate and implicitly asks about managing this toxicity (likely requiring folinic acid).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q377",
    "question_text": "What medication can cause a positive Romberg sign and a scenario suggestive of sensory neuronopathy?",
    "options": "{\"A\": \"Pyridoxine\", \"B\": \"Phenytoin\", \"C\": \"Metronidazole\", \"D\": \"Isoniazid\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of drug-induced neurotoxicity, linking Pyridoxine excess to sensory neuronopathy/ataxia.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q214",
    "question_text": "A patient on anti-TB agents developed seizures. Which of the following agents can cause it?",
    "options": "{\"A\": \"INH\", \"B\": \"Ethambutol\", \"C\": \"Pyrazinamide\", \"D\": \"Rifampicin\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of neurotoxic side effects (seizures) of antituberculosis medications (INH).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q396",
    "question_text": "Naloxone",
    "options": "{\"A\": \"Is an opioid receptor antagonist used to reverse opioid overdose\", \"B\": \"Is a benzodiazepine used to treat seizures\", \"C\": \"Is a stimulant used to treat attention deficit hyperactivity disorder\", \"D\": \"Is an anticholinergic used to treat Parkinson\\u2019s disease\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Naloxone is primarily used as an antidote for opioid overdose, placing it firmly within the scope of toxicology.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q320",
    "question_text": "Flumazenil",
    "options": "{\"A\": \"Is used to treat opioid overdose\", \"B\": \"Is primarily used as an antidote for benzodiazepine overdose/sedation reversal\", \"C\": \"Is a dopamine receptor antagonist\", \"D\": \"Is used to manage status epilepticus\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Flumazenil is primarily used as an antidote for benzodiazepine overdose/sedation reversal, placing it within the scope of toxicology.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q129",
    "question_text": "A patient with HIV on HAART developed seizures. What is the most likely cause?",
    "options": "{\"A\": \"Zidovudine\", \"B\": \"Efavirenz\", \"C\": \"Maraviroc\", \"D\": \"Lamivudine\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on identifying a specific medication (Efavirenz) known for its neurotoxic potential (lowering seizure threshold) as the cause of a seizure in an HIV patient.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q115",
    "question_text": "Which of the following agents can cause sensory ataxia, vibration, and proprioception loss?",
    "options": "{\"A\": \"Pyridoxine\", \"B\": \"Arsenic\", \"C\": \"Lead\", \"D\": \"Mercury\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific neurological toxicity (sensory neuronopathy/ataxia) caused by Pyridoxine excess.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q113",
    "question_text": "A young patient with a history of liver transplant on cyclosporine presents with severe lower limb tremors. What is the best treatment option?",
    "options": "{\"A\": \"Decrease cyclosporine dose\", \"B\": \"Start propranolol\", \"C\": \"Start phenytoin\", \"D\": \"Start lithium\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Concerns a tremor directly induced by a specific medication (cyclosporine), representing a neurotoxic side effect, and asks about management focused on the offending agent.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q50",
    "question_text": "What medication causes sensory ataxia?",
    "options": "{\"A\": \"Pyridoxine\", \"B\": \"Phenytoin\", \"C\": \"Metronidazole\", \"D\": \"Isoniazid\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of drug-induced sensory ataxia caused by pyridoxine toxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q100",
    "question_text": "High-dose pyridoxine toxicity may cause which of the following symptoms?",
    "options": "{\"A\": \"Motor weakness\", \"B\": \"Sensory ataxia\", \"C\": \"Cranial nerve palsies\", \"D\": \"Seizures\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific neurological complication (sensory ataxia/neuropathy) resulting from pyridoxine toxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q53",
    "question_text": "A young patient with a history of alcohol abuse presents with hallucinations, nystagmus, and ataxic gait. MRI shows increased signal intensity in the medial thalamus. What is the most likely diagnosis?",
    "options": "{\"A\": \"Wernicke encephalopathy\", \"B\": \"Korsakoff syndrome\", \"C\": \"Alcoholic cerebellar degeneration\", \"D\": \"Hepatic encephalopathy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes classic symptoms and MRI findings of Wernicke encephalopathy, a condition directly linked to thiamine deficiency, often secondary to chronic alcohol abuse.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q7",
    "question_text": "A patient was found to have tuberculosis, started on medication, and later developed seizures. What is the likely cause of the seizures?",
    "options": "{\"A\": \"Isoniazid\", \"B\": \"Ethambutol\", \"C\": \"Rifampin\", \"D\": \"Pyrazinamide\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Directly asks about a specific neurotoxic side effect (seizures) of an anti-tuberculosis medication (Isoniazid).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q62",
    "question_text": "A patient on long-term use of colchicine developed myopathy and neuropathy. What is the likely cause of these symptoms?",
    "options": "{\"A\": \"Colchicine-induced myopathy\", \"B\": \"Diabetic neuropathy\", \"C\": \"Alcohol-related myopathy\", \"D\": \"Statin-induced myopathy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying a specific neuromuscular toxicity (myopathy and neuropathy) caused by long-term medication use (colchicine).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q50",
    "question_text": "A patient who was arrested by police is encephalopathic and has a halitosis odor. What should you administer?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Flumazenil\", \"C\": \"Naloxone\", \"D\": \"Glucose\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: The presentation (encephalopathy, potential halitosis suggesting alcohol or other substance) strongly suggests possible Wernicke encephalopathy or intoxication, making Thiamine a key consideration in this potentially toxic/metabolic state.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q11",
    "question_text": "A pregnant lady with hyperemesis gravidarum presents with paresthesia in the lower limbs, nystagmus, and ataxia. The likely vitamin deficiency is:",
    "options": "{\"A\": \"Vitamin B1\", \"B\": \"Vitamin B12\", \"C\": \"Vitamin B6\", \"D\": \"Vitamin E\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes symptoms classic for Wernicke encephalopathy (nystagmus, ataxia) precipitated by hyperemesis gravidarum, pointing to Thiamine (Vitamin B1) deficiency.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q74",
    "question_text": "A 53-year-old male presents with abdominal pain, vomiting, diarrhea, and gait difficulty. He is found to have depressed deep tendon reflexes and pale fingernails. What is the most likely culprit toxin?",
    "options": "{\"A\": \"Lead\", \"B\": \"Gold\", \"C\": \"Mercury\", \"D\": \"Arsenic\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on identifying a specific toxin (Arsenic) based on a constellation of systemic and neurological symptoms (GI upset, neuropathy, nail changes - potentially Mees' lines).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q1",
    "question_text": "In Wernicke's encephalopathy, what type of memory is typically impaired?",
    "options": "{\"A\": \"Immediate memory\", \"B\": \"Episodic memory\", \"C\": \"Procedural memory\", \"D\": \"Semantic memory\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge about the specific cognitive deficits (memory impairment) associated with Wernicke's encephalopathy, a condition linked to thiamine deficiency often due to toxicity (alcohol) or malnutrition.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q60",
    "question_text": "In the same scenario as above [Implicitly referring to Q53's Wernicke scenario], what is the recommended treatment?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Vitamin B12\", \"C\": \"Corticosteroids\", \"D\": \"Antiepileptic drugs\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the treatment of Wernicke encephalopathy (established in the linked scenario Q53), which is caused by thiamine deficiency often related to alcohol toxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q5",
    "question_text": "An 85-year-old female treated for herpetic neuralgia became lethargic and confused 5 days after treatment. A CT scan of the brain and CSF analysis were normal. What is the most likely diagnosis?",
    "options": "{\"A\": \"VZV encephalitis\", \"B\": \"Drug-induced encephalopathy\", \"C\": \"Metabolic encephalopathy\", \"D\": \"Stroke\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: The question presents a differential between infectious cause (VZV) and a drug side effect. Given the temporal relationship to treatment initiation and normal CSF/CT, drug-induced encephalopathy (a neurotoxic effect) is a primary consideration.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q2",
    "question_text": "A post-bariatric surgery patient presents with nystagmus and ataxia, with findings suggestive of Wernicke\u2019s encephalopathy. What is the most likely cause?",
    "options": "{\"A\": \"Vitamin B1 deficiency\", \"B\": \"Vitamin B12 deficiency\", \"C\": \"Vitamin D deficiency\", \"D\": \"Vitamin E deficiency\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links classic Wernicke's symptoms (nystagmus, ataxia) to its underlying cause (Vitamin B1 deficiency) in a specific context (post-bariatric surgery) known to predispose to nutritional deficiencies.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q76",
    "question_text": "A tuberculosis (TB) patient started on treatment and then had a seizure. What medication is causing the seizure?",
    "options": "{\"A\": \"Isoniazid\", \"B\": \"Ethambutol\", \"C\": \"Rifampicin\", \"D\": \"Pyrazinamide\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Repeats the concept of Q7, focusing on identifying the specific anti-TB drug (Isoniazid) known to cause neurotoxicity presenting as seizures.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q45",
    "question_text": "Mees lines are associated with which type of poisoning?",
    "options": "{\"A\": \"Arsenic\", \"B\": \"Lead\", \"C\": \"Carbon monoxide\", \"D\": \"Alcohol\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly tests knowledge of a specific physical sign (Mees' lines) associated with heavy metal poisoning (Arsenic).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q64",
    "question_text": "In the same patient with colchicine toxicity [Implicitly referring to Q62], what is the expected biopsy finding?",
    "options": "{\"A\": \"Antitubular\", \"B\": \"Autophagic vacuoles\", \"C\": \"Myophosphorylase\", \"D\": \"Rimmed vacuoles\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about the specific pathological finding (autophagic vacuoles) in muscle biopsy associated with colchicine-induced myopathy, a drug toxicity.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q4",
    "question_text": "Intoxication with which of the following agents would cause sensory ataxia with proprioception and vibratory loss?",
    "options": "{\"A\": \"Dapsone\", \"B\": \"Zidovudine\", \"C\": \"Tacrolimus\", \"D\": \"Pyridoxine\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the specific neurological deficit (sensory ataxia due to proprioception/vibration loss) caused by toxicity from an agent (Pyridoxine overdose).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient on anti-TB medication plus pyridoxine presents with painful neuropathy. Sensory exam and reflexes were normal. What is the diagnosis?",
    "options": "{\"A\": \"Pyridoxine toxicity\", \"B\": \"Vitamin B12 deficiency\", \"C\": \"Diabetic neuropathy\", \"D\": \"Guillain-Barr\\u00e9 syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on identifying neuropathy potentially caused by medication side effects (INH-induced neuropathy, possibly inadequately treated/masked by pyridoxine) or vitamin toxicity (pyridoxine toxicity itself causing a different neuropathy pattern). This falls under neurotoxic effects.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient on anti-TB medication plus pyridoxine presents with painful neuropathy. Sensory exam and reflexes were normal. What is the diagnosis?",
    "options": "{\"A\": \"Pyridoxine toxicity\", \"B\": \"Vitamin B12 deficiency\", \"C\": \"Diabetic neuropathy\", \"D\": \"Guillain-Barr\\u00e9 syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on identifying neuropathy potentially caused by medication side effects (INH-induced neuropathy, possibly inadequately treated/masked by pyridoxine) or vitamin toxicity (pyridoxine toxicity itself causing a different neuropathy pattern). This falls under neurotoxic effects.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q74",
    "question_text": "A patient developed cognitive impairment and ataxia. MRI showed high signals in the mammillary bodies. What is the most likely deficiency?",
    "options": "{\"A\": \"Thiamine\", \"B\": \"Vitamin B12\", \"C\": \"Copper\", \"D\": \"Folate\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to identify a specific nutritional deficiency (Thiamine) causing neurological symptoms (cognitive impairment, ataxia) based on characteristic MRI findings (mammillary body hyperintensities), indicative of Wernicke-Korsakoff syndrome, often related to alcohol toxicity/malnutrition.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q41",
    "question_text": "What is the most common side effect of lithium?",
    "options": "{\"A\": \"Tremor\", \"B\": \"Weight gain\", \"C\": \"Polyuria\", \"D\": \"Hypothyroidism\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on identifying a common neurological side effect (tremor) of a specific medication (lithium).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q359",
    "question_text": "A case presents of a man with an ataxic gait and confusion, accompanied by a peculiar smell from his mouth. His pupils are normal. What is the most appropriate management?",
    "options": "{\"A\": \"Immediate intravenous antibiotics for suspected meningitis\", \"B\": \"Administration of intravenous thiamine before glucose administration\", \"C\": \"Emergent brain MRI to rule out stroke\", \"D\": \"Administration of naloxone for suspected opioid overdose\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt; Originally Neuromuscular",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The combination of ataxia and confusion strongly suggests an encephalopathy. The peculiar smell points towards a metabolic (e.g., DKA, hepatic encephalopathy) or toxic (e.g., alcohol, other ingestions) cause, or a nutritional deficiency (Wernicke's encephalopathy). Management depends on identifying this underlying non-infectious cause, fitting best under Neurotoxicology (which often includes metabolic/nutritional encephalopathies).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q203",
    "question_text": "A patient was on Valproic acid and is discovered to be drowsy. What do you need to check?",
    "options": "{\"A\": \"Ammonia level\", \"B\": \"Liver enzyme\", \"C\": \"Complete blood count\", \"D\": \"Electrolytes\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on investigating a potential complication/toxicity (hyperammonemia) associated with a specific medication (Valproic acid).",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q17",
    "question_text": "What is the case scenario associated with Strachan Syndrome?",
    "options": "{\"A\": \"Vitamin D deficiency\", \"B\": \"Vitamin E deficiency\", \"C\": \"Vitamin A deficiency\", \"D\": \"Vitamin B12 deficiency\"}",
    "correct_answer": "D",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of Strachan syndrome, a neurological disorder linked to nutritional deficiencies (specifically B vitamins, often in POW or malnourished populations), falling under toxic/metabolic/nutritional neurology.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q78",
    "question_text": "A patient on pregabalin (suspected to be abusing the drug); what will you do?",
    "options": "{\"A\": \"Give pregabalin\", \"B\": \"Refer to psychiatry\", \"C\": \"Gradually taper pregabalin dose\", \"D\": \"Monitor for withdrawal symptoms\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the issue of prescription drug abuse (Pregabalin), which falls under neurotoxicology/addiction, although management involves psychiatric referral.",
    "subspecialty": "Neurotoxicology"
  },
  {
    "question_number": "Q57",
    "question_text": "A pregnant patient at 12 weeks GA with migraine came with status migrainosus. What is the management?",
    "options": "{\"A\": \"IV Depakin\", \"B\": \"Dihydroergotamine\", \"C\": \"Subcutaneous sumatriptan\", \"D\": \"Steroid\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the acute management of a severe migraine variant (status migrainosus) specifically in the context of pregnancy, requiring knowledge of safe and effective treatments in this population.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q105",
    "question_text": "Which of the following characteristics is associated with pain in glossopharyngeal neuralgia?",
    "options": "{\"A\": \"Lasting from a few seconds to two minutes\", \"B\": \"Severe intensity\", \"C\": \"Electric shock-like, shooting, stabbing, or sharp in quality\", \"D\": \"Triggered by swallowing or talking\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the defining clinical pain characteristics of glossopharyngeal neuralgia, a specific cranial neuralgia managed under the headache/facial pain subspecialty.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q21",
    "question_text": "What is the first-line treatment for glossopharyngeal neuralgia?",
    "options": "{\"A\": \"Carbamazepine (CBZ)\", \"B\": \"Gabapentin\", \"C\": \"Baclofen\", \"D\": \"Topiramate\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the standard first-line pharmacological treatment for glossopharyngeal neuralgia, a specific cranial neuralgia.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q43",
    "question_text": "A known case of migraine, a female patient in her 1st trimester, came to the ER with a headache. What is the treatment?",
    "options": "{\"A\": \"Triptan\", \"B\": \"Dexamethasone\", \"C\": \"Acetaminophen\", \"D\": \"NSAIDs\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the appropriate acute treatment choice for migraine during early pregnancy, a common clinical scenario in headache management.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q54",
    "question_text": "A patient presents with a small area of headache associated with hair loss. What is the most appropriate treatment?",
    "options": "{\"A\": \"Gabapentin\", \"B\": \"Local anesthesia\", \"C\": \"Topical corticosteroids\", \"D\": \"Oral analgesics\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes symptoms suggestive of a less common primary headache disorder (potentially nummular headache or a localized neuralgia) and asks for treatment, fitting within the Headache subspecialty.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q71",
    "question_text": "A patient recently had a baby delivered by C-section one day ago and came to the ED with a headache that increases while sitting and coughing. Brain MRI showed normal results, and the neurological exam was normal. What will you do next?",
    "options": "{\"A\": \"LP\", \"B\": \"Blood patch\", \"C\": \"MRV\", \"D\": \"Analgesics and hydration\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a classic presentation of post-dural puncture headache (a secondary headache) and asks for the appropriate management (epidural blood patch).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q132",
    "question_text": "In a scenario of SUNA (Short-lasting Unilateral Neuralgiform headache attacks with conjunctival injection and tearing), what is the first line treatment?",
    "options": "{\"A\": \"Lamotrigine\", \"B\": \"Indomethacin\", \"C\": \"Triptans\", \"D\": \"Corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the specific first-line pharmacological treatment for SUNA, a distinct type of Trigeminal Autonomic Cephalalgia (TAC) under the Headache classification.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q133",
    "question_text": "Which of the following features would be most supportive of a diagnosis of medication-overuse headache (MOH) in a patient?",
    "options": "{\"A\": \"Absence of neck pain\", \"B\": \"Constant frontal location\", \"C\": \"Mild severity\", \"D\": \"Worsened severity upon awakening\"}",
    "correct_answer": "D",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the ability to identify a key clinical characteristic used in diagnosing medication-overuse headache (MOH).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q237",
    "question_text": "A patient presents with unilateral headache on a daily basis associated with ptosis and lacrimation. What is the diagnosis?",
    "options": "{\"A\": \"Hemicrania continua\", \"B\": \"Cluster headache\", \"C\": \"Migraine with autonomic features\", \"D\": \"Paroxysmal hemicrania\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the diagnosis based on a classic description of Hemicrania Continua, a primary headache disorder (TAC).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q56",
    "question_text": "Patient came with tongue pain and paresthesia, radiating to the neck, increased with neck movement; what is the diagnosis?",
    "options": "{\"A\": \"Neck-tongue syndrome\", \"B\": \"Glossopharyngeal Neuralgia\", \"C\": \"Trigeminal Neuralgia\", \"D\": \"Cervical Radiculopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Requires diagnosis of Neck-Tongue Syndrome, a rare condition often discussed within the context of cervicogenic or craniofacial pain syndromes under the Headache umbrella.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q54",
    "question_text": "A migraine patient with daily persistent headache, who used to take daily triptans and NSAIDs, what is the next management step?",
    "options": "{\"A\": \"Abrupt discontinuation of the medications\", \"B\": \"Gradual discontinuation of the medications\", \"C\": \"Steroid\", \"D\": \"Initiation of preventive migraine therapy\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Directly addresses the management strategy (medication withdrawal) for Medication Overuse Headache (MOH) superimposed on migraine.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q14",
    "question_text": "A male patient presents with headache, congestion, tearing, with a duration of 15-30 minutes, occurring 5 times per day, always on the same side. His history includes pain provoked by touching the face. What is the most likely diagnosis?",
    "options": "{\"A\": \"SUNCT\", \"B\": \"SUNA\", \"C\": \"Migraine\", \"D\": \"Cluster Headache\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Requires differentiation between various Trigeminal Autonomic Cephalalgias (TACs) based on specific clinical features (duration, frequency, triggers), leading to a SUNCT/SUNA diagnosis.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q6",
    "question_text": "A pregnant patient presents with a severe migraine attack, similar to her previous migraine attacks. What is the appropriate management?",
    "options": "{\"A\": \"Paracetamol\", \"B\": \"Sumatriptan\", \"C\": \"Opioid\", \"D\": \"NSAIDs\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on selecting safe and appropriate acute migraine treatment during pregnancy.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q40",
    "question_text": "A young female patient, known to have migraine controlled on medications, now presents with unilateral headache associated with lacrimation and conjunctival injection, lasting for less than 2 minutes and resolving completely. It occurs up to 40 times per day, and she is completely asymptomatic between the attacks. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT)\", \"B\": \"Chronic paroxysmal hemicrania\", \"C\": \"Hemicrania continua\", \"D\": \"Cluster headache\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests the ability to diagnose SUNCT based on its highly specific clinical phenotype (very short, frequent attacks with autonomic features).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q41",
    "question_text": "A young lady post uneventful delivery by cesarean section came with a history of positional headache that worsens with standing and improves with lying on her back for more than 2 weeks. MRI of the brain was done (image attached). Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Intracranial hypotension\", \"B\": \"Cerebral venous thrombosis\", \"C\": \"Post-dural puncture headache\", \"D\": \"Subarachnoid hemorrhage\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on integrating clinical history (post-procedure postural headache) and implied MRI findings to diagnose intracranial hypotension, a secondary cause of headache.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q65",
    "question_text": "A 35-year-old woman presents with a headache, describing 10 episodes a day of sharp pain over the left eye, lasting about 5 minutes each, which cause her to sit or lie quietly until the attacks pass. Which of the following autonomic phenomena is most commonly associated with this type of headache?",
    "options": "{\"A\": \"Lacrimation\", \"B\": \"Conjunctival injection\", \"C\": \"Horner syndrome\", \"D\": \"Photophobia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a TAC (likely Paroxysmal Hemicrania or SUNCT/SUNA based on description) and asks about characteristic associated autonomic features.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q52",
    "question_text": "In the same case scenario as above, what is the recommended treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Oxcarbazepine\", \"C\": \"Lamotrigine\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assuming the missing preceding scenario described Trigeminal Neuralgia, this question asks about its standard pharmacological treatment, classifying it under management of headache/facial pain syndromes.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q179",
    "question_text": "In a scenario of intracranial hypotension not responding to routine measures, what is the next step?",
    "options": "{\"A\": \"Blood patch\", \"B\": \"Surgical intervention\", \"C\": \"Increased hydration\", \"D\": \"Corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with the specific management (epidural blood patch) for refractory intracranial hypotension headache.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q180",
    "question_text": "In a scenario of glossopharyngeal neuralgia, what should be done next?",
    "options": "{\"A\": \"MRI of the head and neck\", \"B\": \"Refer to ENT specialist\", \"C\": \"Start carbamazepine\", \"D\": \"Perform a cervical spine MRI\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns the initial diagnostic workup and management considerations for glossopharyngeal neuralgia, a cranial neuralgia.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q78",
    "question_text": "In a case of a headache attributed to trigeminal neuralgia, what is the best treatment option?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Indomethacin\", \"C\": \"Gabapentin\", \"D\": \"Baclofen\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the first-line pharmacological treatment specific to trigeminal neuralgia.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q321",
    "question_text": "A male patient reports shock-like electric sensations in half of his face multiple times per day, and he avoids brushing and shaving. What is the likely diagnosis?",
    "options": "{\"A\": \"Trigeminal neuralgia\", \"B\": \"Postherpetic neuralgia\", \"C\": \"Bell's palsy\", \"D\": \"Cluster headache\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the ability to recognize the classic clinical description of trigeminal neuralgia.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q205",
    "question_text": "A 10-week pregnant woman presents with severe acute migraine. Which of the following is the recommended first-line treatment?",
    "options": "{\"A\": \"Acetaminophen\", \"B\": \"Triptan\", \"C\": \"Valproic acid\", \"D\": \"Naproxen\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge of safe and appropriate first-line acute migraine treatment during early pregnancy.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q46",
    "question_text": "A case scenario of a migraine patient who is doing well and has controlled headaches. He requests a prescription for pregabalin, which he takes occasionally on weekends to help him relax. What should you do?",
    "options": "{\"A\": \"Refer to psychiatry\", \"B\": \"Refill for 3 months\", \"C\": \"Give him gabapentin instead\", \"D\": \"Refuse his request and discharge him from outpatient department (OPD)\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses appropriate prescribing practices and management of potential medication misuse within the context of ongoing migraine patient care.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q350",
    "question_text": "A patient presents with severe periorbital episodic headache lasting 5 minutes. What is the most common associated feature?",
    "options": "{\"A\": \"Lacrimation\", \"B\": \"Conjunctival injection\", \"C\": \"Horner's syndrome\", \"D\": \"Nasal congestion\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes features suggestive of a TAC (likely SUNCT/SUNA or Paroxysmal Hemicrania) and asks to identify common associated autonomic features.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q115",
    "question_text": "In a scenario of trigeminal neuralgia, what is needed to reach the diagnosis?",
    "options": "{\"A\": \"Clinical diagnosis, no need for imaging\", \"B\": \"Brain MRI\", \"C\": \"CT scan\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the diagnostic approach for trigeminal neuralgia, including the role of imaging (MRI) often recommended to rule out secondary causes, which is part of the headache/facial pain workup.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q94",
    "question_text": "Triptans can be used in patients with which of the following conditions?",
    "options": "{\"A\": \"Coronary artery disease\", \"B\": \"Hemiplegic migraine\", \"C\": \"Peptic ulcer disease\", \"D\": \"Tension-type headache\"}",
    "correct_answer": "D",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge regarding the appropriate use and contraindications (specifically ruling out vascular risks and specific migraine subtypes) of triptans, a mainstay of migraine treatment.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q106",
    "question_text": "A patient has irritable bowel syndrome, is obese, and has migraine. What would you prescribe as a prophylactic agent?",
    "options": "{\"A\": \"Topiramate\", \"B\": \"Valproate\", \"C\": \"Amitriptyline\", \"D\": \"Propranolol\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on selecting an appropriate migraine prophylactic medication by considering patient comorbidities (obesity, IBS), a key aspect of personalized headache management.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q8",
    "question_text": "A boy presents with a headache that is more pronounced in the morning and is associated with nausea and vomiting. What should be done next?",
    "options": "{\"A\": \"CT brain\", \"B\": \"Prescribe analgesics and observe\", \"C\": \"Refer to psychiatry for anxiety evaluation\", \"D\": \"Start migraine prophylaxis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests recognition of headache red flags (morning worsening, vomiting) indicating the need for urgent neuroimaging to rule out serious underlying pathology, a fundamental concept in headache evaluation.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q1",
    "question_text": "A boy presents with headaches that are worse in the morning and associated with nausea and vomiting. What is the next step in management?",
    "options": "{\"A\": \"CT brain\", \"B\": \"Prescribe analgesics and observe\", \"C\": \"Refer to psychiatry for headache management\", \"D\": \"Start migraine prophylaxis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Identical to Q8, focuses on recognizing headache red flags requiring investigation.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q16",
    "question_text": "A patient with migraine underwent a brain MRI as a routine workup for chronic headache, which showed white matter lesions. What is the most appropriate action?",
    "options": "{\"A\": \"Reassurance\", \"B\": \"Immediate hospitalization\", \"C\": \"Start prophylactic migraine medication\", \"D\": \"Refer for neurosurgery\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with the clinical approach to managing incidental neuroimaging findings (white matter lesions) commonly seen in migraine patients, requiring interpretation within the context of the primary headache disorder.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q55",
    "question_text": "A male patient presents with lacinating pain lasting for seconds, and MRI shows SCA compression over the trigeminal nerve. What is the recommended treatment?",
    "options": "{\"A\": \"Decompressive surgery\", \"B\": \"Carbamazepine\", \"C\": \"Oxcarbazepine\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Presents a classic case of trigeminal neuralgia with identified vascular compression and asks for management options (both medical first-line and surgical).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q35",
    "question_text": "In the evaluation of a patient suspected of suffering from glossopharyngeal neuralgia, which of the following is important to inquire about?",
    "options": "{\"A\": \"Presence of trigger factors\", \"B\": \"Family history of headaches\", \"C\": \"Previous surgeries\", \"D\": \"Medication history\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on key diagnostic clinical features (trigger factors) specific to glossopharyngeal neuralgia.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q34",
    "question_text": "A patient experiences a visual aura for 10-20 minutes followed by a headache. What is the most likely diagnosis?",
    "options": "{\"A\": \"Tension-type headache\", \"B\": \"Cluster headache\", \"C\": \"Migraine\", \"D\": \"Hemicrania continua\"}",
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests the ability to diagnose migraine with aura based on the characteristic temporal sequence of aura followed by headache.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q72",
    "question_text": "A patient has a severe headache with typical migraine features and has had previous episodes during menstruation. What is the most likely diagnosis?",
    "options": "{\"A\": \"Migraine without aura\", \"B\": \"Menstrual migraine\", \"C\": \"Abdominal migraine\", \"D\": \"Tension-type headache\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on diagnosing a specific subtype of migraine (Menstrual Migraine) based on its clear temporal link to the menstrual cycle.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q111",
    "question_text": "Patient came with tongue pain and paresthesia, radiating to the neck, increased with neck movement. What is the diagnosis?",
    "options": "{\"A\": \"Tongue neck syndrome\", \"B\": \"Glossopharyngeal neuralgia\", \"C\": \"Trigeminal neuralgia\", \"D\": \"Cervical radiculopathy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the diagnosis of a specific craniofacial pain syndrome, distinguishing between two conditions often managed within headache/facial pain clinics.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q73",
    "question_text": "In a case with continuous headache and episodes of more intense headache, which treatment is indicated?",
    "options": "{\"A\": \"Indomethacin\", \"B\": \"Valproic acid\", \"C\": \"Lamictal\", \"D\": \"Naproxen\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the pharmacological treatment (specifically Indomethacin) for a headache pattern suggestive of an indomethacin-responsive headache syndrome (e.g., hemicrania continua).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q51",
    "question_text": "Which of the following neurotransmitters has a role in the pathogenesis of migraine headache?",
    "options": "{\"A\": \"Serotonin\", \"B\": \"Acetylcholine\", \"C\": \"Norepinephrine\", \"D\": \"Glutamate\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the fundamental pathophysiology of migraine, specifically the role of neurotransmitters like serotonin.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q15",
    "question_text": "A patient came for a third opinion, diagnosed with Cluster Headache and another trigeminal autonomic cephalgia. How can you distinguish between them?",
    "options": "{\"A\": \"Duration\", \"B\": \"Response to treatment\", \"C\": \"Laterality of pain\", \"D\": \"Presence of autonomic symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on differentiating between specific trigeminal autonomic cephalalgias (like Cluster Headache) based on diagnostic criteria (duration, treatment response).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q39",
    "question_text": "Which medication is considered safe for use in the 1st and 2nd trimester of pregnancy for treating migraine?",
    "options": "{\"A\": \"Acetaminophen\", \"B\": \"NSAID\", \"C\": \"Hydrocodone\", \"D\": \"Sumatriptan\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the specific clinical scenario of treating migraine safely during pregnancy.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q7",
    "question_text": "In a patient with occipital seizures and migraine with aura, which feature is in favor of a visual aura?",
    "options": "{\"A\": \"Circular coloring\", \"B\": \"Typical migraine headache\", \"C\": \"Scintillating\", \"D\": \"30s-1min in duration\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: The question asks to identify features that specifically support a diagnosis of migraine visual aura when differentiating it from occipital seizure visual phenomena, focusing on the characteristics of the headache-related symptom.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q94",
    "question_text": "A young lady post uneventful delivery by cesarean section came with a history of positional headache that worsens with standing and improves with lying on her back for more than 2 weeks. MRI of the brain was done (image attached). Which of the following is the next step in management?",
    "options": "{\"A\": \"Blood patch\", \"B\": \"Continue conservative management\", \"C\": \"Start corticosteroids\", \"D\": \"Perform lumbar puncture\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes classic post-dural puncture headache (a form of intracranial hypotension) and asks about management.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q53",
    "question_text": "What is the attack duration for SUNCT?",
    "options": "{\"A\": \"1 to 5 seconds\", \"B\": \"5 to 240 seconds\", \"C\": \"1 to 10 minutes\", \"D\": \"10 to 30 minutes\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the diagnostic criteria (attack duration) for a specific headache syndrome (SUNCT).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q93",
    "question_text": "A patient came with a history of severe unilateral headache lasting less than 5 minutes, stabbing in nature, associated with tearing and conjunctival injection. Which of the following is the best treatment for him?",
    "options": "{\"A\": \"Indomethacin\", \"B\": \"Lamotrigine\", \"C\": \"Carbamazepine\", \"D\": \"Topiramate\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes symptoms typical of short-lasting trigeminal autonomic cephalalgias (SUNCT/SUNA or Paroxysmal Hemicrania) and asks for appropriate treatment.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q62",
    "question_text": "According to the International Classification of Headache Disorders 3rd edition (ICHD-3), how many attacks are required for the diagnosis of short-lasting unilateral neuralgiform headache attacks?",
    "options": "{\"A\": \"At least 10 attacks\", \"B\": \"At least 15 attacks\", \"C\": \"At least 20 attacks\", \"D\": \"At least 25 attacks\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the diagnostic criteria (number of attacks) for a specific headache syndrome (SUNHA) per ICHD-3 guidelines.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q118",
    "question_text": "In a scenario of intracranial hypotension, which of the following is the most common MRI brain finding?",
    "options": "{\"A\": \"Leptomeningeal enhancement\", \"B\": \"Enlarged pituitary gland\", \"C\": \"Decreased venous sinus size\", \"D\": \"Decreased anterior-posterior diameter of the brainstem\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for characteristic imaging findings in a specific headache-related condition (intracranial hypotension).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q102",
    "question_text": "A patient with migraine headache has white matter changes that are not typical for multiple sclerosis lesions. What is the most appropriate management?",
    "options": "{\"A\": \"Reassurance\", \"B\": \"IV Methylprednisolone\", \"C\": \"Oral Steroid\", \"D\": \"Referral to a specialist\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the common clinical scenario of interpreting non-specific white matter changes in migraineurs and the appropriate management approach (often reassurance).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q86",
    "question_text": "Which of the following statements is true regarding medication overuse headache?",
    "options": "{\"A\": \"It is worse when waking up from sleep\", \"B\": \"It is mild in intensity\", \"C\": \"It shows normal MRI findings\", \"D\": \"It improves with continued use of the overused medication\"}",
    "correct_answer": "C",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge about the clinical characteristics and diagnostic features of Medication Overuse Headache (MOH).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q48",
    "question_text": "A patient presents with recurrent attacks of headache lasting 4 days, accompanied by ptosis and ophthalmoplegia. What is the most likely diagnosis?",
    "options": "{\"A\": \"Ophthalmoplegic migraine\", \"B\": \"Optic Neuritis\", \"C\": \"Brainstem Migraine\", \"D\": \"Cluster Headache\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires diagnosing a specific syndrome (recurrent painful ophthalmoplegic neuropathy, formerly Ophthalmoplegic Migraine) based on characteristic features (headache with ophthalmoplegia), which falls under headache/cranial neuralgia classifications.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q72",
    "question_text": "How does pediatric migraine compare to adult migraine?",
    "options": "{\"A\": \"Bilateral and shorter\", \"B\": \"Less vomiting\", \"C\": \"Less aura\", \"D\": \"More frequent attacks\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Compares the typical clinical features and presentation of migraine headaches in children versus adults, focusing on the headache disorder itself.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q116",
    "question_text": "In a scenario of nummular headache, what is the recommended treatment?",
    "options": "{\"A\": \"Gabapentin\", \"B\": \"Acetaminophen\", \"C\": \"Topiramate\", \"D\": \"Amitriptyline\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the appropriate pharmacological treatment for a specific, less common primary headache syndrome (nummular headache).",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q328",
    "question_text": "Which medication is absolutely contraindicated in pregnancy for the treatment of migraine?",
    "options": "{\"A\": \"Acetaminophen\", \"B\": \"NSAIDs\", \"C\": \"Opioids\", \"D\": \"Ergotamine\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the safe pharmacological management of migraine, specifically identifying a medication (Ergotamine) with absolute contraindication during pregnancy.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q285",
    "question_text": "What is the first-line treatment for migraine in pregnancy?",
    "options": "{\"A\": \"Acetaminophen\", \"B\": \"NSAIDs\", \"C\": \"Opioids\", \"D\": \"Triptans\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the specific management (first-line abortive therapy) of migraine during pregnancy.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q248",
    "question_text": "A young patient presents with trigeminal neuralgia. What is the next best step in management?",
    "options": "{\"A\": \"CT scan\", \"B\": \"Reassurance\", \"C\": \"MRI\", \"D\": \"Lumbar Puncture (LP)\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the initial diagnostic workup (requiring MRI) for trigeminal neuralgia, particularly in a young patient to rule out secondary causes. Trigeminal neuralgia is a common facial pain syndrome managed within headache/facial pain contexts.",
    "subspecialty": "Headache"
  },
  {
    "question_number": "Q513",
    "question_text": "A patient experiences unilateral severe periorbital headache with autonomic features lasting 10-15 minutes, occurring up to 10 times per day. What is the most appropriate treatment?",
    "options": "{\"A\": \"Verapamil\", \"B\": \"Indomethacin\", \"C\": \"Topiramate\", \"D\": \"Oxygen therapy\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes symptoms highly suggestive of a Trigeminal Autonomic Cephalalgia (likely SUNCT/SUNA or Paroxysmal Hemicrania given duration/frequency/options) and asks about treatment options relevant to these syndromes.",
    "subspecialty": "Headache"
  }
]